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Recent work suggests potentially promising relationships between sequence variation in 
Neuregulin-1 (NRG1) and both schizophrenia and neurocognitive function. Cognitive deficits 
are very common in schizophrenia and have been shown to be familial in nature. Based on these 
findings, we hypothesized that cognitive deficits may be related to variation in NRG1 in an age-
dependent manner during adolescence and adulthood, thus providing a possible mechanism by 
which NRG1 could act as a late neurodevelopmental susceptibility gene for schizophrenia. 
This question was examined using individuals from 39 multigenerational multiplex 
families, including 58 affected participants and 361 unaffected relatives aged 15-85 years. 
Participants were genotyped for 36 NRG1 single nucleotide polymorphisms (SNPs) previously 
associated with schizophrenia. Participants completed diagnostic interviews and a computerized 
neurocognitive battery that assessed eight cognitive domains. 
Pedigree-based variance component analyses were performed to estimate the main effects 
of age and individual SNPs, and the interactions between age and SNPs in predicting cognition 
for each domain. There were multiple nominally significant NRG1 x age interactions across 
several domains and markers, although few remained significant after modified Bonferroni 
correction. Overall, this study suggests a potential role of NRG1 x age interactions in cognitive 
performance within multiplex families with schizophrenia, especially within the domains of 
DEVELOPMENTAL GENETIC ASPECTS OF 
SCHIZOPHRENIA, NEUREGULIN-1, AND COGNITION 
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 v 
Emotional Processing, Abstraction/Mental Flexibility, Attention, and Sensorimotor Dexterity 
and the NRG1 markers SNP8NRG221132, SNP8NRG221533/rs35753505, rs776401, and 
rs1473438 that warrants further investigation.  
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PREFACE 
I would like to thank my committee members for all of their assistance and guidance throughout 
this project. 
1 
1.0 INTRODUCTION 
Schizophrenia is a psychotic disorder whose acute phases are characterized by positive 
symptoms, including hallucinations, delusions, and disorganized speech and behavior. In chronic 
phases, patients frequently experience negative symptoms, including affective flattening, 
avolition, and alogia. The course of the disorder is persistent for the majority of patients, with 
full remission to premorbid functioning being relatively uncommon. Clinical age of onset peaks 
in young adulthood for the majority of people who develop the disorder, with onset during 
childhood or after the age of 40 being relatively rare. Men and women are diagnosed equally; 
however, males’ age of onset peaks 5-10 years earlier than women’s. 
A major question regarding schizophrenia concerns these developmental aspects, in 
particular its age of onset. The literature is quite consistent, finding that the age of greatest risk of 
disorder onset is in the post-pubertal, late adolescent-young adulthood age range. Most work on 
these questions has evaluated early developmental hypotheses that posit that schizophrenia-
specific factors are present very early in life, possibly in utero, but that they are not expressed 
until later normative developmental processes occur and “release” them (Murray & Lewis, 1987; 
Pogue-Geile, 1991; Weinberger, 1987). Late developmental hypotheses, on the other hand, 
suggest that schizophrenia-specific neuronal changes reflecting genetic or environmental factors 
occur in adolescence or early adulthood, closer to the actual age of onset of the disorder 
(Feinberg, 1982a; Pogue-Geile, 1991). Both hypotheses emphasize the importance of such 
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possible late genetic effects on schizophrenia, but few studies have focused on these effects in 
the young adult period.  
The importance of genes in the etiology of schizophrenia is well accepted; however, 
relatively little is known about how schizophrenia susceptibility genes’ effects change through 
the lifespan to contribute to changes in brain function and clinical onset. Ideally, prospective 
longitudinal studies of gene expression in multiple brain regions could be done up to the onset of 
schizophrenia. Given that such a study would currently be impractical and unethically invasive, 
other avenues must be pursued. An alternate method would be to perform expression assays in 
post-mortem samples, but these analyses usually occur many decades after clinical onset. The 
limitations of ideal and other currently available study designs make it necessary to develop 
alternate methods to address the question of late developmental changes in schizophrenia’s 
genetic effects.  
Given these constraints, investigating changes in genetic effects during the peak age of 
onset of schizophrenia could employ individuals with elevated genetic liability to schizophrenia, 
such as relatives of patients with this disorder. In the absence of gene expression data from 
relevant brain regions, a characteristic or trait that is affected by the genetic liability to 
schizophrenia should be used. Neurocognitive functions are excellent candidate traits given their 
strong genetic correlations with schizophrenia. Although a prospective study of cognition among 
relatives of schizophrenia patients before, during, and after the peak age of onset would be ideal, 
cross-sectional measurements among a relative sample that has a broad age range is more 
economical. Finally, a gene that is associated with schizophrenia and known to have strong 
developmental effects should be used in such an analysis.  
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The current study employed a multigenerational, multiplex family sample, which 
theoretically increases the frequency of schizophrenia risk alleles. The participants were assessed 
for cognitive function, an endophenotype of schizophrenia that is strongly familially related to 
the disorder, and the age range of relatives was broad and included the peak age of onset of 
schizophrenia. We investigated variants of the gene neuregulin-1 (NRG1), which has been 
associated with schizophrenia and has both developmental and cognitive effects. Evaluating the 
relationships between NRG1 and cognition in the relatives of individuals with schizophrenia 
from a developmental perspective aims to address questions of how particular gene variants may 
contribute to liability to the disorder through their impact on cognition in an age-dependent 
manner, with a specific focus on the period that is the peak of age of onset for the disorder. Each 
of these study components will be discussed in greater detail below. 
1.1 DEVELOPMENT & SCHIZOPHRENIA 
1.1.1 Age of Onset in Schizophrenia 
Although there are difficulties in determining the onset of schizophrenia and significant 
differences in how this event is defined between studies (e.g., age of first hospitalization, age of 
psychotic disorder diagnosis, age of first positive psychotic symptom, age of first symptom of 
mental illness), most studies report different age of onset patterns between males and females, 
despite a relatively equal prevalence for both sexes (Pogue-Geile, 1997). Appearance of first 
psychotic symptom peaks at 20-24 years of age for males with risk generally decreasing with 
age, while the major peak for females is at 20-24 years of age with a second risk period in the 
peri-menopausal period (Pogue-Geile, 1997; Rajji, Ismail, & Mulsant, 2009). The median age of 
first diagnosed psychotic episode is earlier for males than females, however, with males’ onset 
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being typically between the ages of 18 and 25, and females’ being between 20 and 30 years of 
age (American Psychiatric Association, 2000). The age of first hospitalization closely follows 
this pattern (Pogue-Geile, 1997). The presence of a non-uniform, non-linear pattern of onset 
suggests that this disorder is likely related to important developmental factors during the post-
pubertal, young adult age range. Such factors may be related to changes in gene expression, 
environmental exposures, or a combination of gene-environment elements that result in an overt 
change in functioning and/or symptom presence (Pogue-Geile, 1997).  
1.1.2 Early Developmental Models 
The ways in which genetic and/or environmental changes that occur throughout development 
may lead to schizophrenia are currently unknown, but two main developmental models have 
been proposed. The early developmental model hypothesizes that schizophrenia-specific changes 
in gene expression or environmental insults occur early but do not result in overt abnormality 
until later in life when the schizophrenia-causing abnormality is released by a nonspecific factor 
during the course of otherwise normal development (Murray & Lewis, 1987; Pogue-Geile, 1991; 
Weinberger, 1987). In other words, the maturation of brain systems associated with adolescence 
and adulthood release abnormalities that have been present as early as conception in patients who 
go on to develop this disorder. 
Much of the initial support for this hypothesis comes from studies that have assessed pre- 
and perinatal developmental factors in this disorder. Retrospective studies of patients with 
schizophrenia have found multiple differences between children who go onto develop the 
disorder compared to those that do not. Specific impairments included reduced premorbid IQ, as 
well as problems with cognition and language, social and emotional development, and motor 
performance (Murray et al., 2004; Tarbox & Pogue-Geile, 2008). In addition, a significant subset 
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of patients with schizophrenia has minor physical abnormalities that suggest anomalies in very 
early development, despite causing little or no functional problems (Compton & Walker, 2009). 
Such features include abnormalities in craniofacial traits, eyes and ears, hands and feet, and torso 
(Compton & Walker, 2009). There is also evidence of abnormal cerebral dominance that may be 
related to a significantly higher proportion of left-handed patients compared to healthy control 
samples (Murray & Lewis, 1987).  
Many studies have also shown a significant increase of obstetric complications in patients 
with schizophrenia. Specifically, meta-analyses of studies that assessed prenatal complications or 
infection, abnormal growth and development of the fetus during pregnancy, and problems during 
labor and delivery estimated that the odds ratio of developing schizophrenia after exposure to 
obstetric complications is 2.0 (Rapoport, Addington, Frangou, & Psych, 2005).  
Despite the evidence for the early developmental model, it cannot exclude the causal role 
of genetic and environmental insults that occur after birth and does not explain a significant 
percentage of patients who do not have physical abnormalities or other birth-related risk factors. 
In addition, although such early developmental problems are more common in patients with 
schizophrenia, they are generally non-specific. For example, hypoxia increases the risk of 
numerous negative outcomes other than schizophrenia, including epilepsy, cerebral palsy, and 
infant mortality. It is not known how such non-specific events may lead to schizophrenia at 
different neurodevelopmental phases (Schmidt-Kastner, van Os, Steinbusch, & Schmitz, 2006), 
which is a weakness of the early developmental models. 
1.1.3 Late Developmental Models 
In contrast, late developmental hypotheses suggest that abnormalities in maturational processes 
lead to psychosis, preceding the development of overt symptoms by a much shorter time period 
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(Pogue-Geile, 1991). As mentioned, many studies suggest that there are premorbid indicators for 
a subset of patients with schizophrenia that suggest a neurodevelopmental abnormality early in 
life; however, there is also a significant subset of patients with schizophrenia whose premorbid 
functioning is average or above average (Feinberg, 1982a, 1982b). In addition, there are no early 
risk factors or lesions that are specific to schizophrenia or found in all patients, suggesting that 
late genetic and environmental factors may influence the development of this disorder.  
One potential biological mechanism that may support the late developmental models is 
the pattern of synaptic pruning that occurs in healthy compared to schizophrenia groups. The 
density of synaptic connections between neurons peaks at approximately age 2, with a significant 
decline in synaptic density beginning at this time and continuing until late adolescence. This 
decline is followed by a relatively constant level of synaptic density until late life (Huttenlocher, 
1979). Studies have found rather consistent evidence of extreme synaptic pruning in patients 
with schizophrenia compared to healthy individuals, suggesting that an abnormality in this 
process may result in conversion to psychosis (MacDonald & Chafee, 2006; Saugstad, 1989). 
Importantly, this excessive synaptic loss is present in adolescence, suggesting that it is not 
secondary to medication effects or the chronic nature of the disorder (Bennett, 2008). Moreover, 
the eliminated synapses are mostly glutamatergic in nature, which is interesting in light of the 
hypothesis that glutamatergic systems are disrupted in schizophrenia. 
In addition to a loss of synapses during adolescence, there is a corresponding loss of 
dendritic spines that normally occurs during this time, without a corresponding loss in overall 
neurons. Spines are located on the dendrites of most major neuron types in the brain, including 
those found in the cortex, striatum, and cerebellum. They typically receive excitatory input, as 
they generally express glutamatergic receptors, including both N-methyl-D-aspartic acid 
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(NMDA) and α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor types. 
Just as patients with schizophrenia seem to have increased synaptic loss, they also have 
excessive spine loss, particularly in the dorsolateral prefrontal cortex (DLPFC) (Bennett, 2008). 
Recent neuroimaging studies provide evidence that this loss also occurs during adolescence and 
is not secondary to the effects of the disorder or its treatment (Bennett, 2008). The 
neuropathological observation that patients have increased pruning of synapses and loss of 
dendritic spines during early adolescence makes the hypothesis that schizophrenia is a disorder 
related to such changes very appealing (Jaaro-Peled et al., 2009). 
It may also be that late acting genes are triggered by environmental stressors during 
young adulthood. One environmental factor that may increase the risk of schizophrenia is the 
experience of trauma during the typical risk period. Studies estimate that 50-60% of the general 
population has been exposed to trauma, while traumatic exposure is significantly increased 
among patients with schizophrenia, in the range of 75-98% of cases (Lysaker, Outcalt, & Ringer, 
2010). Importantly, this range includes studies of trauma experienced before and/or after the 
onset of the disorder. In a study that assessed the rate of significant life events in the month 
preceding the onset of the disorder, it was found that 46% of the patient sample had experienced 
at least one of these events (Brown & Birley, 1968). These data suggest that exposure to trauma 
or stressful life events may play a role in timing the onset of the disorder, in addition to a large 
literature that suggests that stress can exacerbate symptoms of the disorder after it has developed. 
Although trauma and stressful life events are non-specific, stress hormones impact the normal 
structural remodeling of the brain and can lead to dendritic atrophy, reduced neurogenesis, and 
potentially, synaptic loss in the prefrontal cortex (PFC) and hippocampal regions (McEwen, 
2010; Radley & Morrison, 2005). Given the ongoing maturation of the PFC, it is not surprising 
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that this period of time is also thought to be one in which the brain is particularly vulnerable to 
environmental stresses, such as stress related to negative life events (Harris et al., 2009). Such 
effects may be due to the effects of late gene-environment interactions, in which environmental 
factors influence the phenotype of interest differently depending on genetic background of the 
individual. 
In summary, both the early and late developmental hypotheses highlight the importance 
of genetic and environmental risk factors, as well as changes during the late adolescent-young 
adulthood period. There appears to be some support for both hypotheses and intermediate models 
are also plausible. 
1.2 SCHIZOPHRENIA & COGNITION 
Although there is significant symptom heterogeneity among patients, one relatively common 
problem in schizophrenia is cognitive dysfunction. Cognitive deficits are not unique to this 
disorder and are seen in other psychiatric and neurological disorders; however, the patterns of 
deficits in schizophrenia are somewhat distinct from other illnesses (Buchanan et al., 2005). 
Overall, patients have measurable deficits in nearly every cognitive domain compared to healthy 
individuals, but there is evidence that attention, memory, and executive function are more 
significantly impaired than verbal and visuospatial abilities (Buchanan et al., 2005; Goldberg & 
Green, 2002). The cognitive impairment seen in schizophrenia is so common and impacts patient 
functioning to such a great extent that some have suggested that it is one of the core impairments 
in this disorder (Murray et al., 2004). 
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1.2.1 Cognition as an Endophenotype 
In addition to being considered a core feature of schizophrenia, cognitive deficits have also been 
shown to be state independent, that is, they are present in both the acute and chronic phases of 
the illness (Heydebrand, 2006). Such deficits are also heritable, with similar deficits being 
commonly detected in individuals at high-risk for developing the disorder and the unaffected 
biological relatives of patients (Simon et al., 2007; Snitz, MacDonald, & Carter, 2006; 
Thompson, Watson, Steinhauer, Goldstein, & Pogue-Geile, 2005). Although generally less 
impaired than patients, the unaffected relatives of patients typically demonstrate small-medium 
impairments in performance across a wide range of cognitive tasks and abilities (Snitz et al., 
2006), with the largest deficits seen on tasks that require attention and working memory, 
memory, and executive functioning abilities (Snitz et al., 2006). Such dysfunctions are found 
regardless of relative type (e.g., parent, sibling, or child of a patient with schizophrenia) or 
presence of schizotypal features in relatives. This suggests that cognitive deficits may be an 
endophenotype of schizophrenia (Goldberg & Green, 2002). Endophenotypes are traits that can 
be useful in identifying genetic factors that increase the risk of a disorder (Braff, Freedman, 
Schork, & Gottesman, 2007; Braff, Schork, & Gottesman, 2007; Gottesman & Gould, 2003).  
In assessing the relationship between cognition and schizophrenia, genetic correlations 
(Rg) are typically used to estimate the proportion of variance that is shared between two traits 
due to common genetic effects. In other words, this measure reflects pleiotropic effects in which 
genes influence both schizophrenia risk and different domains of cognitive function (Hare et al., 
Unpublished data). A recent study (Toulopoulou et al., 2007) found significant genetic 
correlations between schizophrenia and Wechsler Adult Intelligence Scale estimates among a 
sample of monozygotic and dizygotic twins who were concordant or discordant for 
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schizophrenia and a sample of healthy control individuals. The full scale intelligence quotient, 
verbal comprehension, perceptual organization, and working memory genetic correlations were 
all significant and ranged from -0.34 to -0.79. Processing speed was not significant in this 
sample.  
In the only other known study of genetic correlations between schizophrenia and 
cognition, Hare et al. (unpublished data) found that abstraction/mental flexibility, attention, 
language, spatial processing, facial memory, and emotion processing were all significantly 
different from zero, with genetic correlations ranging from -0.34 to -0.56 in a multigenerational, 
multiplex family sample of schizophrenia. Spatial and verbal memory domains were not 
significant in this sample. 
1.2.1.1 Heritability of Neurocognitive Function. A large literature has consistently shown 
that most cognitive domains have some genetic basis. A number of studies have documented 
heritability estimates for multiple cognitive areas in families with one or more members with 
schizophrenia (Glahn et al., 2007; Greenwood et al., 2007; Husted, Lim, Chow, Greenwood, & 
Bassett, 2009; Toulopoulou et al., 2007; Tuulio-Henriksson et al., 2002; Yokley et al., 2012), 
with the most commonly assessed domains being: intelligence; attention and working memory; 
emotional processing; memory; executive functioning; processing speed; sensorimotor dexterity; 
and spatial processing. Of studies that included affected individuals in their heritability estimates, 
the majority found significant genetic effects for individual tasks, with heritability in the range of 
0.09-0.77 across all tasks and domains. Here, intelligence showed the highest heritability across 
two studies (Husted et al., 2009; Toulopoulou et al., 2007), in the range of 0.70-0.74, while at 
least one task in the processing speed, executive function, and attention/working memory 
domains had very high heritability, in the range of 0.74-0.78 (Glahn et al., 2007; Husted et al., 
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2009). Only one known study (Glahn et al., 2007) has estimated heritability in schizophrenia 
families where the affected member was excluded from the estimate, finding that most tasks 
have significant genetic effects in the range of 0.00-0.79 across all tasks and domains. Here, 
processing speed, attention/working memory, and verbal memory all had at least one task 
showing very high heritability, in the range of 0.75-0.79 (Glahn et al., 2007).  
Together, the findings regarding cognitive dysfunction as an endophenotype of 
schizophrenia, the heritability of cognition, and genetic correlations between schizophrenia and 
cognition provide strong evidence that neurocognitive function is a good measure of 
schizophrenia’s genetic effects, especially in the domains of attention/working memory, 
executive function, and memory. 
1.3 COGNITIVE DEVELOPMENT THROUGH THE LIFESPAN 
Overall, ability in all areas of cognition increases from birth until young adulthood. The order of 
structural brain development mimics the pattern of increasing brain activation that is believed to 
underlie improvements in complex cognitive functions. Postnatal brain development occurs in a 
precise order, beginning with the sensorimotor regions and progressing throughout the brain 
ending with the DLPFC. Subcortical structure development is relatively complete by late 
childhood, while cortical development continues into early adulthood, thus full brain 
development is not completed until mid-adulthood (Craik & Bialystok, 2006).  
Brain structure and function are impacted by the onset of puberty in humans, and animal 
studies provide evidence that hormone changes related to pubertal onset further develop the 
brain, leading to plasticity and reorganization (Blakemore, Burnett, & Dahl, 2010). The human 
PFC also continues to mature during this period, including the aforementioned synaptic pruning, 
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loss of grey matter, and generally linear increase in white matter volume related to continued 
myelination. Although not much evidence is available about the relationship that puberty itself 
has with cognitive function in humans (Blakemore et al., 2010; Luna & Sweeney, 2001), 
longitudinal studies show significant improvements from early to late adolescence (Crown, 
1993), likely related to the continued brain maturation (Luna & Sweeney, 2001). Executive 
function improvements (including planning, reasoning, verbal fluency, and flexible problem 
solving) are especially noteworthy in this developmental period (Luna & Sweeney, 2001).  
Overall, the brain is refined during adolescence through processes of synaptic pruning 
and continued myelination (Luna & Sweeney, 2001). The temporal relationship between 
continued maturation of brain systems in adolescence and the typical age of onset of 
schizophrenia adds further support to late developmental hypotheses, as abnormalities in this 
stage of life may lead to variability in complex cognitive functioning and schizophrenia onset 
(Feinberg, 1982a; Luna & Sweeney, 2001).  
In midlife, general knowledge does not decline, but retrieval of stored information is 
reduced, leading some abilities to be maintained, while others decline (Lachman, 2004). 
Crystallized intelligence, or experience-related tacit knowledge, increases through the lifespan 
and is maintained; however, fluid intelligence, or logical reasoning and problem-solving, 
declines in the mid-20s and after (Craik & Bialystok, 2006). Such changes in cognition are likely 
related to the pattern of further maturation and decline of the brain. The frontal cortex is the last 
to fully mature, yet it is also the first to be impaired by the aging process (Craik & Bialystok, 
2006), thus although cognitive function increases significantly early in life, it plateaus and/or 
begins to decline near the time of highest risk of schizophrenia. Overall, the development and 
decline of complex cognitive functions are associated with dynamic processes across the 
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lifespan. The consistent findings regarding the time of highest risk for schizophrenia and 
continued cognitive and brain maturation makes the late adolescent-early adulthood stage an 
interesting period in which to assess these relationships.  
1.4 OVERVIEW OF SCHIZOPHRENIA GENETICS 
Although studies have identified potentially important non-shared environmental contributions to 
the risk of developing schizophrenia, studies of families, twins, and adoptees have consistently 
estimated high heritability (h
2
) for the disorder, in the range of 0.80-0.85. These findings suggest 
that genetic variation is the most important factor overall (Cardno & Gottesman, 2000; Sullivan, 
Kendler, & Neale, 2003). Despite strong genetic features, the genetic risk for schizophrenia is 
believed to be transmitted in a complex, polygenic manner (Gottesman & Shields, 1967), which 
has been confirmed by recent linkage and association studies that have implicated over 130 
potential susceptibility genes in the pathogenesis of the disorder, each with small effect sizes and 
inconsistent replication attempts (Carter, 2006).  
1.5 NEUREGULIN-1 & SCHIZOPHRENIA 
1.5.1 NRG1 Genetic Associations with Schizophrenia 
As mentioned, the genetic effects on schizophrenia are well accepted, but studies have generally 
found small effect sizes for individual variants and have been plagued by inconsistent replication 
attempts. Two recent meta-analyses reassessed inconsistencies among the more than 20 genome-
wide linkage studies of this disorder, with chromosomal regions 8p and 22q being the only loci 
identified by both studies (Badner & Gershon, 2002; Lewis et al., 2003). Similar inconsistencies 
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are found among association studies of schizophrenia, with NRG1, dysbindin (DTNBP1), 
regulator of G-protein signaling 4 (RGS4), and metabotropic glutamate receptor 3 (GRM3) being 
among the most commonly replicated genes (see Harrison & Weinberger, 2005 for a review). On 
the other hand, recently completed genome-wide linkage (Holmans et al., 2009) and association 
(Purcell et al., 2009; Ripke et al., 2012; Shi et al., 2009; Stefansson et al., 2009) studies have not 
found significant results for NRG1. 
NRG1 was originally identified as a candidate gene for schizophrenia by a fine mapping 
linkage study of Icelandic multiplex families with the disorder (Stefansson et al., 2002) after 
previous studies had identified the 8p region as potentially possessing schizophrenia-related 
genes (Pulver et al., 1995). Over 60 replication attempts of this association between 
schizophrenia and NRG1 have been conducted using different designs and different ethnic and 
geographical samples, with more than half finding evidence of an association (Allen et al., 2008). 
Overall, estimates of relative risk lie between 1.0 and 2.2 for individual NRG1 variants and 
haplotypes (Tosato, Dazzan, & Collier, 2005).  
The combination of findings from genetic linkage and association studies suggest that the 
8p chromosomal region may harbor a schizophrenia risk gene, and that NRG1 may be this 
susceptibility gene. The known biological functions of NRG1 overlap with a number of the 
dysfunctions believed to be a part of the pathogenesis of the disorder, making this gene both a 
positional and functional candidate for schizophrenia (Harrison & Law, 2006).  
1.5.2 NRG1’s Structure & Function 
Positionally, NRG1 lies at 8p22-p11, encompassing 1.3 million bases and including at least 21 
alternatively spliced exons (Steinthorsdottir et al., 2004), although only 0.3% of the gene codes 
for protein (Scolnick, Petryshen, & Sklar, 2006). NRG1 encodes 15-20 proteins from the 
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transcription of 6 promoters with significant alternative splicing (Law et al., 2006; Talmage, 
2008). In total, there are six known splicing isoforms, but much is still being learned about their 
distributions in the human nervous system and their developmental expression patterns. 
This gene is highly polymorphic, with nearly 350 SNPs required to “tag” the gene. Most 
variants associated with schizophrenia are noncoding, and are instead intronic or upstream of the 
transcription site. Thus, NRG1 variants associated with the disorder may impact disorder risk by 
their regulatory roles, such as impacting the stability of the mRNA and/or through alternative 
splicing (Law et al., 2006; Mei & Xiong, 2008).  
Functionally, NRG1 is a ligand for the ErbB receptor family, which are receptor tyrosine 
kinases (Scolnick et al., 2006; Wolpowitz et al., 2000). NRG1 is generally released from the 
presynaptic cell and binds to and modifies postsynaptic ErbB receptors. NRG1 has multiple roles 
in the development and organization of the human nervous system, as well as roles in its 
continued function throughout life, through its relationship with this receptor system. It acts as a 
pleiotropic growth factor (D. Li, Collier, & He, 2006) with more than 12 known functions. The 
multiple isoforms of NRG1 produce the wide diversity in this gene’s functions over the lifespan 
via the formation of different proteins (Law, Shannon Weickert, Hyde, Kleinman, & Harrison, 
2004; Rapoport et al., 2005).  
Many of the processes that NRG1 is involved in are thought to be altered in 
schizophrenia, either by direct or indirect means, leading to multiple possibilities by which 
NRG1 may be involved in the pathogenesis of this disorder (Corfas, Roy, & Buxbaum, 2004). Of 
particular interest in the current study are the functions of NRG1 that also have important 
developmental implications, including control of neuronal migration and differentiation, 
synaptogenesis and modulation of synaptic transmission, hormonal control of puberty, regulation 
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of NMDA receptors (NMDAR), and the modulation of long-term potentiation (LTP) (Harrison 
& Law, 2006; Jaaro-Peled et al., 2009). 
1.5.2.1 Neuronal Migration & Differentiation. NRG1 has multiple roles in pre- and 
perinatal development. Specifically, it aids in the processes of radial and tangential migration 
and axon guidance in the cortex by stimulating neurite outgrowth and radial glia cell growth 
(Jaaro-Peled et al., 2009; Mei & Xiong, 2008). In addition, it promotes myelination via its roles 
in oligodendrocyte differentiation and development (Jaaro-Peled et al., 2009; Mei & Xiong, 
2008).  
When compared to control groups, patients with schizophrenia have consistently been 
found to have decreased brain volume and enlarged ventricles (R. E. Gur et al., 2000; Honea, 
Crow, Passingham, & Mackay, 2005), significant differences in neuronal density and migration 
(Sei et al., 2007; Weinberger & Marenco, 2003), and reduced oligodendrocyte levels and 
subsequent disturbances in myelination (Corfas et al., 2004), suggesting a possible role for 
NRG1 in these atypically occurring processes. 
1.5.2.2 Synaptogenesis & Modulation of Synaptic Transmission. A recent study (Fazzari 
et al., 2010) found that NRG1-ErbB4 signaling promotes both inhibitory and excitatory 
synaptogenesis in animals. NRG1’s role in the synapse also extends beyond synaptogenesis to 
synaptic maintenance and maturation. Increased NRG1, and resultant over-expression of ErbB4, 
selectively increases AMPA receptor synaptic currents (Bennett, 2008; B. Li, Woo, Mei, & 
Malinow, 2007); dendritic spine size, development, and maturation (Barros et al., 2009); and 
dendritic arborization (Krivosheya et al., 2008). Prevention of NRG1-ErbB4 signaling has been 
shown to result in the opposite effects.  
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Overall, NRG1 may impact the formation, maturation, and/or stability of synapses in 
important brain regions directly (Fischbach 2007), as aberrant synaptic connections seen in 
schizophrenia may be due to problems with dendritic arborization, activity-dependent dendritic 
spine plasticity, myelination, and/or pruning (Jaaro-Peled et al., 2009). Although it is not known 
how altered expression of NRG1 results in schizophrenia symptoms, it is possible that abnormal 
expression of NRG1 and subsequent changes in synapse formation, maturation, stability, and 
transmission (Fischbach, 2007; Krivosheya et al., 2008) could play a part in the disorder’s 
pathogenesis.  
1.5.2.3 Hormonal Control of Puberty. NRG1-ErbB signaling has also been shown to play 
an important part in the neuroendocrine regulation of puberty and hormone production and 
release in animal studies. Specifically, transgenic mice expressing a dominant-negative form of 
ErbB4 receptors in hypothalamic astrocytes show delayed pubertal onset and reduced fertility 
due to abnormally low release of luteinizing hormone-releasing hormone, one of the 
neuropeptides that regulates sexual development (Prevot et al., 2003). The release of this 
hormone generally initiates puberty, thus NRG1 signaling problems may lead to abnormal 
initiation and regulation of hormone levels, which may increase schizophrenia risk due to 
disruption of neurodevelopmental processes (Corfas et al., 2004), and is particularly interesting 
in light of the typical post-pubertal onset patterns of this disorder. 
1.5.2.4 Regulation of NMDAR and Modulation of LTP. Although the focus of much of 
the research on the pathophysiology of schizophrenia has been on dopamine receptors, the role 
of other neurotransmitters cannot be ignored. NRG1 is known to regulate both the expression 
and plasticity of multiple neurotransmitter receptor systems, including NMDAR and others 
(Corfas et al., 2004; Hashimoto et al., 2004; MacDonald & Chafee, 2006), that are thought to be 
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altered in schizophrenia. Of particular interest in this study is that NRG1 is believed to play a 
role in the maturation of NMDAR, which are tetrameric and composed of multiple subunit types, 
including NR1, NR2A-NR2D, and NR3A-NR3B (Kristiansen, Huerta, Beneyto, & Meador-
Woodruff, 2007; Meador-Woodruff & Kleinman, 2002). NRG1 is believed to promote the 
maturation of this receptor system via its roles in regulating receptor subunit composition. 
Specifically, NRG1 facilitates a change from receptor structures that are primarily comprised of 
NR2B receptor subunits to those with a higher proportion of NR2C subunits. This is interesting 
because glutamate-dopamine connections are known to mature during puberty in multiple brain 
regions, including the PFC. This maturation is believed to be triggered by the levels of dopamine 
receptors as well as the mature composition of NMDAR that are reached at this developmental 
stage.  
 The maturational process of NMDAR may also be related to psychosis in that some (but 
not all) studies (Farber, 2003; Olney & Farber, 1995a, 1995b) have shown that the administration 
of NMDAR antagonists induces psychosis and reversible morphological changes to neurons in 
the animal retrosplenial cortex in a selective manner—only causing such changes in animals that 
are in or have passed through puberty at the time of drug administration. Consistent with these 
animal findings is that pre-pubertal humans rarely develop psychotic symptoms after 
administration of NMDA antagonists used for anesthetic purposes, such ketamine, while adults 
commonly do (Farber, 2003). This further suggests that these circuits are not activated until the 
post-pubertal developmental stage and may be related to NMDAR subunit composition. 
In the adult brain, NRG1-ErbB4 signaling is believed to modulate plasticity (Jaaro-Peled 
et al., 2009). Upon NRG1 binding with ErbB4, ErbB4 becomes hyperphosphorylated, which is 
believed to lead to hypophosphorylation of activated NMDAR via the shared connections ErbB 
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and NMDA receptors have with postsynaptic density 95 (PSD95). PSD95 is an electron-dense 
area on the tip of dendritic spines and is where most glutamatergic receptors are localized. 
Increased NRG1 release has been found to result in sustained increases in the intensity of ErbB4-
PSD95 interactions and results in increased ErbB4 expression on dendritic spines (Bennett, 2008, 
2009; B. Li et al., 2007). Thus, increased NRG1-ErbB4 signaling may result in a prolonged state 
of NMDAR hypofunction, as has been found in the PFC of patients with schizophrenia (Hahn et 
al., 2006) and is thought to be related to changes in expression of NRG1, rather than a specific 
mutation or polymorphism (Fischbach, 2006; Gu, Jiang, Fu, Ip, & Yan, 2005).  
In addition, LTP is one of the mechanisms that is believed to underlie neuronal plasticity 
and is currently the main experimental model of learning and memory. NMDAR-dependent LTP 
involves the strengthening of connections between cells that leads to long-term improvements in 
synaptic efficacy through changes to pre- and postsynaptic cells (Lau & Zukin, 2007). Although 
the way in which NRG1 controls LTP is unknown, current evidence suggests that both low and 
high levels of NRG1-ErbB4 signaling impair synaptic plasticity and the induction and 
maintenance of LTP (Mei & Xiong, 2008). In their recent review, Mei and Xiong (2008) suggest 
that this phenomenon may be due to basal NRG1 signaling activity, ErbB4 receptor levels, and 
neuron activity that all combine to drive NRG1 expression. Further, they suggest that the NRG1-
ErbB4 signaling effects lie downstream of the NMDAR. Evidence from recent studies supports 
the idea that NRG1 prevents LTP and depotentiates this process in the hippocampus by 
promoting AMPA receptor internalization; however, this effect is not seen in other brain regions, 
including the PFC (Buonanno, 2010). Thus, the impact of NRG1-ErbB4 signaling on plasticity 
likely varies by brain region, and abnormally high expression of NRG1 may result in cognitive 
dysfunction like that seen in schizophrenia.  
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1.5.3 NRG1 Expression Patterns 
Although there have been promising linkage and association findings from studies of molecular 
genetics in schizophrenia, these polymorphisms are not necessarily related to protein structure, 
function, or specific model of pathogenesis. This may suggest that the expression of these genes, 
especially those with neurodevelopmental roles, needs to be better understood. With the 
exception of somatic mutations that are acquired over the lifespan, DNA sequence does not 
change; however, the level that individual genes are expressed, that is, the amount of functional 
protein or RNA product produced by the gene, does vary over the lifespan, with different 
patterns for different genes and tissues.  
1.5.3.1 NRG1 Expression & Age in the Healthy Brain. Animal studies have found a wide 
distribution of NRG1 expression throughout the brain and nervous system during embryonic 
development, with a more selective expression pattern with aging (Addington et al., 2007). In the 
human brain, NRG1 mRNA expression is highest during prenatal and early postnatal 
development and then significantly decreases to a near stable level with continued aging, 
suggesting that NRG1 has a continual presence and function in the adult brain, including 
schizophrenia-related regions (Buonanno, 2010; Pankonin, Sohi, Kamholz, & Loeb, 2009). 
As previously mentioned, there are multiple splicing isoforms: three major (Types I-III) 
and three minor isoform families (Types IV-VI), with promoter use and splicing patterns being 
related to developmental stage, tissue, and cell type (Talmage, 2008). Although different NRG1 
isoforms are believed to play different roles in neurodevelopment, not much is known about 
whether specific NRG1 isoforms impact schizophrenia risk more than others (Hashimoto et al., 
2004). Decreased overall NRG1 expression has been shown to be related to a significant 
reduction in the number of functional NMDAR in animals (Esper, Pankonin, & Loeb, 2006); 
 21 
however, it is thought that increased expression, specifically of Types I or IV, would lead to a 
decrease in NMDAR signaling and thus a hypofunctional state (Law et al., 2006). 
 In a recent study in which NRG1 mRNA and protein were localized in the healthy adult 
human brain, widespread expression was found in multiple regions and cell types thought to be 
involved in the pathogenesis of schizophrenia (Law et al., 2004). Specifically, NRG1 mRNA 
was detected in the DLPFC, cingulate cortex, thalamus, amygdala, hippocampal formation, 
cerebellum, and multiple brainstem nuclei in pyramidal neurons, some interneurons, Purkinje, 
and Golgi cells. NRG1 protein was detected in the hippocampal formation, DLPFC, brainstem 
nuclei, and cerebellum in pyramidal, Purkinje, and white matter cells.  
 In a recent study of age-related NRG1 expression in Brodmann Area 10 of healthy human 
PFC, Colantuoni et al. (2008) found that there is a significant reduction of NRG1 expression at 
the end of the schizophrenia risk period. Specifically, expression significantly decreased in early 
adulthood (ages 18-30) followed by a mostly constant expression pattern throughout late 
adulthood (ages 31-67). There were no significant differences between sexes, as may have been 
hypothesized (Colantuoni et al., 2008).  
A more recent study (Harris et al., 2009) assessed type I and IV NRG1 expression in the 
human PFC (Brodmann area 46) of healthy individuals aged 0-49, finding a similar pattern. 
Specifically, NRG1 expression was highest at birth and decreased significantly until the mid-
20’s, at which point it became largely constant over the rest of the lifespan. Importantly, Harris 
et al. (2009) point out that this gene is “minimally expressed” during the late adolescent period in 
healthy humans. The findings from Colantuoni et al. (2008) and Harris et al. (2009) suggest that, 
in addition to its role in early brain development, NRG1 expression is also important in the 
maturation of the brain, particularly the PFC, via a changing expression pattern.  
 22 
At this time, the distribution of individual NRG1 proteins is largely unknown (Buonanno, 
2010); however, type I isoform is expressed at high levels during the early phases of 
development and is believed to be a factor underlying neuronal plasticity due to its activity-
dependent regulation and involvement with NMDAR regulation and expression (Hashimoto et 
al., 2004). In fact, LTP has been found to increase type I expression in multiple brain regions 
(Hashimoto et al., 2004). Type II is expressed in the adult human central nervous system (CNS), 
while type III is mostly related to sensory and motor neuron function, and both have some role in 
development and plasticity (Hashimoto et al., 2004). 
Overall, studies have consistently suggested that NRG1 is expressed throughout the 
lifespan, with the highest expression levels seen during childhood and early adolescence, and a 
dramatic reduction in expression near the peak age of onset for schizophrenia. This temporal 
relationship makes investigating the role that NRG1 variants play in cognition across the lifespan 
particularly interesting. 
1.5.3.2 NRG1 Expression in Schizophrenia Patients. A recent study of post-mortem gene 
expression in normal control individuals and schizophrenia patients by Torkamani et al. (2010) 
found that the genetic pattern that distinguished the two participant groups was at the level of 
gene expression. Specifically, previous studies have shown that genes related to 
neurodevelopment are naturally down-regulated with age, most significantly between birth and 
the early-mid twenties (Torkamani, Dean, Schork, & Thomas, 2010). Torkamani et al. (2010) 
found that the age-related decreases in the expression of multiple genes seen in normal controls 
were not present in the schizophrenia sample, suggesting that there is not the normal age-related 
expression decrease of these genes, which may trigger the onset of overt symptoms and 
functional changes. Although this study did not assess NRG1, studies have found that NRG1 
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expression is not uniform across the lifespan, such that the expression slope (rate of change) is 
associated with age, similar to other neurodevelopmental genes. 
There are no studies that assess NRG1 expression over the lifespan in patients with 
schizophrenia, to our knowledge; however, several cross-sectional studies have found differences 
between patient and control groups. One study (Zhang et al., 2008) found that the total level of 
NRG1 mRNA expression in peripheral blood lymphocytes was significantly lower in 
unmedicated patients compared to their unaffected siblings and healthy control individuals, and 
that this level increased in the patient group with the introduction of antipsychotic medication. 
Another study that assessed peripheral blood lymphocytes found increased expression of the type 
III isoform β3 in patients compared to their healthy siblings (Petryshen et al., 2005).  
Altered NRG1 expression has also been found in the CNS tissue of patients with 
schizophrenia when compared to healthy samples. Specifically, three studies found increased 
expression of NRG1. Type I NRG1 mRNA was found to be upregulated in the DLPFC 
(Hashimoto et al., 2004) and hippocampus of patients (Law et al., 2006), while levels of NRG1-
intracellular domain protein were found to be increased in the PFC of patients (Chong et al., 
2008). One study found that an element of NRG1 expression was decreased in patients: 
expression of NRG1 type I, which is only expressed by white matter interstitial neurons and 
some GABAergic cortical interneurons, was reduced in patients with schizophrenia compared to 
healthy individuals (Bertram et al., 2007). Another study (Boer, Berk, & Dean, 2009) found no 
association between NRG1 type I protein expression in Brodmann’s area 46 within the PFC 
and schizophrenia when compared to healthy controls.  
When isoform ratios were considered, Hashimoto et al. (2004) found decreased type II 
NRG1 expression relative to types I and III, while Law et al. (2006) found that types II and III 
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were not altered, but there was a relative increase of type I to types II-IV. Type I-III isoform 
levels have also been positively correlated with participant age in normal controls, but not in 
schizophrenia patients (Hashimoto 2004), while type I expression was significantly positively 
correlated with antipsychotic medication dosage in patients (Tabares-Seisdedos & Rubenstein, 
2009).  
Taken together, the results of expression studies in schizophrenia patients suggest that 
there are alterations of NRG1 expression in multiple brain regions and blood components, but 
that these patterns likely vary significantly by brain region and isoform assessed. Overall, most 
studies found an increased pattern of expression in patients compared to healthy samples, 
congruent with the idea that neurodevelopmental gene expression may not appropriately down-
regulate in patients with the disorder. 
1.5.4 NRG1 & Neurocognitive Functioning 
Six previous studies assessing specific NRG1 gene variants and cognition in humans have found 
mixed results. One NRG1 variant used in studies of cognition has been SNP8NRG221533 
(renamed: rs35753505). In healthy participants rs35753505 was found to have no association 
with working memory performance (Krug et al., 2008), but was associated with semantic verbal 
fluency (Kircher et al., 2009) and sustained attention (Stefanis et al., 2007). The same single 
nucleotide polymorphism (SNP) was also tested in patients with schizophrenia, finding 
significant effects on blood flow in several brain regions, but not task performance (Kircher et 
al., 2008).  
A second NRG1 variant studied in the context of cognition is SNP8NRG243177 
(renamed: rs6994992). This SNP was associated with premorbid IQ and fronto-temporal 
activation in patients (Hall et al., 2006), as well as verbal IQ and brain activation in verbal 
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fluency tasks in participants at high-risk for developing the disorder (Hall et al., 2006), although 
non-significant findings between rs6994992 and premorbid IQ in patients have also been 
reported (Crowley et al., 2008). A third study found that rs6994992 was moderately associated 
with spatial working memory in a general population sample (Stefanis et al., 2007). 
Microsatellite 433E1006 has also been tested for association with cognition in a study of Greek 
male military conscripts, finding that it was modestly associated with sustained attention and 
verbal working memory (Stefanis et al., 2007). 
Overall, there is evidence that NRG1 is associated with cognitive function in healthy, at 
risk, and schizophrenia samples. The exact nature of this relationship or how it may change 
across the lifespan, however, is not understood. 
1.6 AIMS & HYPOTHESES 
Given its potential roles in lifespan development, cognition, and schizophrenia, we hypothesize 
that NRG1 gene variants may contribute to liability to the disorder through their impact on 
cognition in an age-dependent manner. This is the first study of its kind, to our knowledge, as 
previous studies have relied on postmortem non-schizophrenia samples and lacked antemortem 
cognitive assessment. 
 The specific questions this study aims to address are: 
1) Is cognition genetically correlated with schizophrenia in this multiplex family 
sample? Significant genetic correlation is a prerequisite for performing the proposed 
analyses. We hypothesize that there will be significant genetic correlations between 
schizophrenia and most cognitive domains, indicating joint genetic effects on these 
traits.  
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2) Is cognition heritable in this multiplex family sample? Trait heritability is a 
prerequisite for performing genetic analyses and we hypothesize that there will be 
significant heritability for most domains.  
3) Is cognitive functioning associated with age in this sample, and if so, how? We 
hypothesize that there will be a significant relationship between age and cognitive 
function for all domains. Special attention will be paid to cognitive functions that 
show changes in schizophrenia’s peak age of onset range.  
4) What is the relationship between NRG1 SNPs and cognition in the present sample? 
Although it is not necessary to have significant main effects in order to have 
significant interaction effects, it is important to know whether those main effects exist 
when interpreting the impact of the interactions, as these associations would suggest 
that NRG1’s mechanism of increasing risk for schizophrenia may be due, in part, to 
its relationship to cognition. We hypothesize that there will be multiple significant 
relationships between NRG1 variants and most cognitive domains.  
5) Most importantly, are there significant interactions between NRG1 SNPs and age in 
predicting cognitive function in multiple domains? We hypothesize that there will be 
significant interactions and that there will be larger effects of NRG1 variants on 
cognition during the peak age of onset time period (ages 18-30) than for other ages. If 
there are not significant interactions, however, this would suggest that NRG1’s 
effects are generally consistent across different ages and that differential effects at age 
of onset are rather minimal.  
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2.0  METHODS 
2.1  PARTICIPANTS 
2.1.1  Recruitment and Inclusion Criteria 
Probands and their family members were identified by the University of Pittsburgh (PITT) 
and/or the University of Pennsylvania (PENN) through mental health and consumer 
organizations in Pennsylvania, New Jersey, Delaware, Ohio, West Virginia, Kentucky, 
Michigan, and Indiana. Probands were included if they had a diagnosis of schizophrenia, were of 
European-American origin, 18 years or older, and competent to provide informed consent. In 
addition, they also had to have one or more first degree relatives with a diagnosis of 
schizophrenia or schizoaffective disorder-depressed type, and have a large, multigenerational 
family with ten or more first and second degree relatives. Probands were excluded if they did not 
provide consent to contact their family members, their IQ was lower than 70, they were not 
proficient in English, and/or their diagnosis was complicated by the effects of substance use, 
prescription medications, or medical conditions.  
Relatives had to be 15 years or older and willing to provide signed consent. Exclusion 
criteria for this group included: IQ < 70, not being proficient in English, and/or a CNS disorder 
that would interfere with the interpretation of cognitive measures.  
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Control participants were recruited from the same areas as patients and relatives and were 
included if they met the inclusion/exclusion criteria during a standardized screening. Attempts 
were made to group match potential control participants to index family members on age, sex, 
and ethnic background. Recruitment at the PITT site was done through random digit dialing in 
the area codes where probands and family members were recruited. After the study was 
described to potential participants, a telephone screen was used to exclude those with psychosis 
or cognitive disorders. All participants who passed the telephone screen and matching criteria 
were consented and enrolled in the study.  
Recruitment for PENN controls was done through advertisements and word of mouth. A 
screening interview was used to detect psychotic and cognitive disorders. In addition, a second 
group of PENN controls was included whose data had been gathered prior to the current study. 
These controls were administered the same interview as the other PENN control participants to 
screen for psychopathology and completed the same study procedures. For both sites, control 
participants were excluded if they had any Axis I disorder with psychotic features or a cluster A 
personality disorder, if they were taking psychotropic medications, or had a first degree relative 
with psychosis. They also had to be medically and neurologically healthy.  
Written informed consent was obtained after the study procedures had been fully 
explained in accordance with the Institutional Review Boards of PITT, PENN, and the Texas 
Biomedical Research Institute. For participants younger than the age of 18, the participant’s 
assent and parents’ consents were obtained.  
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2.2   PROCEDURES 
2.2.1  Diagnostic Assessment 
Clinical evaluation included the Diagnostic Interview for Genetic Studies, version 2.0 (DIGS) 
(Nurnberger et al., 1994), the Family Interview for Genetic Studies (FIGS) (Maxwell, 1992), and 
a review of medical records. Assessment was conducted by trained interviewers with established 
reliability under the supervision of investigators; however, interviewers were not blind to the 
status (proband, relative, control) of the individuals participating in the study. To further ensure 
reliability, investigators who had not evaluated the individual reviewed each case independently 
and provided DSM-IV multiaxial lifetime diagnoses, with differences being resolved by 
consensus. In addition, complex cases were discussed between sites. At each site, interrater 
reliability among investigators and interviewers was tested at regular intervals using videotaped 
interviews and bimonthly joint interviews. Each team of interviewers reviewed 10 videotaped 
DIGS evaluations from the other site. Kappa values for exchanged tapes were maintained at or 
above 0.8. Finally, the two teams met twice a year for further diagnostic and reliability training. 
In place of the DIGS, 109 control participants from the PENN site were administered a 
diagnostic checklist to make diagnoses and rule-out schizophrenia-spectrum disorders.  
2.2.2  Neurocognitive Measures 
Participants were administered a computerized neurocognitive battery previously tested in both 
healthy and patient samples (R. C. Gur, Ragland, Moberg, Bilker et al., 2001; R. C. Gur, 
Ragland, Moberg, Turner et al., 2001). The battery took approximately 60 minutes to complete 
and was administered by research assistants using desktop or laptop computers. The tests 
included training modules and had automated scoring to ensure reliability of results. Tests were 
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administered in a fixed order. Raw scores were converted to z-scores using the mean and 
standard deviation (SD) from the control group used in the present study. Z-scores for domains 
with more than one test (Emotional Processing) or with two conditions (Attention: letter and 
number) were calculated by converting the raw scores for both tasks to z-scores using the 
method described above and then averaging the standard scores. Domain scores for tasks with 
immediate and delayed conditions (Verbal, Facial, and Spatial Memory) were calculated by 
averaging the performance on both conditions and then converting the raw average to a z-score.  
Three performance indices were calculated: accuracy (number of correct responses), 
speed (median reaction time for correct responses), and efficiency (ratio of accuracy to the log of 
speed). Efficiency was analyzed in the current study because it is a single score that incorporates 
both accuracy and speed to provide an index of correct responses per unit of time that reflects 
general ideas of good performance (i.e., for a given level of accuracy, quicker responses are 
better and for a given level of speed, more accurate responses are better). In addition, using the 
combined efficiency index also reduces the number of statistical comparisons relative to 
analyzing both accuracy and speed separately.  
The battery assessed the following domains (as previously reported in R.E. Gur et al., 
2007): 
2.2.2.1 Abstraction/Mental Flexibility.  The Penn Conditional Exclusion Test (Kurtz, 
Ragland, Moberg, & Gur, 2004) presents four objects at a time, and the participant selects the 
object that does not belong with the other three based on one of three sorting principles. Sorting 
principles change and feedback guides their identification (time: 12 minutes).  
2.2.2.2 Attention. The Penn Continuous Performance Test (Kurtz, Ragland, Bilker, Gur, 
& Gur, 2001) uses a continuous performance test paradigm where the participant responds to 
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seven-segment displays whenever they form a digit or letter, depending on the condition. 
Working memory demands are eliminated because the stimulus is present (time: 8 minutes).  
2.2.2.3 Spatial Processing. Judgment of Line Orientation (Benton, Varney, & Hamsher, 
1975) is a computer adaptation of Benton’s test. Participants see two lines at an angle and 
indicate the corresponding lines on a simultaneously presented array (time: 6 minutes).  
2.2.2.4 Emotion Processing. Identification of facial affect was tested with two 40-item 
tasks. During the Penn Emotion Recognition Task, participants labeled faces as being happy, 
sad, angry, fearful, or neutral. During the second task, the Emotion Intensity Discrimination Test 
(R. E. Gur et al., 2006), each stimulus was comprised of two faces of the same individual 
showing the same emotion (happy or sad) with different intensities. The participant selects the 
more intense expression. Sets were balanced for gender, age, and ethnicity (5 minutes).  
2.2.2.5 Verbal Memory. The Penn Word Memory Test (R. C. Gur et al., 1993) presents 
20 target words followed by an immediate recognition trial with targets interspersed with 20 
distractors equated for frequency, length, concreteness, and low imageability using Paivio’s 
norms. Delayed recognition is measured at 20 minutes (time: 4 minutes).  
2.2.2.6 Facial Memory. The Penn Face Memory Test (R. C. Gur et al., 1993) presents 20 
digitized faces subsequently intermixed with 20 foils equated for age, gender, and ethnicity. 
Participants indicate whether or not they recognize each face immediately and after a 20 minute 
delay (time: 4 minutes).  
2.2.2.7 Spatial Memory. The Visual Object Learning Test (Glahn, Gur, Ragland, Censits, 
& Gur, 1997) presents 20 Euclidean shapes subsequently interspersed with foils immediately and 
after a 20 minute delay (time: 4 minutes).  
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2.2.2.8 Sensorimotor Dexterity. The participant uses a mouse to click on squares 
appearing at varied locations on the screen (R. C. Gur, Ragland, Moberg, Turner et al., 2001). 
The stimuli become progressively smaller (time: 2 minutes).  
2.2.2.9 Quality Control. To help ensure the validity of the cognitive data, participants 
with missing data on 10 or more measures (i.e., the accuracy, speed, and efficiency variables of 
the 8 cognitive tests) in the battery were excluded from the sample prior to this study.  
2.2.2.10 Estimation of IQ. All participants were administered the reading subtest of the 
Wide Range Achievement Test-III (WRAT) as an estimate of intelligence. This measure is 
commonly used to estimate crystallized verbal intelligence and is relatively robust to the effects 
of most psychiatric symptoms and brain injury. Raw scores were age-standardized based on 
published manual norms. 
2.2.3  Selection of SNPs and Primer Design 
The SNP set for the current study is based on a previously designed primer. The primer 
incorporated SNPs that were positively associated with schizophrenia by at least one study, near 
microsatellite haplotype blocks previously associated with schizophrenia (e.g. HapICE, HapIRE, 
etc.), and those that are exonic. This SNP pool was submitted to Applied Biosystems, Inc. (ABI) 
SNPlex Genotyping System 48-plex Assay Design and Ordering System (accessed 07/2007) in 
order to create the primer. The design system checked for a non-competitive reaction, deleterious 
pooling, and small pooling within the proposed primer set. This design cleared the algorithm as 
being able to function appropriately within one primer pool. All SNPs have a minor allele 
frequency of at least 5% in European American populations according to Ensembl (release 43), 
dbSNP (build 127), and HapMap (release 21a). 
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Nineteen of the 36 SNPs previously incorporated into this primer have been chosen as the 
“target” SNPs for the current study. These SNPs were chosen based on their previous positive 
associations with schizophrenia reported in the literature (N=15), a history of consistent positive 
associations with cognition within the current participant pool (N=2), or both (N=2). The 
remaining 17 SNPs are “non-target” SNPs, as they do not meet any of the above criteria. SNP 
information and a line diagram of the gene with the SNP set are shown in Table 1 and Figure 1.  
 
Marker Position Type Category
Major 
Allele
Minor 
Allele
Minor Allele 
Frequency HWE (p)
SNP Failure 
(%) 
SNP8NRG221132* 31,473,740 Upstream Target G A 0.1112 0.2860 0 (0.00%)
SNP8NRG221533/rs35753505 31,474,141 Upstream Target T C 0.3300 0.5655 3 (0.83%)
rs4298458 31,484,870 Upstream Target G C 0.4230 0.3518 0 (0.00%)
SNP8NRG241930* 31,494,334 Intron Target G T 0.3391 0.8434 4 (1.11%)
rs1081062 31,500,264 Intron Target T C 0.2637 0.7076 1 (0.28%)
rs4566990 31,573,695 Intron Non-target G A 0.3649 0.2224 0 (0.00%)
rs1354335 31,640,979 Intron Non-target C G 0.1695 0.2893 8 (2.22%)
rs1354336 31,644,871 Intron Non-target T C 0.2508 0.3228 5 (1.39%)
rs1354334 31,680,070 Intron Non-target G T 0.3841 0.6355 0 (0.00%)
SNP8NRG444511/rs13268724 31,698,396 Intron Target T A 0.1730 0.1840 0 (0.00%)
rs776401 31,716,962 Intron Target T C 0.3677 0.7222 2 (0.55%)
rs1473438 31,733,759 Intron Non-target A G 0.3675 0.7583 2 (0.55%)
rs1462893 31,831,015 Intron Non-target C G 0.2141 0.4446 1 (0.28%)
rs10954821 31,898,990 Intron Non-target G A 0.3084 0.7686 0 (0.00%)
rs726908 32,058,628 Intron Non-target A G 0.4809 0.4549 3 (0.83%)
rs10954855 32,382,236 Intron Target T A 0.2510 0.5524 0 (0.00%)
rs2439306 32,425,591 Intron Non-target G A 0.2201 0.3435 19 (5.26%)
rs2466062 32,443,090 Intron Non-target A G 0.2809 0.2068 1 (0.28%)
rs3924999 32,453,358 Exon (Arg to Gln change) Target C T 0.3808 0.4807 1 (0.28%)
rs2466060 32,475,691 Intron Target G A 0.4842 0.5194 39 (10.80%)
rs2439272 32,493,092 Intron Target C T 0.4268 0.5262 1 (0.28%)
rs6468121 32,500,809 Intron Non-target G T 0.4598 0.3310 4 (1.11%)
rs2466058 32,507,149 Intron Target G A 0.0893 0.6600 0 (0.00%)
rs2466049 32,514,916 Intron Target C T 0.0799 0.5201 2 (0.55%)
rs723811 32,527,281 Intron Non-target T C 0.0929 0.4824 0 (0.00%)
rs6988339 32,545,916 Intron Target A G 0.4233 0.9869 0 (0.00%)
rs2975498 32,552,189 Intron Target A G 0.1843 0.1476 0 (0.00%)
rs2919382 32,560,765 Intron Target T C 0.1692 0.0329 0 (0.00%)
rs2976525 32,572,983 Intron Target A C 0.0884 0.8648 0 (0.00%)
rs4262285 32,582,701 Intron Target C T 0.0410 0.4502 0 (0.00%)
rs3735776 32,585,434 Intron Non-target C A 0.1568 0.8928 47 (13.02%)
rs4512342 32,607,874 Intron Non-target T G 0.1024 0.8893 1 (0.28%)
rs10503929 32,613,983 Exon (Met to Thr change) Target T C 0.1779 0.4907 0 (0.00%)
rs6992642 32,624,387 Dow nstream Non-target T C 0.4059 0.6583 12 (3.32%)
rs3735781 32,624,828 Dow nstream Non-target A G 0.4185 0.4703 2 (0.55%)
rs3735782 32,624,857 Dow nstream Non-target C A 0.4773 0.4553 1 (0.28%)
Note.  *Position estimated as these deCODE SNPs do not have dbSNP ID.
Table 1. Characteristics of individual SNPs included in the current study
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Position Marker
Figure 1. Line diagram of NRG1 w ith current SNP set marker locations
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2.2.4  Genotyping Methods 
Blood was collected in ethylenediamine tetraacetic acid (EDTA) tubes and frozen until 
bulk DNA extraction was performed. At that time, blood was thawed in a 47C water bath and 
DNA was extracted according to the phenol-chloroform method. Quantification of DNA was 
then completed using the Invitrogen Quant-iT PicoGreen method (Chadwick et al., 1996). After 
extraction and quantification, samples were transferred to 96-well plates to begin ABI’s SNPlex 
Genotyping method (SNPlex 3130xl, data collection v3). This system allowed simultaneous 
genotyping of up to 48 SNPs per well of DNA.  
2.2.4.1 Quality Control Procedures: Individual Analysis of DNA Samples. After the 
SNPlex procedure, data were uploaded into GeneMapper 4.0 software to assess the quality of 
results. Each DNA sample was assessed separately for low peaks, failure of the size standard, 
and failure of the sample as a means of detecting procedural error and poor quality DNA 
samples. In addition, all participant samples with a peak intensity of less than 100Rfu were 
excluded on a SNP-by-SNP basis, as this generally suggests that the sample’s peak at the given 
SNP was not high enough to genotype accurately. Any problem samples identified using the 
above methods were rerun using the procedures outlined above. Samples that failed both 
genotyping stages, failed on 10 or more individual SNPs, or had any Mendelian Errors, as 
assessed by PedCheck (O'Connell & Weeks, 1998), were excluded from analysis prior to this 
study.  
2.2.4.2 Quality Control Procedures: SNP-wise Analysis. After the analysis of individual 
DNA samples was complete, cluster analysis was used to determine genotyping outliers at the 
level of each individual SNP. These outliers were suggestive of either poor DNA quality or 
competition between primers at annealing sites during the reaction. Five SNPs (rs3735776, 
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rs726908, rs3735781, rs2919382, and SNP8NRG241930) could not be clustered by 
GeneMapper, but were clustered independently by three of the investigators (JLY, KP, and 
MET) and results were checked for fidelity. Every SNP was in Hardy-Weinberg Equilibrium, 
except rs2919382 (p=0.0329; as calculated by SOLAR), with between 0% and 13.02% 
genotyping failure per SNP (mean failure = 1.22%, SD = 2.85). The LD patterns of the final SNP 
set, as measured by rho in SOLAR, can be seen in Figure 2. As expected, most of the SNPs were 
in very low LD with each other. 
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2.2.5 Statistical Analysis 
Genetic analyses were performed using the Sequential Oligogenic Linkage Analysis Routines 
(SOLAR) program. SOLAR is a maximum likelihood variance component analytic program 
designed for multigenerational pedigrees of variable size and complexity (Almasy & Blangero, 
1998). However, SOLAR does not have any graphing capabilities, necessitating the use of SPSS 
for graphing, as well as for descriptive statistical procedures and some inferential analyses. In 
addition, the P-values Adjusted for Correlated Tests (pACT) (Conneely & Boehnke, 2007) 
program, as implemented in the statistical program R, was used for multiple comparison 
correction. The specific program used for each analysis is noted below. 
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3.0  RESULTS 
3.1 COMPOSITION OF THE SAMPLE 
In total, there were 675 pedigree members and 230 normal controls enrolled in the overall study. 
A total of 603 pedigree members and 218 controls completed the diagnostic portion of the study, 
and 568 pedigree members and 199 controls also completed the cognitive battery (<10 missing 
test scores). Five hundred fifty-three of these pedigree members provided DNA. Of these, 419 
pedigree members were successfully genotyped for NRG1 and also completed the diagnostic and 
cognitive portions of the study (meeting quality control indices for genotyping and cognitive 
assessment), thus forming the final sample for this study. No controls were genotyped, thus the 
final sample of controls included those who were enrolled and completed the diagnostic and 
cognitive portions of the study (N=199), without regard NRG1 genotyping. 
Within the 419 individuals, 58 were affected and 361 were unaffected participants drawn 
from 39 multiplex, multigenerational families. For the purposes of this study, “affected” 
members are those who were diagnosed with schizophrenia or schizoaffective disorder-depressed 
type, while “unaffected” participants were defined as those diagnosed with any psychopathology 
other than schizophrenia or schizoaffective disorder-depressed type, including those with no 
diagnosis. As shown in Table 2, family size (counting only individuals included in the current 
study) ranged from one to 37 members (average members per family = 9.26, SD=1.39).  
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As shown in Table 3, there were 58 first-degree relatives of the index proband, 86 second-degree 
relatives, 95 third-degree relatives, 90 biological relatives extended past the third-degree, and 32 
non-biological relatives (e.g., spouses) within the final sample.  
N % Male Age
Age 
range
Participant 
Education
Participant 
Education 
range WRAT
% Right 
handed % Pitt Site
Affected Individuals 58 67.24 43.94 (9.37) 22-60 12.45 (2.73) 7-20 89.60 (17.07) 91.38 41.38
Unaffected Relatives 361 47.65 44.92 (17.42) 15-85 13.33 (2.89) 6-20 100.83 (13.25) 85.04 43.77
First-degree relatives 58 41.38 48.76 (16.80) 15-83 12.88 (3.07) 7-20 100.02 (12.04) 82.76 48.28
Parents of proband 16 37.50 65.00 (10.86) 49-83 11.56 (2.94) 7-18 98.25 (12.66) 75.00 62.50
Sibling of proband 33 42.42 48.42 (9.77) 18-68 13.58 (3.01) 9-20 99.24 (12.47) 84.85 36.36
Child of proband 9 44.44 21.11 (4.37) 15-27 12.67 (3.00) 9-17 105.22 (8.97) 88.89 66.67
Second-degree relatives 86 55.81 47.55 (21.05) 15-85 12.84 (2.94) 6-20 101.32 (14.25) 80.23 43.02
Grandparent of proband 3 66.67 71.00 (1.00) 70-72 12.67 (3.51) 9-16 108.67 (9.07) 100.00 100.00
Aunt/Uncle of proband 42 57.14 64.69 (11.03) 42-85 12.50 (2.79) 8-18 101.79 (11.13) 78.57 40.48
Half-sibling of proband 2 100.00 32.00 (1.41) 31-33 11.00 (1.41) 10-12 91.50 (7.78) 100.00 50.00
Niece/Nephew  of proband 39 51.28 28.08 (9.47) 15-56 13.31 (3.11) 6-20 100.84 (17.04) 79.49 41.03
Third-degree relatives 95 48.42 44.97 (12.55) 18-74 13.88 (2.91) 9-20 101.71 (11.48) 84.21 56.84
1st Cousin of proband 95 48.42 44.97 (12.55) 18-74 13.88 (2.91) 9-20 101.71 (11.48) 84.21 56.84
Extended relatives 90 44.44 35.90 (16.33) 16-81 13.24 (2.61) 8-19 99.82 (14.44) 90.00 42.22
Non-biological relatives 32 43.75 56.13 (11.56) 26-78 14.06 (2.81) 10-20 101.33 (14.63) 90.63 3.13
Controls 199 42.71 47.24 (19.06) 18-84 15.03 (2.76) 8-20 108.34 (8.40) 87.94 44.20
Note.  Means and standard deviations are presented, unless otherw ise labelled. Affected: schizophrenia or schizoaffective-depressed 
type, Unaffected: any diagnosis other than affected diagnoses (including those w ith no diagnosis), WRAT: Wide Range Achievement 
Test (age-standardized value), Pitt: University of Pittsburgh site
Table 3. Demographics and genetic relationships in the study sample
Table 2. Frequency distribution of family size (included members) in the sample
Included 
Members in 
Count of 
Families
1 5
2 3
3 4
4 2
5 2
6 2
7 5
8 1
9 3
10 1
11 1
12 1
13 1
17 1
19 1
20 1
23 2
24 1
29 1
37 1
Mean 9.256
Standard Deviation 1.393
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As seen in Figure 3, the unaffected relative sample had a wide age range, with participants as 
young as 15 and as old as 85.  
 
 
Figure 3. Frequency distribution of age in the unaffected relative sample. 
 
The clinical composition of the sample is shown in Table 4. Affected individuals were 
diagnosed with schizophrenia (94.8%) or schizoaffective disorder-depressed type (5.2%). In 
addition, 32.8% of the affected sample had a comorbid diagnosis of a substance-related disorder, 
and 10.3% had a comorbid non-psychotic mood disorder that was not major depressive disorder 
(including mood disorders due to substance use or general medical conditions, and mood 
disorder NOS).  
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Schizophrenia
Schizoaffective 
disorder, 
Depressed
Schizoaffective 
disorder, Bipolar Bipolar I & II
Other 
Psychosis
Cluster A 
Personality 
Disorder
MDD w ith 
Psychotic 
Features MDD
Other Mood 
Disorder
Substance-
related 
Disorder
Affected Individuals 55 3 0 0 0 0 0 0 6 19
Unaffected Relatives 0 0 2 5 9 18 2 70 37 82
First-degree relatives 0 0 0 0 4 2 0 15 5 14
Parents of proband 0 0 0 0 1 1 0 5 1 3
Sibling of proband 0 0 0 0 3 1 0 10 3 8
Child of proband 0 0 0 0 0 0 0 0 1 3
Second-degree relatives 0 0 1 2 1 7 1 15 4 20
Grandparent of proband 0 0 0 0 0 1 0 0 0 1
Aunt/Uncle of proband 0 0 1 1 1 4 0 4 1 10
Half-sibling of proband 0 0 0 0 0 0 0 1 0 1
Niece/Nephew  of proband 0 0 0 1 0 2 1 10 3 8
Third-degree relatives 0 0 1 2 2 2 0 14 12 21
1st Cousin of proband 0 0 1 2 2 2 0 14 12 21
Extended relatives 0 0 0 0 1 6 0 20 15 20
Non-biological relatives 0 0 0 1 1 1 1 6 1 7
Controls 0 0 0 0 0 0 0 24 4 16
Note.  The follow ing categories are mutually exclusive:  schizophrenia, schizoaffective disorder-depressed, schizoaffective disorder-bipolar, Bipolar I & II, and MDD (major depressive 
disorder) w ith and w ithout psychotic features. Non-mutually exclusive diagnoses (e.g., other psychosis, cluster A personality disorder, other mood disorder, and substance-related 
disorder) may be comorbid w ith each other and/or mutually exclusive conditions.
Table 4. Clinical composition of the study sample by genetic relationship
 
 
As shown in Table 5, unaffected relatives were further classified into three hierarchical 
mutually exclusive groups: spectrum, other psychopathology, and no diagnosis. The “spectrum” 
group consisted of 36 individuals diagnosed with disorders believed to fall in the “schizophrenia 
spectrum,” including schizoaffective disorder-bipolar type (5.6%), bipolar disorder I and II 
(13.9%), major depressive disorder (MDD) with psychotic features (5.6%), other organic or 
nonorganic psychosis (25.0%), and cluster A personality disorder (50.0%). Some individuals in 
this group also met criteria for comorbid non-psychotic MDD or other mood disorder (22.2%) 
and substance disorders (44.4%).  
 
Schizoaffective 
disorder, Bipolar Bipolar I & II
Other 
Psychosis
Cluster A 
Personality 
Disorder
MDD w ith 
Psychotic 
Features MDD
Other Mood 
Disorder
Substance-
related 
Disorder
Spectrum 2 5 9 18 2 3 5 16
Other Psychopathology 0 0 0 0 0 67 32 66
No diagnosis 0 0 0 0 0 0 0 0
Note.  The follow ing categories are mutually exclusive:  schizoaffective disorder-bipolar, Bipolar I & II, and MDD (major depressive disorder) w ith and 
w ithout psychotic features. Non-mutually exclusive diagnoses (e.g., other psychosis, cluster A personality disorder, other mood disorder, and substance-
related disorder) may be comorbid w ith each other and/or mutually exclusive conditions. Spectrum: schizoaffective disorder-bipolar type, bipolar disorder I 
& II, MDD w ith psychotic features, other organic or nonorganic psychosis, and cluster A personality disorder; Other Psychopathology: individuals w ith 
psychopathology falling into any non-spectrum diagnosis; No Diagnosis: individuals w ith no diagnosable psychopathology on any clinical measure.
Table 5. Clinical composition of the unaffected relative sample by diagnostic category
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Individuals who did not meet criteria for schizophrenia-spectrum diagnoses were grouped 
into either the other psychopathology group or the no diagnosis group. The “other 
psychopathology” group consisted of 147 individuals diagnosed with MDD and other mood 
disorders (67.3%) and substance disorders (44.9%). Those individuals with no diagnosis on the 
clinical evaluations were grouped into the “no diagnosis” group (N=178). Demographic 
information for all diagnostic groups is provided in Table 6. 
 
N % Male Age Age range Education
Education 
range WRAT
% Right 
handed
% Pitt 
Site
First-degree 
relatives
Second-
degree 
relatives
Third-
degree 
relatives
Extended 
biological 
relatives
Non-
biological 
relatives
Spectrum 36 69.44 47.75 (16.25) 20-83 13.28 (2.91) 8-20 99.57 (16.02) 91.67 13.89 6 12 7 7 4
Other Psychopathology 147 51.02 42.87 (15.82) 16-82 13.21 (2.89) 6-20 98.62 (12.67) 85.03 48.30 25 25 40 46 11
No Diagnosis 178 40.44 46.04 (18.67) 15-85 13.44 (2.89) 8-20 103.05 (12.80) 83.71 46.07 27 49 48 37 17
Note.  Means and standard deviations are presented, unless otherw ise labelled. Spectrum: schizoaffective disorder-bipolar type, bipolar disorder I & II, MDD w ith psychotic 
features, other organic or nonorganic psychosis, and cluster A personality disorder; Other Psychopathology: individuals w ith psychopathology falling into any non-spectrum 
diagnosis; No Diagnosis: individuals w ith no diagnosis on any clinical measure; WRAT: Wide Range Achievement Test (age-standardized value); Pitt: University of Pittsburgh site
Table 6. Demographic and pedigree information for the unaffected relative sample by diagnostic category
 
 
Among the 199 controls, 19.6% were diagnosed with some type of psychopathology on 
the clinical measures (non-psychotic MDD or another mood disorder: 14.1%; substance-related 
disorder: 8.0%), while 70.4% had no diagnosis. No participant in any group met criteria for a 
cognitive disorder. 
3.2  DEMOGRAPHIC COMPARISONS 
Pairwise demographic comparisons between the affected, unaffected, and normal control 
samples showed multiple significant differences, as seen in Table 7. Comparisons between the 
affected and control samples revealed that there were significantly more females, higher levels of 
education, and higher WRAT scores in the control group, with no group difference in participant 
age. The same pattern of findings was found when comparing affected and unaffected relatives 
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on these variables. Comparisons between unaffected relatives and controls found that controls 
had significantly higher education and WRAT scores, but that there were no differences between 
these groups on age or sex. 
 
Statistic (df) p-value Statistic (df) p-value Statistic (df) p-value
Sex 10.82 (1) 0.001 7.68 (1) 0.006 1.26 (1) 0.262
Age -1.80 (195.43) 0.074 -0.42 (417) 0.678 -1.42 (378.26) 0.157
Education -5.91 (255) 0.000000 -2.18 (417) 0.030 -6.16 (558) 0.000000
WRAT -7.84 (69.62) 0.000000 -4.74 (67.73) 0.00001 -7.09 (315.73) 0.000000
Affecteds vs. Unaffected 
Relatives
Unaffected Relatives vs. 
ControlsAffecteds vs. Controls
Note. Chi-square statistics are reported for sex comparisons, w hile t-tests are reported for age, education, 
and WRAT. WRAT: Wide Range Achievement Test (age-standardized value), df: degrees of freedom. 
Signif icant (p<0.05) values are bolded. Variable coding: group (1: affected, 2: unaffected, 3: controls), sex (1: 
male, 2: female). See text for a description of the direction of effects.
Table 7. Demographic comparisons betw een groups in the study sample
 
When the unaffected relative sample was broken down into spectrum, other 
psychopathology, and no diagnosis groups, few significant demographic differences were found, 
as seen in Table 8. Comparisons between spectrum and no diagnosis groups found no significant 
differences in age, education, or WRAT score, but the spectrum group had significantly more 
males than the no diagnosis group. This same pattern was found when comparing spectrum 
individuals with the other psychopathology group. Comparisons between the other 
psychopathology and no diagnosis groups found no differences in sex, age, or education; 
however, the no diagnosis group had significantly higher WRAT scores than the other 
psychopathology group. 
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3.3  NEUROCOGNITIVE PERFORMANCE 
3.3.1 Missing Data Rates and Outlier Analysis 
Averaging over all of the tests in the computerized neurocognitive battery, the rate of missing 
efficiency data per test in the whole sample was 3.24%, with affected, unaffected, and control 
groups having 3.88%, 2.08%, and 5.15% rates of missing data, respectively. Average rates of 
missing efficiency domain scores (out of eight) per person were 0.310, 0.166, and 0.412 for 
affected, unaffected, and control groups, respectively. Missing data could have been the result of 
computer malfunction, participant’s unwillingness to complete the test, and/or data that was 
deemed invalid due to either participant’s behavior during testing or non-standard testing 
conditions. PENN controls recruited prior to the current study had higher rates of missing data 
due to tests that were added to the battery at a later time.  
Data from each cognitive domain were checked for outliers by box plot analysis 
collapsed over the affected, unaffected, and control groups. There were no extreme outliers, 
defined as a data point six or more standard deviations from the next most extreme score, for any 
domain. Table 9 presents skewness and kurtosis for each participant group and cognitive domain. 
Statistic (df) p-value Statistic (df) p-value Statistic (df) p-value
Sex 10.16 (1) 0.001 3.96 (1) 0.047 3.63 (1) 0.057
Age -0.51 (212) 0.611 -1.65 (181) 0.101 1.65 (322.85) 0.100
Education 0.30 (212) 0.762 -0.12 (181) 0.901 0.71 (323) 0.481
WRAT 1.39 (196) 0.166 -0.38 (176) 0.706 3.04 (304) 0.003
Spectrum vs. Other 
Psychopathology
Other Psychopathology vs. 
No DiagnosisSpectrum vs. No Diagnosis
Note. Chi-square statistics are reported for sex comparisons, w hile t-tests are reported for age, education, 
and WRAT. WRAT: Wide Range Achievement Test (age-standardized value), df: degrees of freedom. 
Signif icant (p<0.05) values are bolded. Variable coding: group (0: no diagnosis, 1: other psychopathology, 
2: spectrum), sex (1: male, 2: female). See text for a description of the direction of effects.
Table 8. Demographic comparisons betw een diagnostic groups in the unaffected relative sample
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For affected participants, six domains showed negative skew (only Abstraction/Mental 
Flexibility and Spatial Memory did not) in the range of -1.43 to 0.85. Kurtosis for this group was 
in the range of -1.06 to 2.41. The pattern in unaffected participants was somewhat different as 
each domain was negatively skewed (range: -4.14 to -0.08) and kurtosis had a much larger range 
(range: -0.47 to 24.56). The control group’s cognitive performance was also all negatively 
skewed (range: -2.50 to -0.10) with a smaller kurtosis range than unaffected individuals (range: -
0.48 to 9.09). Attention and Sensorimotor Dexterity showed the highest levels of skewness and 
kurtosis for all participant groups, thus there is little evidence of heteroscedasticity.  
 
Abstraction & 
Mental Flexibility
Attention
Spatial 
Processing
Emotional 
Processing
Verbal Memory Facial Memory Spatial Memory
Sensorimotor 
Dexterity
Skewness (SE) 0.846 (0.322) -1.426 (0.322) -0.351 (0.330) -0.144 (0.316) -0.364 (0.314) -0.049 (0.314) 0.069 (0.316) -1.234 (0.325)
Kurtosis (SE) -0.884 (0.634) 2.407 (0.634) -1.055 (0.650) 0.023 (0.623) -0.106 (0.618) -0.777 (0.618) -0.943 (0.623) 1.635 (0.639)
Skewness (SE) -0.515 (0.131) -2.040 (0.131) -0.880 (0.130) -0.743 (0.129) -0.808 (0.129) -0.612 (0.129) -0.078 (0.129) -4.136 (0.131)
Kurtosis (SE) -1.058 (0.261) 5.069 (0.262) 0.878 (0.259) 0.491 (0.257) 0.681 (0.256) 0.362 (0.256) -0.471 (0.257) 24.559 (0.262)
Skewness (SE) -0.828 (0.172) -2.329 (0.192) -0.544 (0.174) -0.879 (0.175) -0.430 (0.179) -0.373 (0.177) -0.096 (0.172) -2.503 (0.176)
Kurtosis (SE) -0.384 (0.343) 8.749 (0.383) 0.271 (0.346) 1.954 (0.347) 0.302 (0.355) 0.004 (0.353) -0.477 (0.343) 9.086 (0.350)
Note.  SE: standard error
Controls
Unaffected
Affected
Table 9. Cognitive performance by group and domain: Skew ness & Kurtosis
 
3.3.2 Cognitive Performance by Group 
Table 10 presents the standardized means and standard deviations for each group using the 
control group’s performance data as the reference group.  
 
Abstraction & 
Mental Flexibility Attention
Spatial 
Processing
Emotional 
Processing Verbal Memory Facial Memory Spatial Memory
Sensorimotor 
Dexterity
N 55 55 52 57 58 58 57 54
Mean (SD) -1.227 (1.17) -1.805 (2.07) -1.123 (1.45) -1.550 (1.28) -1.206 (1.37) -0.921 (0.93) -0.786 (1.00) -1.397 (1.75)
N 348 344 353 359 360 360 359 345
Mean (SD) -0.169 (1.11) -0.344 (1.43) -0.211 (1.10) -0.289 (1.15) -0.33 (1.09) -0.256 (1.00) -0.174 (0.95) -0.235 (1.27)
N 199 159 195 194 185 188 199 191
Mean (SD) 0.000 (1.00) 0.000 (1.00) 0.000 (1.00) 0.000 (1.00) 0.000 (1.00) 0.000 (1.00) 0.000 (1.00) 0.000 (1.00)
Note.  SD: standard deviation
Controls
Unaffected
Affected
Table 10. Cognitive performance by group and domain: Means & Standard Deviations
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As expected, there were significant performance differences between groups on every domain, as 
seen in Table 11, with omnibus F statistics ranging from 14.51 to 42.42 (p=0.000). Pairwise 
contrasts showed significant differences between affected and control individuals, as well as 
affected compared to unaffected individuals on each domain, in which the affected group 
consistently performed worse than other groups. Contrasts between the unaffected relatives and 
control group found significant differences for all domains, except Abstraction/Mental 
Flexibility. The performance of the unaffected group was consistently worse than the control 
group.  
 
Statistic (df) p-value Statistic (df) p-value Statistic (df) p-value Statistic (df) p-value
Abstraction & Mental Flexibility 28.47 (2, 599) 0.000 55.76 (1, 599) 0.000 45.67 (1, 599) 0.000 3.12 (1, 599) 0.078
Attention 34.41 (2, 555) 0.000 67.86 (1, 555) 0.000 51.59 (1, 555) 0.000 6.56 (1, 555) 0.011
Verbal Memory 26.90 (2, 600) 0.000 53.59 (1, 600) 0.000 31.97 (1, 600) 0.000 11.12 (1, 600) 0.001
Facial Memory 19.17 (2 ,603) 0.000 38.13 (1, 603) 0.000 22.42 (1, 603) 0.000 8.19 (1, 603) 0.004
Spatial Memory 14.51 (2 ,612) 0.000 29.08 (1, 612) 0.000 19.57 (1, 612) 0.000 4.12 (1, 612) 0.043
Sensorimotor Dexterity 21.29 (2, 597) 0.000 52.96 (1 ,587) 0.000 40.68 (1, 587) 0.000 4.35 (1, 587) 0.037
Spatial Processing 26.73 (2, 587) 0.000 42.50 (1, 597) 0.000 30.93 (1, 597) 0.000 4.60 (1, 597) 0.032
Emotional Processing 42.42 (2, 607) 0.000 84.39 (1, 607) 0.000 62.30 (1, 607) 0.000 8.42 (1, 607) 0.004
Table 11. Cognitive performance comparisons betw een groups
Affecteds vs. Controls
Unaffected Relatives vs. 
Controls
Affecteds vs. Unaffected 
RelativesOmnibus (all groups)
Note. All analyses used the F statistic. Signif icant (p<0.05) values are bolded. Variable coding: group (1: affected, 2: unaffected, 3: controls). See text for a 
description of the direction of effects.  
 
Some differences in cognitive performance by diagnostic group among unaffected 
relatives were also found (means for each group shown in Table 12).  
 
Abstraction & 
Mental 
Flexibility
Attention
Spatial 
Processing
Emotional 
Processing
Verbal 
Memory
Facial Memory
Spatial 
Memory
Sensorimotor 
Dexterity
N 34 33 33 35 36 36 36 34
Mean (SD) -0.491 (1.27) -0.343 (1.58) -0.088 (1.15) -0.900 (1.39) -0.843 (1.40) -0.915 (1.16) -0.382 (1.09) -0.796 (2.60)
N 142 147 145 147 146 147 147 144
Mean (SD) -0.170 (1.09) -0.490 (1.63) -0.155 (1.08) -0.254 (1.03) -0.362 (1.07) -0.134 (0.94) -0.109 (0.91) -0.152 (1.06)
N 172 164 175 177 178 177 176 167
Mean (SD) -0.105 (1.08) -0.214 (1.18) -0.281 (1.11) -0.198 (1.17) -0.201 (1.02) -0.223 (0.97) -0.186 (0.95) -0.191 (0.99)
Note.  SD: standard deviation
No Diagnosis
Other 
Psychopathology
Spectrum
Table 12. Cognitive performance by diagnostic category in the unaffected sample
 
 
 47 
Specifically, omnibus effects were detected for the domains of Verbal and Facial Memory, 
Sensorimotor Dexterity, and Emotional Processing, as seen in Table 13. Pairwise contrasts for 
these domains found significant differences between spectrum and no diagnosis groups, as well 
as spectrum compared to other psychopathology groups. The same pattern was found for a 
comparison between the spectrum and combined no diagnosis/other psychopathology groups. In 
all contrasts, the spectrum group’s performance was always poorer than the comparison group. 
No contrasts between the other psychopathology and no diagnosis groups were significant. There 
were also no significant differences on any domain between control individuals with a diagnosis 
and those without (0.200 ≤ p ≤ 0.924; data not tabled), indicating that non-schizophrenia-related 
psychopathology does not significantly impair cognitive performance in this sample.  
 
Statistic (df) p-value Statistic (df) p-value Statistic (df) p-value Statistic (df) p-value Statistic (df) p-value
Abstraction & Mental Flexibility 1.73 (2, 345) 0.180 3.45 (1, 345) 0.064 2.32 (1, 345) 0.129 0.26 (1, 345) 0.610 3.13 (1, 345) 0.078
Attention 1.44 (2, 341) 0.238 0.22 (1, 341) 0.638 0.29 (1, 341) 0.594 2.88 (1, 341) 0.090 0.00 (1, 341) 0.972
Spatial Processing 0.74 (2, 350) 0.479 0.84 (1, 350) 0.359 0.10 (1, 350) 0.753 1.03 (1, 350) 0.312 0.41 (1, 350) 0.521
Emotional Processing 5.68 (2, 356) 0.004 11.11 (1, 356) 0.001 9.12 (1, 356) 0.003 0.19 (1, 356) 0.663 11.07 (1, 356) 0.001
Verbal Memory 5.40 (2, 357) 0.005 10.59 (1, 357) 0.001 5.73 (1, 357) 0.017 1.78 (1, 357) 0.183 8.75 (1, 357) 0.003
Facial Memory 9.44 (2, 357) 0.000 15.01 (1, 357) 0.000 18.49 (1, 357) 0.000 0.67 (1, 357) 0.414 18.41 (1, 357) 0.000
Spatial Memory 1.22 (2, 356) 0.297 1.27 (1, 356) 0.260 2.39 (1, 356) 0.123 0.52 (1, 356) 0.470 1.97 (1, 356) 0.161
Sensorimotor Dexterity 3.76 (2, 342) 0.024 6.46 (1, 342) 0.011 7.14 (1, 342) 0.008 0.07 (1, 342) 0.785 7.47 (1, 342) 0.007
Table 13. Cognitive performance comparisons betw een diagnostic categories in the unaffected sample
Note.  Comparisons based on signif icant omnibus F tests (p<0.05) discussed in text. All analyses used the F statistic. Signif icant (p<0.05) values are bolded. Variable coding: group (0: no diagnosis, 1: 
other psychopathology, 2: spectrum). See text for a description of the direction of effects.
Omnibus (all groups) Spectrum vs. No Diagnosis
Other Psychopathology vs. 
No Diagnosis
Spectrum vs. Other 
Psychopathology
Spectrum vs. (No Diagnosis 
& Other Psychopathology)
 
3.3.3 Relationship between Cognitive Performance and Demographic Characteristics 
As seen in Table 14, Pearson correlations between demographic characteristics and individual 
cognitive domains in the unaffected sample found multiple significant relationships: 1) education 
and WRAT were both significantly positively associated with all cognitive tasks; 2) handedness 
was negatively associated only with Spatial Processing performance (right handed individuals 
performing better); and 3) site was negatively associated with Abstraction/Mental Flexibility 
performance (PENN individuals performing better). 
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Statistic p-value Statistic p-value Statistic p-value Statistic p-value Statistic p-value Statistic p-value Statistic p-value Statistic p-value
Education 0.27 0.000 0.30 0.000 0.39 0.000 0.27 0.000 0.25 0.000 0.21 0.000 0.12 0.021 0.28 0.000
WRAT 0.32 0.000 0.34 0.000 0.45 0.000 0.36 0.000 0.38 0.000 0.23 0.000 0.12 0.027 0.23 0.000
Handedness -0.04 0.488 0.03 0.646 -0.17 0.002 0.01 0.879 -0.04 0.457 -0.01 0.792 -0.04 0.503 -0.01 0.843
Site -0.11 0.050 -0.06 0.270 -0.07 0.197 -0.04 0.490 -0.01 0.843 0.09 0.078 0.00 0.946 -0.02 0.661
Table 14. Pearson correlations betw een demographic characteristics and cognitive performance in the unaffected sample
Note. WRAT: Wide Range Achievement Test (age-standardized values). Coding: handedness (right = 1, left = 2); site (PENN = 70, PITT = 71). Signif icant (p<0.05) values are 
bolded.
Abstraction & 
Mental Flexibility
Emotional 
Processing
Spatial 
Processing
Sensorimotor 
DexteritySpatial MemoryFacial MemoryVerbal MemoryAttention
 
3.3.4 Genetic Correlations between Affected Status and Cognitive Performance 
Genetic correlations (Rg) were estimated between affected status and each cognitive domain 
using the combined affected and unaffected groups. Age and sex were screened as covariates for 
each analysis and retained if p<0.1. No covariates were used in modeling Rg for Verbal Memory 
due to recurrent convergence failure when covariates were included.  
As seen in Table 15, Rg ranged from -0.143 to -0.604 and was negative in direction for all 
analyses indicating that the closer the genetic relationship with an affected individual, the poorer 
the cognitive performance. Rg was significantly different from zero (p<0.05) for four domains: 
Abstraction/Mental Flexibility, Attention, Spatial Processing, and Verbal Memory. Emotional 
processing tended towards significance (p=0.054). These findings indicate that genetic effects on 
affected status and cognitive domains are shared by some degree (i.e., pleiotropy). However, Rg 
was significantly different from 1.0 for all eight domains indicating that the genetic effects on 
affected status and cognition are not identical.  
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p-value p-value 
Significant 
Covariates
Significant 
Covariates 
(different from 0) (different from +/-1)  (Cognitive Domain)^ (Affected Status)^
Abstraction & Mental Flexibility 419 -0.604 0.0047 0.0105 age, sex sex
Attention 419 -0.552 0.0147 0.0045 age sex
Spatial Processing 419 -0.459 0.0072 0.0000005 age, sex sex
Emotional Processing 419 -0.358 0.0542 0.000009 age, sex sex
Verbal Memory 419 -0.466 0.0120 0.00001 none# none#
Facial Memory 419 -0.318 0.1374 0.00005 age, sex sex
Spatial Memory 419 -0.237 0.2147 0.000001 age sex
Sensorimotor Dexterity 419 -0.143 0.5587 0.0011 age sex
Note.  Rg: genetic correlation.  ^Age and sex w ere screened as covariates for each analysis. # No covariates could be included in the estimation of Rg 
for this domain due to recurrent convergence failure. Signif icant (p<0.05) values are bolded.
RgN
Table 15. Genetic correlations betw een affected status and cognitive performance
 
3.3.5 Heritability of Cognitive Domains 
Heritabilities for each cognitive domain are shown in Table 16. Heritability was estimated in the 
unaffected sample including age and sex as potential covariates that were retained in the model if 
p<0.1. Heritability ranged from 0.169 to 0.583 and was significant for all domains except 
Abstraction/Mental Flexibility. These analyses indicate that a significant proportion of variation 
in cognitive performance is due to genetic variation for nearly all of the cognitive domains.  
 
N h2 p-value
Significant 
Covariate(s)
Abstraction & Mental Flexibility 348 0.172 0.059 age, sex
Attention 344 0.169^ 0.023 age
Spatial Processing 353 0.583^ 1.00 x 10-7 age, sex
Emotional Processing 359 0.394^ 3.00 x 10-5 age, sex
Verbal Memory 360 0.535 9.00 x 10-9 age, sex
Facial Memory 360 0.323 0.0002 age
Spatial Memory 359 0.453 9.00 x 10-6 age
Sensorimotor Dexterity 345 0.187^ 0.0278 age
Note. h2: heritability. ^ The tdist command w as used to normalize the distribution w hen 
kurtosis (as measured by SOLAR) w as high. Potential covariates screened for inclusion 
(and included if p<0.10) included age and sex for all cognitive domains. Signif icant 
(p<0.05) values are bolded.
Table 16. Heritability of cognitive domains
 
3.3.6 Designation of Target Domains 
Five “target” domains for the staged statistical analysis were designated based on the genetic 
correlation and heritability findings. The target domains were defined as those with Rg 
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significantly (p<0.1) different from zero and significant (p<0.1) heritability. This liberal 
significance threshold (p<0.1) was used in order to capture those traits that showed high Rg 
values, as Rg provides information about the genetic variance underlying the relationship 
between cognition and schizophrenia, which heritability estimates do not. The target domains 
included: Abstraction/Mental Flexibility, Attention, Spatial Processing, Emotional Processing, 
and Verbal Memory. The Rg for these domains ranged from -0.358 to -0.604, while heritability 
estimates ranged from 0.172 to 0.583. Facial memory, Spatial Memory, and Sensorimotor 
Dexterity were designated as non-target domains. 
3.4 STAGED ANALYSES 
3.4.1 Stage 1 Analysis: Covarying Cognitive Domains with Sex 
All cognitive domains were independently covaried with sex to determine the proportion of 
variance explained by this variable using SOLAR. As seen in Table 17, four domains 
(Abstraction/Mental Flexibility, Spatial Processing, Emotional Processing, and Verbal Memory) 
showed nominally significant (p<0.05) covariance with sex. In these domains, sex explained 
between 1.02% and 9.23% of the variance in cognitive performance. The sex effects indicated 
that females performed better on Abstraction/Mental Flexibility and Verbal Memory, while 
males performed better on the domains of Spatial and Emotional Processing performance. 
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Table 17. Stage 1 analysis: Covarying cognitive domains w ith sex
p-value
Proportion of variance 
explained by sex
Abstraction & Mental Flexibility 0.0334 0.01021
Attention 0.2327 0.00229
Spatial Processing 4.00 x 10-7 0.09225
Emotional Processing 6.00 x 10-5 0.03911
Verbal Memory 0.0033 0.03739
Facial Memory 0.0881 0.00628
Spatial Memory 0.3138 0.00393
Sensorimotor Dexterity 0.2079 0.01383
Note.  Nominally signif icant (p<0.05) values are bolded.  See text for a 
description of the direction of effects.  
3.4.2 Stage 2 Analysis: Estimation of the Main Effects of Age on Cognition 
3.4.2.1 Linear & Curvilinear Regression in SPSS. SPSS was used for linear and 
curvilinear regression and graphing as a means of investigating the relationship between 
cognitive performance and age using the residuals from the previous stage. The model data are 
provided in Figures 4 (target domains) and 5 (non-target domains). Tolerance levels were 
sufficient (>0.18) for every model. First derivatives (F’(x)) of the regression equations enabled 
the localization of the slope change when the average age of the sample was added (this was 
done to aid interpretability, as the regression was done on a mean age-centered variable to reduce 
multicollinearity). 
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 Figure 4. Graphs of the relationship between age and performance on target cognitive domains 
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3.4.2.1.1 Target Domains. Of the five target domains, one showed a linear relationship 
with age and four showed a significant quadratic function. Verbal Memory showed a linear 
function with a negative slope. The quadratic and cubic terms in this equation did not 
significantly increase the prediction of task performance and were dropped from the model. In 
this domain, cognitive performance declined with age. 
The remaining four target domains showed a significant quadratic relationship between 
age and cognitive performance. The cubic term did not significantly increase the prediction of 
task performance and was dropped from each of the models. In these domains, task performance 
Figure 5. Graphs of the relationship between age and performance on non-target cognitive domains 
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increased at a decreasing rate until reaching a peak and then decreased with continued age. The 
ages at which cognitive performance shifted from improving to declining for Attention (36.4 
years) and Spatial Processing (40.3 years) are generally past the time of highest onset risk for 
schizophrenia, although Emotional Processing (22.6 years) and Abstraction/Mental Flexibility 
(25.8 years) are well within the peak risk range for the disorder, particularly for women. 
3.4.2.1.2 Non-Target Domains. Of the three non-target domains, one showed a linear 
relationship with age, one a quadratic relationship, and one a cubic function. Like Verbal 
Memory, Spatial Memory showed a linear function with a negative slope. In this domain, each 
additional year of age is associated with task performance decline. Facial Memory did not follow 
the pattern seen in Verbal and Spatial Memory and instead showed a quadratic function. In this 
domain, task performance increased at a decreasing rate until reaching a peak at age 28.0 years 
and then decreased with continued aging. This peak is somewhat beyond the greatest risk period 
for men, although it does fall within the women’s risk period. 
Sensorimotor dexterity showed a cubic function with age: a negative slope until 
approximately 20 years of age, a generally flat slope between 20 and 55 years, and a decline in 
performance thereafter. Specific estimates of slope change could not be established for this 
domain due to its unsolvable derivative (see Figure 5 for the equation which includes imaginary 
numbers). This pattern of function and age is suggestive of a change near the first risk period for 
both sexes and the peri-menopausal risk period for women. 
3.4.2.2 Estimation of the Main Effects of Age Using SOLAR. SOLAR was used to 
estimate the main effects of age on cognitive performance and confirm the SPSS findings 
because of its unique ability to take into account the pedigree structure of the data. This 
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estimation was done separately for each cognitive domain using the residuals from the stage 1 
analyses. The linear, quadratic, and cubic effects of age were estimated for every domain.   
The linear component of age (age
1
) was a nominally significant (p<0.05) covariate for 
every domain. Table 18 presents the percentage of variance in performance explained by age, 
which ranged from 2.67% to 22.83% overall. Increased age was associated with poorer 
performance on all cognitive tasks. The estimates of the quadratic main effects of age (age
2
) on 
cognition (after accounting for the linear effects) are also presented in Table 18. 
 
p-value
Proportion of variance 
explained by age p-value
Proportion of variance 
explained by age 2 p-value
Proportion of variance 
explained by age 3
Abstraction & Mental Flexibility 2.02 x 10-13 0.14931 0.00009 0.03747 0.7524 0.00499
Attention 0.00004 0.02671 1.93 x 10-8 0.03727 0.1976 *
Spatial Processing 0.0245 0.02987 0.00009 0.03554 1.0000 0.00815
Emotional Processing 4.38 x 10-21 0.22834 4.38 x 10-6 0.04366 1.0000 0.06391
Verbal Memory 6.16 x 10-10 0.10141 0.0607 0.00347 1.0000 0.05556
Facial Memory 7.54 x 10-13 0.13325 2.22 x 10-6 0.04538 1.0000 0.01118
Spatial Memory 3.34 x 10-8 0.07808 0.1062 0.00815 1.0000 0.02046
Sensorimotor Dexterity 4.20 x 10-18 0.18401 0.0116 * 0.5100 *
Note. Nominally signif icant (p<0.05) values are bolded. *Proportion of variance cannot be estimated due to its relatively small effect and repeated instability in the model.
Linear CubicQuadratic
Table 18. Stage 2 analysis: Estimation of the linear, quadratic, and cubic main effects of age on cognition
 
 
 
As expected, age
2
 was a nominally significant covariate for every domain that showed a 
quadratic function in the regression analyses (i.e., Abstraction/Mental Flexibility, Attention, 
Spatial and Emotional Processing, and Facial Memory), as well as the domain that showed a 
cubic function (i.e., Sensorimotor Dexterity), but was not significant for Verbal and Spatial 
Memory. The amount of variation explained by age
2
 ranged between 3.6% and 4.5% for 
individual domains with significant quadratic effects, excluding Sensorimotor Dexterity, which 
was not able to be estimated due to repeated instability in the model. The estimate of the cubic 
main effects of age (age
3
) after accounting for both linear and quadratic elements was not 
significant for any domain, including Sensorimotor Dexterity (p=0.51), also presented in Table 
18.  
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Given the general agreement between the SOLAR and SPSS findings, the main effects of 
age retained in succeeding analyses will include the following: age
1
 (Verbal and Spatial 
Memory); age
1
 and age
2
 (Abstraction/Mental Flexibility, Attention, Spatial and Emotional 
Processing, and Facial Memory); and age
1
, age
2
, and age
3 
(Sensorimotor Dexterity). 
3.4.3 Stage 3 Analysis: Estimation of the Main Effects of SNPs on Cognition 
The main effects of individual SNPs on cognitive performance were estimated separately for 
each cognitive domain in SOLAR using the residuals from the stage 2 analyses. Given the 
different elements that were estimated in stage 2, the residuals used are those from the highest 
power of age that was significant in the SPSS regression analysis. The unadjusted significance 
levels and proportion of variance explained by individual SNPs for each domain are shown in 
Table 19. In general, there were few nominally significant main effects on cognition. 
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Marker
Abstraction & 
Mental 
Flexibility Attention
Spatial 
Processing
Emotional 
Processing
Verbal 
Memory Facial Memory
Spatial 
Memory
Sensorimotor 
Dexterity
SNP8NRG221132 0.2520 0.8693 0.3030 0.3404 0.1162 0.3395 0.8177 0.9770
SNP8NRG221533/rs35753505 0.5350 0.3424 0.4214 0.1361 0.3858 0.7403 0.5595 0.6610
rs4298458 0.9784 0.4516 0.9209 0.5283 0.3939 0.6376 0.6775 0.3142
SNP8NRG241930 0.9402 0.5343 0.8788 0.4890 0.0425 (0.022) 0.9365 0.8912 0.8350
rs1081062 0.9403 0.1397 0.5759 0.6432 0.8431 0.9507 0.1292 0.9652
rs4566990 0.6432 0.9590 0.6804 0.2174 0.8944 0.6732 0.3318 0.6332
rs1354335 0.3591 0.2992 0.3672 0.8881 0.2335 0.5497 0.3577 0.6957
rs1354336 0.2946 0.3458 0.0823 0.3252 0.3519 0.4742 0.8719 0.9630
rs1354334 0.8508 0.5324 0.8472 0.2613 0.8507 0.5884 0.4321 0.7127
SNP8NRG444511/rs13268724 0.5544 0.3419 0.3202 0.9311 0.1703 0.4919 0.2713 0.7814
rs776401 0.8514 0.9383 0.2119 0.6189 0.5062 0.9355 0.4022 0.5203
rs1473438 0.7507 0.9728 0.2265 0.4699 0.4140 0.8055 0.3456 0.7655
rs1462893 0.3604 0.2714 0.9185 0.3237 0.1200 0.0131 (0.023) 0.1126 0.0721
rs10954821 0.7787 0.3068 0.1331 0.4330 0.3042 0.9510 0.8138 0.4661
rs726908 0.0907 0.4044 0.2821 0.0420 (0.018) 0.7670 0.6588 0.4061 0.3483
rs10954855 0.2500 0.0166 (0.029) 0.3035 0.0188 (0.021) 0.3264 0.7271 0.3240 0.6958
rs2439306 0.8060 0.8288 0.4571 0.8125 0.1491 0.4653 0.4546 0.3082
rs2466062 0.2264 0.7845 0.4280 0.6526 0.1311 0.7911 0.5724 0.1323
rs3924999 0.8181 0.3768 0.5874 0.0385 (0.010) 0.5847 0.8977 0.3372 0.3186
rs2466060 0.2160 0.9826 0.4599 0.5684 0.2674 0.8833 0.0385 (0.017) 0.7273
rs2439272 0.4028 0.8263 0.5728 0.7959 0.2594 0.7421 0.6480 0.3968
rs6468121 0.8639 0.2945 0.4629 0.4187 0.2657 0.6247 0.5506 0.1788
rs2466058 0.4109 0.6298 0.8797 0.2303 0.9124 0.4946 0.9233 0.3463
rs2466049 0.4504 0.5703 0.9095 0.2021 0.9608 0.5717 0.8729 0.3280
rs723811 0.8013 0.4230 0.8675 0.6819 0.1888 0.8495 0.7670 0.3860
rs6988339 0.3896 0.2970 0.2100 0.1821 0.0582 0.4671 0.7459 0.8483
rs2975498 0.5835 0.1918 0.4504 0.3883 0.1172 0.5959 0.6326 0.3343
rs2919382 0.3927 0.1027 0.7496 0.3305 0.1864 0.4616 0.6166 0.4842
rs2976525 0.3644 0.6613 0.2356 0.6710 0.3588 0.7750 0.6231 0.9819
rs4262285 0.6980 0.7109 0.2343 0.9053 0.7277 0.8213 0.3799 0.2147
rs3735776 0.0418 (0.014) 0.9080 0.7620 0.1525 0.4795 0.3793 0.5046 0.1032
rs4512342 0.0340 (0.015) 0.8609 0.5976 0.2434 0.6651 0.4437 0.9133 0.5008
rs10503929 0.1991 0.1316 0.8424 0.8202 0.9940 0.4382 0.7762 0.2453
rs6992642 0.9862 0.7022 0.2130 0.5331 0.6914 0.0778 0.4459 0.8685
rs3735781 0.6797 0.7176 0.0962 0.3141 0.3559 0.0824 0.4846 0.8705
rs3735782 0.5613 0.9162 0.1245 0.6337 0.5994 0.1364 0.4706 0.7968
Note. Unadjusted p-values are reported. Nominally signif icant (p<0.05) values are bolded and proportion of variance is provided in parentheses w hen the effect is signif icant (p<0.05). 
Shaded cells indicate target SNPs-target cognitive domain estimations. 
Table 19. Stage 3 analysis: Estimation of the main effects of individual SNPs on cognitive domains
 
 
3.4.3.1 Target Domains. In total, there were six SNPs that had nominally significant 
effects on cognitive performance across the target cognitive domains and explained a small 
proportion of the variance in cognition, ranging from 1.0% to 2.9%. These effects were evenly 
divided between target SNPs and non-target SNPs.  
3.4.3.1.1 Target SNPs. There were four nominally significant target domain, target SNP 
effects across three SNPs. Emotional processing had the most unadjusted significant SNP effects 
(rs10954855 and rs3924999), while Attention and Verbal Memory each had one (rs10954855 
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and SNP8NRG241930, respectively), and Abstraction/Mental Flexibility and Spatial Processing 
had no significant target SNP effects. Across these four effects, the individual SNPs explained 
only a small proportion of the variance, in the range of 1.0-2.9%.  
3.4.3.1.2 Non-target SNPs. There were three nominally significant target domain, non-
target SNP effects across three SNPs. Abstraction/Mental Flexibility had the most unadjusted 
significant SNP effects (rs3735776 and rs4512342), while Emotional Processing had one 
(rs726908), and Attention, Spatial Processing, and Verbal Memory had none. Across these three 
effects, individual SNPs explained a small proportion of the variance, in the range of 1.4-1.8%. 
3.4.3.2 Non-Target Domains. In total, there were two SNPs that had nominally 
significant effects on cognitive performance across the three non-target cognitive domains. 
Across these effects, the individual SNPs explained a small proportion of the variance of 
cognition, ranging from 1.7% to 2.3%. 
3.4.3.2.1 Target SNPs. There was one nominally significant non-target domain, target 
SNP effect, which was seen in Spatial Memory (rs2466060), while Facial Memory and 
Sensorimotor Dexterity had no significant findings. Marker rs2466060 explained 1.7% of the 
variance in Spatial Memory performance. 
3.4.3.2.2 Non-target SNPs. There was one nominally significant non-target domain, non-
target SNP effect, which was seen in Facial Memory (rs1462893), while Spatial Memory and 
Sensorimotor Dexterity had no significant findings. Marker rs1462893 explained 2.3% of the 
variance in Facial Memory performance. 
3.4.4 Stage 4 Analysis: Estimation of Age x SNP Interactions on Cognition 
Using the residuals from the stage 3 analyses, the interactions between age and individual SNPs 
on cognitive performance were estimated separately for each cognitive domain. Interactions 
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estimated in this step included age
1
 x SNP, age
2
 x SNP, and age
3
 x SNP, based on the findings of 
the previously reported main effects of age. For example, interactions for Verbal Memory were 
limited to age
1
 x SNP, while interactions for Abstraction/Mental Flexibility included age
1
 x SNP 
and age
2
 x SNP, and Sensorimotor Dexterity included age
1
 x SNP, age
2
 x SNP, and age
3
 x SNP. 
In the case of domains with quadratic or cubic patterns, all interactions for an individual SNP 
were estimated simultaneously, providing individual p-values for each component and the total 
proportion of variance explained.  
Because the joint effects of the different levels of interactions (e.g., linear plus quadratic) 
might be significant even if an individual level was not, the log likelihood (LL) difference [-
2(LLModel1 - LLModel2)] was calculated for the model with sex, age (linear, quadratic, and cubic, as 
appropriate), and SNP main effects (Model1) compared to the model with those components plus 
the age x SNP interactions (linear, quadratic, and cubic, as appropriate) (Model2). The LL 
difference score is distributed as a chi-square function and has two degrees of freedom for 
domains with a quadratic function and three for those with a cubic shape. The log likelihoods, 
their differences, interaction significance levels, and the total proportion of variance explained 
can be found in Tables 20-27 and are discussed individually below. Graphs for significant model 
changes and interactions are presented in Figures 6-11 and discussed individually below. 
Importantly, the number of participants in each genotype group differs for individual SNPs due 
to the frequency of the minor allele (see Table 1 for minor allele frequencies for each SNP), and 
thus the number of participants who have the minor allele homozygote (genotype 2) is 
sometimes very small, and in these cases, should not be interpreted graphically. This is noted for 
each domain below. Overall there were several nominally significant total age interaction effects 
(LL model differences) and specific component interactions (linear, quadratic, and/or cubic) 
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across multiple SNPs and domains. All nominally significant (p<0.05) effects are discussed 
below. These are considered nominal because they have not undergone correction for multiple 
comparisons, which will be discussed in the coming sections. 
3.4.4.1 Target Domains. Across all target domains, there were nine nominally significant 
total age interaction effects and 19 nominally significant specific interaction components, for a 
total of 20 nominally significant independent SNP-domain findings.  
3.4.4.1.1 Abstraction/Mental Flexibility. As seen in Table 20, there were five nominally 
significant findings in this domain. Among target SNPs, there was one significant total age 
interaction effect and a significant linear interaction component (but not a quadratic one) for 
rs35753505. Target markers rs3924999, rs2466058, and rs2466049 also all had significant linear 
interaction components without quadratic components or a significant total age interaction effect. 
There was only one non-target SNP, rs726908, with a significant finding in this domain, which 
was a significant linear component.  
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The individual patterns of cognitive function by age for each SNP (minor allele dosage) 
for this domain are graphed in Figure 6. Quadratic curve-fitting was applied due to the quadratic 
nature of this domain with age. Compared to the “wild type” genotype (major allele homozygote; 
genotype 0), the effect of the minor allele is generally advantageous to Abstraction/Mental 
Flexibility performance, especially in later life. Although there is some divergence in 
Marker Model1 Model2 -2LL Difference
Linear 
Component 
p-values
Quadratic 
Component 
p-values
Total Proportion 
of Variance 
Explained
SNP8NRG221132 -169.6226 -169.2579 0.7293 0.4843 0.6605
SNP8NRG221533/rs35753505 -169.3440 -165.9100 6.8679 (p=0.032) 0.0089 0.4939 0.019
rs4298458 -170.2784 -169.3661 1.8246 0.1793 0.9496
SNP8NRG241930 -169.7219 -168.2671 2.9095 0.1024 0.6902
rs1081062 -169.5706 -169.4597 0.2218 0.7094 0.8056
rs4566990 -170.1715 -170.0550 0.2331 0.7620 0.6876
rs1354335 -165.7326 -165.1457 1.1738 0.3371 0.6035
rs1354336 -169.0830 -168.7487 0.6686 0.8810 0.4180
rs1354334 -170.2611 -169.6595 1.2032 0.3332 0.5406
SNP8NRG444511/rs13268724 -170.1040 -169.8385 0.5312 0.5020 0.7731
rs776401 -168.8111 -168.3538 0.9146 0.5026 0.4231
rs1473438 -169.4962 -169.0970 0.7982 0.6124 0.4150
rs1462893 -169.5417 -167.9233 3.2368 0.0720 0.8000
rs10954821 -170.2393 -169.6992 1.0802 0.3006 0.7995
rs726908 -168.1517 -166.1425 4.0184 0.0469 0.9888 0.010
rs10954855 -169.6172 -169.1525 0.9295 0.3369 0.9884
rs2439306 -161.6780 -161.2424 0.8712 0.3507 0.9161
rs2466062 -166.3367 -166.1724 0.3288 0.6151 0.7780
rs3924999 -169.8575 -167.8946 3.9259 0.0495 0.9838 0.009
rs2466060 -152.9567 -151.8587 2.1960 0.1398 0.9268
rs2439272 -169.8808 -169.8496 0.0624 0.8715 0.8587
rs6468121 -168.2628 -167.9787 0.5681 0.4510 0.9625
rs2466058 -169.9406 -167.5779 4.7254 0.0371 0.5254 0.015
rs2466049 -169.2609 -166.7365 5.0489 0.0304 0.5370 0.016
rs723811 -170.2471 -169.9058 0.6827 0.9579 0.4244
rs6988339 -169.9087 -169.7267 0.3641 0.7913 0.5899
rs2975498 -170.1284 -168.8231 2.6106 0.1062 0.8543
rs2919382 -169.9135 -168.8754 2.0762 0.1498 0.8438
rs2976525 -169.8674 -168.2792 3.1764 0.0967 0.5097
rs4262285 -170.2035 -170.0869 0.2331 0.6691 0.6318
rs3735776 -140.9455 -139.4364 3.0183 0.0827 0.6701
rs4512342 -167.7131 -166.0192 3.3879 0.0683 0.5282
rs10503929 -169.4543 -168.2288 2.4511 0.1322 0.9203
rs6992642 -165.5366 -164.5481 1.9770 0.1628 0.8166
rs3735781 -169.8271 -169.1467 1.3607 0.2587 0.7169
rs3735782 -167.2990 -167.2932 0.0117 0.9942 0.9142
Interaction Components
Note. Total NGR1  x age interaction effect includes linear and quadratic effects for this domain. Model 1 includes the main effects of sex, 
age and age2, and each individual SNP. Model 2 provides the same elements as Model 1 plus SNP x age and SNP x age2. -2LL Difference is 
distributed as a chi-square function (critical value: 5.99, df=2, p<0.05). Shaded cells indicate target SNPs-target cognitive domain estimations. 
Nominally signif icant (p<0.05) difference values are bolded.
Total NRG1  x Age Interaction Effect
Table 20. Abstraction & Mental Flexibility (Target): Model comparisons and estimation of specif ic components of the SNP x age 
interaction in cognitive performance prediction
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performance by genotype early in life, especially for rs35753505, the age at which the 
performance-allele patterns begin to diverge is in midlife, between age 30 and 50. In the case of 
rs35753505, having two copies of the minor allele results in a pattern in which performance is 
low earlier in life, better at midlife, and again low later in life. Given that rs2466058 and 
rs2466049 each only have three minor allele homozygotes, the pattern of this genotype should 
not be interpreted.  
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Figure 6. Abstraction & Mental Flexibility (Target): Graphs of the interactions between SNP minor allele dose and age in predicting cognitive 
performance. 
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3.4.4.1.2 Attention. As seen in Table 21, there were five nominally significant findings in 
this domain. Target markers rs2439272 and rs6988339 had significant linear interaction 
components without quadratic components or a significant total age interaction effect. Among 
non-target SNPs, there was one significant total age interaction effect: rs6468121. This SNP also 
showed a significant linear interaction component, but not a quadratic one. One additional non-
target SNP, rs3735782, had a significant finding in this domain with a significant linear 
component.  
Marker Model1 Model2 -2LL Difference
Linear 
Component 
p-values
Quadratic 
Component 
p-values
Total Proportion 
of Variance 
Explained
SNP8NRG221132 -357.4238 -356.6516 1.5444 0.5081 0.2292
SNP8NRG221533/rs35753505 -354.6446 -353.4421 2.4051 0.8122 0.1220
rs4298458 -357.1540 -355.7184 2.8712 0.8417 0.0916
SNP8NRG241930 -352.9311 -352.4656 0.9310 0.3575 0.7929
rs1081062 -355.5673 -355.3827 0.3693 0.8077 0.5641
rs4566990 -357.4360 -354.9695 4.9331 0.2551 0.0337 0.035
rs1354335 -349.0740 -348.5732 1.0016 0.3173 0.9878
rs1354336 -348.7144 -348.5910 0.2469 0.8625 0.6466
rs1354334 -357.2424 -355.6170 3.2509 0.2895 0.0913
SNP8NRG444511/rs13268724 -356.9857 -355.8392 2.2930 0.1510 0.5981
rs776401 -352.3736 -352.3417 0.0637 0.8030 0.9501
rs1473438 -355.8434 -355.6956 0.2955 0.6262 0.8427
rs1462893 -356.2099 -355.6803 1.0593 0.3122 0.7507
rs10954821 -356.9151 -356.2272 1.3759 0.2887 0.5952
rs726908 -354.7936 -353.6934 2.2004 0.2986 0.2810
rs10954855 -354.5674 -352.7588 3.6173 0.3997 0.1195
rs2439306 -342.6799 -341.5797 2.2004 0.1570 0.7168
rs2466062 -356.2178 -354.2491 3.9374 0.0913 0.3736
rs3924999 -351.9861 -351.1125 1.7473 0.2670 0.5775
rs2466060 -332.2580 -330.9639 2.5883 0.1742 0.4560
rs2439272 -357.1377 -354.8512 4.5729 0.0397 0.6445 0.013
rs6468121 -346.8393 -343.5527 6.5732 (p=0.037) 0.0108 0.8677 0.032
rs2466058 -357.3211 -356.1929 2.2564 0.9767 0.1338
rs2466049 -355.6136 -354.4161 2.3949 0.9331 0.1248
rs723811 -357.1163 -355.2227 3.7871 0.4561 0.1078
rs6988339 -356.8935 -354.5159 4.7552 0.0431 0.4175 0.006
rs2975498 -356.5854 -355.7432 1.6845 0.9133 0.1978
rs2919382 -356.1061 -355.2213 1.7696 0.6277 0.2350
rs2976525 -357.3414 -357.1336 0.4156 0.5334 0.8045
rs4262285 -357.3686 -356.0036 2.7300 0.1155 0.2430
rs3735776 -306.9429 -306.1164 1.6531 0.5266 0.2030
rs4512342 -356.7993 -354.5329 4.5328 0.2071 0.1552
rs10503929 -356.3004 -355.9509 0.6990 0.5051 0.4826
rs6992642 -350.0546 -349.4034 1.3022 0.2598 0.9735
rs3735781 -355.2641 -354.4073 1.7137 0.2077 0.9753
rs3735782 -353.5881 -351.1248 4.9265 0.0535 0.4659 0.041
Total NRG1  x Age Interaction Effect
Note. Total NGR1  x age interaction effect includes linear and quadratic effects for this domain. Model 1 includes the main effects of sex, 
age and age2, and each individual SNP. Model 2 provides the same elements as Model 1 plus SNP x age and SNP x age2. -2LL Difference is 
distributed as a chi-square function (critical value: 5.99, df=2, p<0.05). Shaded cells indicate target SNPs-target cognitive domain 
estimations. Nominally signif icant (p<0.05) difference values are bolded.
Interaction Components
Table 21. Attention (Target): Model comparisons and estimation of specif ic components of the SNP x age interaction in cognitive 
performance prediction
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The individual patterns of cognitive function by age for each SNP (minor allele dosage) 
for this domain are graphed in Figure 7. Quadratic curve-fitting was applied due to the quadratic 
nature of this domain with age. Compared to the wildtype, the effect of the minor allele is mixed 
with regard to Attention performance. For rs4566990, the effect of the minor allele is generally 
advantageous, with minor allele homozygotes performing best, followed by heterozygotes, and 
then major allele homozygotes. There is notable divergence in the pattern of the minor allele 
homozygote from the other two genotypes, where individuals with this genotype perform better 
at early and late life, and approximately the same as the other groups at midlife. Markers 
rs2439272 and rs6988339 also show a minor allele advantage with less dramatic differences 
between groups. The point at which the genotype patterns diverge for these SNPs is at 
approximately 30 years of age. For SNPs rs6468121 and rs3735782, the minor allele confers a 
slight disadvantage, especially later in life. The age at which the genotypes diverge is at 
approximately age 20 and 60 for rs6468121, and age 30 for rs3735782.  
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Figure 7. Attention (Target): Graphs of the interactions between SNP minor allele dose and age in predicting cognitive performance. 
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3.4.4.1.3 Spatial Processing. As seen in Table 22, there was one nominally significant 
finding in this domain. No target markers had significant total age interaction effects or 
significant specific interactions. Among non-target SNPs, there were no significant total age 
interaction effects, but rs1473438 showed a significant quadratic interaction component. No 
other non-target SNPs showed significant interaction components for this domain.  
 
Marker Model1 Model2 -2LL Difference
Linear 
Component 
p-values
Quadratic 
Component 
p-values
Total Proportion 
of Variance 
Explained
SNP8NRG221132 -292.9784 -292.7258 0.5051 0.7736 0.5015
SNP8NRG221533/rs35753505 -292.0196 -291.8825 0.2741 0.6397 0.9280
rs4298458 -293.5039 -293.4815 0.0448 0.8330 0.9636
SNP8NRG241930 -281.1672 -281.1198 0.0947 0.7733 0.9057
rs1081062 -290.2224 -290.1878 0.0693 0.8200 0.8875
rs4566990 -293.4240 -292.7884 1.2712 0.4814 0.3348
rs1354335 -287.3766 -287.3003 0.1526 0.8435 0.7305
rs1354336 -288.6889 -288.3353 0.7072 0.6020 0.4845
rs1354334 -293.4903 -292.8605 1.2595 0.4551 0.3512
SNP8NRG444511/rs13268724 -293.0147 -292.9227 0.1840 0.7918 0.7301
rs776401 -292.0766 -290.7771 2.5990 0.8198 0.1075
rs1473438 -287.8408 -286.6230 2.4357 0.8892 0.0453 0.013
rs1462893 -292.9988 -292.8675 0.2626 0.6237 0.8500
rs10954821 -292.3808 -292.1795 0.4025 0.8980 0.5259
rs726908 -286.1235 -285.7226 0.8017 0.3960 0.7305
rs10954855 -292.9794 -292.5096 0.9396 0.5000 0.4482
rs2439306 -279.1184 -278.8578 0.5211 0.5129 0.7182
rs2466062 -288.0496 -286.9711 2.1569 0.8156 0.1573
rs3924999 -292.7086 -291.3963 2.6247 0.8235 0.1175
rs2466060 -266.7944 -266.3585 0.8717 0.5680 0.5367
rs2439272 -292.3204 -291.9451 0.7507 0.4999 0.7064
rs6468121 -290.5676 -290.1262 0.8829 0.3640 0.9069
rs2466058 -293.4974 -293.2266 0.5416 0.5483 0.7071
rs2466049 -288.3463 -288.0539 0.5847 0.5317 0.7001
rs723811 -293.4949 -293.1548 0.6802 0.6921 0.5040
rs6988339 -292.7232 -290.7077 4.0311 0.0619 0.4248
rs2975498 -293.2240 -292.3485 1.7509 0.1964 0.5776
rs2919382 -293.4579 -292.9276 1.0607 0.3515 0.7157
rs2976525 -292.8056 -291.8695 1.8720 0.1718 0.9393
rs4262285 -292.8015 -292.4215 0.7600 0.6078 0.8703
rs3735776 -257.3983 -256.7800 1.2365 0.3258 0.4051
rs4512342 -292.8648 -292.5431 0.6433 0.4235 0.9014
rs10503929 -293.4891 -292.9120 1.1540 0.3560 0.8962
rs6992642 -274.0872 -273.7098 0.7550 0.0988 0.6789
rs3735781 -291.3142 -290.7864 1.0557 0.0593 0.6650
rs3735782 -289.9949 -289.8918 0.2061 0.6638 0.9152
Total NRG1  x Age Interaction Effect Interaction Components
Note. Total NGR1  x age interaction effect includes linear and quadratic effects for this domain. Model 1 includes the main effects of sex, 
age and age2, and each individual SNP. Model 2 provides the same elements as Model 1 plus SNP x age and SNP x age2. -2LL Difference 
is distributed as a chi-square function (critical value: 5.99, df=2, p<0.05). Shaded cells indicate target SNPs-target cognitive domain 
estimations. Nominally signif icant (p<0.05) difference values are bolded.
Table 22. Spatial Processing (Target): Model comparisons and estimation of specif ic components of the SNP x age interaction in 
cognitive performance prediction
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The pattern of cognitive function by age for rs1473438 is graphed in Figure 8. Quadratic curve-
fitting was applied due to the quadratic nature of this domain with age. Compared to the 
wildtype, the effect of the minor allele changed with age. Although the patterns are somewhat 
divergent earlier in life, the genotype effects are most significant after approximately age 30, 
when each copy of the minor allele confers additional benefit to performance. However, the 
minor allele homozygote’s performance decreases dramatically at approximately age 60 and 
after, while the heterozygote and major allele homozygote’s performance remains largely stable. 
 
 
Figure 8. Spatial Processing (Target): Graphs of the interactions between SNP minor allele dose and age in predicting cognitive 
performance. 
 
 
3.4.4.1.4 Emotional Processing. As seen in Table 23, there were nine nominally 
significant findings in this domain. Among target SNPs, there were three significant total age 
interaction effects for markers rs35753505, rs4298458, and rs776401. Both rs35753505 and 
rs4298458 showed a significant linear component, while rs776401 had a significant quadratic 
component. Target marker rs4262285 had a significant linear interaction component without a 
quadratic component or a significant total age interaction effect.  
Among non-target SNPs, there were four significant total age interaction effects for 
markers rs4566990, rs1354334, rs1473438, and rs10954821. Markers rs4566990, rs1354334, 
and rs1473438 showed only significant quadratic components, while rs10954821 had no 
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significant specific interaction components. Non-target marker rs723811 had a significant 
quadratic interaction component without a linear component or a significant total age interaction 
effect.  
 
Marker Model1 Model2 -2LL Difference
Linear 
Component 
p-values
Quadratic 
Component 
p-values
Total Proportion 
of Variance 
Explained
SNP8NRG221132 -163.4921 -161.5331 3.9180 0.2198 0.1205
SNP8NRG221533/rs35753505 -162.9386 -157.7109 10.4554 (p=0.005) 0.0061 0.2702 0.032
rs4298458 -163.7478 -160.0451 7.4055 (p=0.025) 0.0133 0.2936 0.023
SNP8NRG241930 -161.9187 -160.5955 2.6464 0.3437 0.1794
rs1081062 -163.7745 -161.8262 3.8966 0.1268 0.2633
rs4566990 -163.1861 -159.7209 6.9302 (p=0.031) 0.8872 0.0085 0.019
rs1354335 -160.0081 -158.7853 2.4454 0.3153 0.2140
rs1354336 -160.5400 -159.5251 2.0298 0.7263 0.1569
rs1354334 -163.3157 -159.1082 8.4150 (p=0.015) 0.6761 0.0049 0.023
SNP8NRG444511/rs13268724 -163.9429 -163.1453 1.5952 0.4718 0.2867
rs776401 -158.0433 -153.2594 9.5679 (p=0.008) 0.5094 0.0020 0.026
rs1473438 -163.0141 -158.4875 9.0531 (p=0.011) 0.3408 0.0028 0.025
rs1462893 -163.5226 -161.2465 4.5522 0.0875 0.1476
rs10954821 -163.6393 -160.5289 6.2208 (p=0.045) 0.1934 0.0590
rs726908 -161.7459 -161.7296 0.0326 0.9269 0.8806
rs10954855 -161.1848 -160.6171 1.1353 0.5298 0.3532
rs2439306 -158.6094 -158.4656 0.2877 0.5965 0.8871
rs2466062 -161.3080 -160.8756 0.8648 0.9411 0.3530
rs3924999 -158.7767 -158.0150 1.5235 0.4938 0.3541
rs2466060 -145.1698 -144.9138 0.5120 0.4916 0.9469
rs2439272 -164.0009 -163.0586 1.8846 0.1764 0.9225
rs6468121 -160.7770 -160.4460 0.6620 0.4486 0.7487
rs2466058 -163.2273 -162.8096 0.8354 0.5996 0.4614
rs2466049 -162.7925 -162.3530 0.8790 0.5474 0.4817
rs723811 -163.8627 -161.6383 4.4487 0.3171 0.0420 0.011
rs6988339 -163.0563 -162.4097 1.2933 0.8001 0.2741
rs2975498 -163.5746 -162.9669 1.2153 0.4641 0.4771
rs2919382 -163.4732 -163.2286 0.4892 0.9093 0.4867
rs2976525 -163.8565 -163.5694 0.5742 0.5152 0.6781
rs4262285 -163.9396 -160.9494 5.9804 0.0168 0.1014 0.012
rs3735776 -249.5935 -249.5626 0.0617 0.8822 0.8811
rs4512342 -163.3292 -162.9954 0.6675 0.4271 0.9826
rs10503929 -163.9209 -163.6166 0.6085 0.9631 0.4723
rs6992642 -162.3351 -161.7737 1.1226 0.4373 0.4499
rs3735781 -162.3219 -161.8263 0.9913 0.5809 0.3821
rs3735782 -162.8334 -162.5371 0.5927 0.8152 0.4562
Total NRG1  x Age Interaction Effect Interaction Components
Note. Total NGR1  x age interaction effect includes linear and quadratic effects for this domain. Model 1 includes the main effects of sex, 
age and age2, and each individual SNP. Model 2 provides the same elements as Model 1 plus SNP x age and SNP x age2. -2LL Difference is 
distributed as a chi-square function (critical value: 5.99, df=2, p<0.05). Shaded cells indicate target SNPs-target cognitive domain 
estimations. Nominally signif icant (p<0.05) difference values are bolded.
Table 23. Emotional Processing (Target): Model comparisons and estimation of specif ic components of the SNP x age interaction in 
cognitive performance prediction
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The individual patterns of cognitive function by age for each SNP (minor allele dosage) 
for this domain are graphed in Figure 9. Quadratic curve-fitting was applied due to the quadratic 
nature of this domain with age. Compared to the wildtype, the minor allele had mixed effects on 
Emotional Processing performance over the lifespan. The minor alleles of SNPs rs4566990, 
rs1354334, rs10954821, and rs723811 showed a benefit to performance both in early (at or 
before age 30) and later life (at or after age 60), with less dramatic effects at midlife. Markers 
rs776401and rs1473438, however, showed the opposite pattern whereby the minor allele 
conferred a detriment to performance early and late in life. The minor alleles for SNPs 
rs35753505 and rs4298458 conferred a detriment to performance early in life, but an advantage 
later in life, with the change in direction occurring at approximately age 50. Finally, rs4262285 
showed the opposite pattern, with minor alleles conferring an advantage early and a detriment at 
age 40 and later. Given that rs723811 and rs4262285 each have fewer than three minor allele 
homozygotes, the pattern of this genotype should not be interpreted. 
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Figure 9. Emotional Processing (Target): Graphs of the interactions between SNP minor allele dose and age in predicting cognitive performance. 
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Figure 9 (continued). Emotional Processing (Target): Graphs of the interactions between SNP minor allele dose and age in 
predicting cognitive performance. 
 
 
3.4.4.1.5 Verbal Memory. As seen in Table 24, there were no significant linear interaction 
components for target or non-target SNPs. 
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3.4.4.2 Non-Target Domains. Across all non-target domains, there were 11 nominally 
significant total age interaction effects and 12 nominally significant specific interactions, for a 
total of 14 nominally significant findings.  
3.4.4.2.1 Facial Memory. As seen in Table 25, there were no significant findings in this 
domain at the level of total age interaction effects or individual interaction components.  
 
Marker
Linear 
Component 
p-value
Proportion of 
Variance
SNP8NRG221132 0.9928
SNP8NRG221533/rs35753505 0.8596
rs4298458 0.9433
SNP8NRG241930 0.7826
rs1081062 0.7966
rs4566990 0.9255
rs1354335 0.8591
rs1354336 0.7387
rs1354334 0.5145
SNP8NRG444511/rs13268724 0.9658
rs776401 0.4429
rs1473438 0.5844
rs1462893 0.4600
rs10954821 0.4771
rs726908 0.2185
rs10954855 0.9144
rs2439306 0.8344
rs2466062 0.5271
rs3924999 0.8884
rs2466060 0.2243
rs2439272 0.0814
rs6468121 0.0675
rs2466058 0.8256
rs2466049 0.9406
rs723811 0.2750
rs6988339 0.6490
rs2975498 0.2376
rs2919382 0.4963
rs2976525 0.3643
rs4262285 0.4174
rs3735776 0.7835
rs4512342 0.7455
rs10503929 0.7098
rs6992642 0.3471
rs3735781 0.5392
rs3735782 0.5588
Verbal Memory
Table 24. Verbal memory (Target): Model comparisons and estimation of specif ic components of 
the SNP x age interaction in cognitive performance prediction
Note. P-values are reported. Proportion of variance is provided for signif icant (p<0.05) effects. 
Shaded cells indicate target SNPs-target cognitive domain estimations. Nominally signif icant (p<0.05) 
values are bolded.
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3.4.4.2.2 Spatial Memory. As seen in Table 26, there was one nominally significant linear 
component: rs4566990. The pattern of the interaction between this SNP and age in predicting 
performance in this domain is shown in Figure 10.  
 
 
 
Marker Model1 Model2 -2LL Difference
Linear 
Component 
p-values
Quadratic 
Component 
p-values
Total Proportion 
of Variance 
Explained
SNP8NRG221132 -134.2221 -133.6261 1.1920 0.3165 0.6917
SNP8NRG221533/rs35753505 -134.9580 -134.9158 0.0845 0.9989 0.7765
rs4298458 -134.5674 -134.5308 0.0731 0.8385 0.8540
SNP8NRG241930 -130.9093 -129.6435 2.5316 0.1223 0.6652
rs1081062 -134.7651 -134.4270 0.6764 0.7695 0.4285
rs4566990 -134.5894 -133.2575 2.6638 0.1201 0.5185
rs1354335 -134.0868 -133.5772 1.0193 0.3222 0.8781
rs1354336 -134.7986 -134.6521 0.2929 0.5884 0.9322
rs1354334 -134.5319 -133.8978 1.2683 0.3072 0.5601
SNP8NRG444511/rs13268724 -134.4422 -133.6122 1.6599 0.1984 0.9003
rs776401 -129.5437 -129.5301 0.0271 0.9739 0.8695
rs1473438 -134.8768 -134.8463 0.0609 0.8528 0.9093
rs1462893 -131.7359 -130.9798 1.5123 0.2754 0.6508
rs10954821 -134.6764 -133.9660 1.4208 0.6143 0.2501
rs726908 -134.3478 -134.1883 0.3191 0.5802 0.9389
rs10954855 -134.6174 -134.4258 0.3833 0.9936 0.5384
rs2439306 -132.8196 -132.1287 1.3817 0.5217 0.2949
rs2466062 -134.2010 -133.2364 1.9293 0.6732 0.1816
rs3924999 -134.8057 -134.5792 0.4529 0.9162 0.5223
rs2466060 -118.8033 -118.3805 0.8456 0.3602 0.9375
rs2439272 -134.6315 -134.1058 1.0514 0.6721 0.3316
rs6468121 -134.5519 -134.1539 0.7960 0.6248 0.4639
rs2466058 -134.4451 -133.1268 2.6367 0.1136 0.7144
rs2466049 -134.3041 -133.1398 2.3286 0.1394 0.7082
rs723811 -134.6603 -134.2938 0.7331 0.3975 0.9597
rs6988339 -134.4139 -133.5752 1.6773 0.9044 0.1956
rs2975498 -134.5377 -134.5248 0.0258 0.8801 0.9737
rs2919382 -134.4074 -134.1756 0.4635 0.4964 0.9456
rs2976525 -134.6375 -134.5366 0.2017 0.7283 0.7651
rs4262285 -134.6528 -133.7665 1.7727 0.2440 0.5691
rs3735776 -120.7999 -120.6977 0.2045 0.7263 0.8587
rs4512342 -134.5231 -134.2192 0.6080 0.9699 0.4532
rs10503929 -134.3778 -133.6123 1.5310 0.2795 0.8405
rs6992642 -131.4009 -129.6965 3.4089 0.3586 0.1071
rs3735781 -132.2077 -130.6589 3.0976 0.3647 0.1235
rs3735782 -133.7047 -131.9772 3.4551 0.5991 0.0747
Total NRG1  x Age Interaction Effect Interaction Components
Note. Total NGR1  x age interaction effect includes linear and quadratic effects for this domain. Model 1 includes the main effects of sex, age 
and age2, and each individual SNP. Model 2 provides the same elements as Model 1 plus SNP x age and SNP x age2. -2LL Difference is 
distributed as a chi-square function (critical value: 5.99, df=2, p<0.05). Nominally signif icant (p<0.05) difference values are bolded.
Table 25. Facial Memory (Non-target): Model comparisons and estimation of specif ic components of the SNP x age interaction in cognitive 
performance prediction
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Marker
Linear 
Component 
p-values
Proportion of 
Variance
SNP8NRG221132 0.4957
SNP8NRG221533/rs35753505 0.1251
rs4298458 0.1221
SNP8NRG241930 0.3615
rs1081062 0.8944
rs4566990 0.0381 0.007
rs1354335 0.2997
rs1354336 0.1883
rs1354334 0.1191
SNP8NRG444511/rs13268724 0.2055
rs776401 0.1315
rs1473438 0.0969
rs1462893 0.3605
rs10954821 0.5599
rs726908 0.1348
rs10954855 0.8411
rs2439306 0.4186
rs2466062 0.7366
rs3924999 0.6787
rs2466060 0.1037
rs2439272 0.7940
rs6468121 0.6693
rs2466058 0.3620
rs2466049 0.2467
rs723811 0.7559
rs6988339 0.8954
rs2975498 0.4546
rs2919382 0.8370
rs2976525 0.4285
rs4262285 0.1664
rs3735776 0.9560
rs4512342 0.5004
rs10503929 0.5756
rs6992642 0.5045
rs3735781 0.3520
rs3735782 0.6542
Spatial Memory
Table 26. Spatial memory (Non-target): Model comparisons and estimation of specif ic components 
of the SNP x age interaction in cognitive performance prediction
Note. P-values are reported. Proportion of variance is provided for signif icant (p<0.05) effects. 
Nominally signif icant (p<0.05) values are bolded.
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Figure 10. Spatial Memory (Non-target): Graphs of the interactions between SNP minor allele dose and age in predicting cognitive 
performance. 
 
Linear curve-fitting was applied due to the linear relationship between this domain and 
age. Compared to the wildtype, the minor allele had inconsistent effects depending on the 
dosage. The major allele homozygote and heterozygote show a consistent pattern throughout life, 
with the major allele homozygote consistently performing slightly better than the heterozygote. 
The minor allele homozygote shows a different pattern: it shows better performance early in life, 
but worse later in life, intersecting with the major allele homozygote and heterozygote between 
age 40 and 50.  
3.4.4.2.3 Sensorimotor Dexterity. As seen in Table 27, there were 13 nominally 
significant findings in this domain, the most of any domain studied. Among target SNPs, there 
were seven significant total age interaction effects across markers SNP8NRG221132, 
SNP8NRG241930, rs776401, rs2439272, rs2466058, rs2466049, and rs2976525. 
SNP8NRG221132 and rs776401 had significant linear and cubic components without significant 
quadratic contributions. SNP8NRG241930, rs2439272, and rs2466058 had significant cubic 
N0: 134
N1: 161
N2: 51
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components without linear or quadratic contributions. Marker rs2466049 and rs2976525 had 
significant total age interaction effects without specific linear, quadratic, or cubic components.  
 
Marker Model1 Model2 -2LL Difference
Linear 
Component 
p-values
Quadratic 
Component 
p-values
Cubic 
Component 
p-values
Total Proportion 
of Variance 
Explained
SNP8NRG221132 -233.3970 -223.5782 19.6376 (p=0.0002) 0.0041 0.1293 0.0001 0.0311
SNP8NRG221533/rs35753505 -233.8804 -230.8417 6.0773 0.1682 0.5729 0.1282
rs4298458 -232.8909 -232.1265 1.5289 0.7569 0.3893 1.0000
SNP8NRG241930 -229.2886 -221.1448 16.2877 (p=0.001) 0.1082 0.1569 0.0052 0.0784
rs1081062 -233.5803 -232.1197 2.9211 0.8407 0.3210 0.3207
rs4566990 -233.2836 -231.9239 2.7193 0.5624 0.3306 0.3015
rs1354335 -228.6087 -228.7543 -0.2913 1.0000 0.5486 1.0000
rs1354336 -232.4276 -228.9710 6.9131 0.1253 0.4524 0.0216 *
rs1354334 -233.3296 -231.2885 4.0822 0.6978 0.3016 0.2545
SNP8NRG444511/rs13268724 -233.3589 -233.0771 0.5636 1.0000 0.4078 1.0000
rs776401 -213.0308 -196.3154 33.4307 (p=0.000000) 0.0321 0.1883 0.00006 0.0332
rs1473438 -231.6103 -219.6078 24.0050 (p=0.00003) 8.437 x 10-7 0.1729 0.0002 0.0246
rs1462893 -231.8464 -226.6286 10.4356 (p=0.015) 0.7602 0.0831 0.1965
rs10954821 -233.1319 -229.4734 7.3169 0.2850 1.0000 0.0998
rs726908 -232.1440 -224.1396 16.0087 (p=0.001) 0.0574 0.2973 1.0000
rs10954855 -233.3210 -231.7313 3.1793 0.2496 0.4636 0.1099
rs2439306 -216.2951 -214.0053 4.5797 0.0972 0.2915 0.0954
rs2466062 -231.7141 -230.6562 2.1159 0.4905 1.0000 0.2031
rs3924999 -233.4284 -232.2748 2.3073 0.0431 0.9337 1.0000 0.0255
rs2466060 -202.1204 -200.1234 3.9940 0.0595 0.3170 0.3478
rs2439272 -233.5364 -228.0079 11.0572 (p=0.011) 0.1373 0.2049 0.0189 0.0320
rs6468121 -219.4760 -214.7174 9.5172 (p=0.023) 0.6223 0.2083 0.0648
rs2466058 -232.9539 -228.8462 8.2153 (p=0.042) 0.1711 0.0902 0.0500 0.0725
rs2466049 -231.5896 -227.3691 8.4409 (p=0.038) 0.2011 0.0902 0.0549
rs723811 -233.0217 -229.8754 6.2925 1.0000 0.7377 0.1565
rs6988339 -233.3791 -232.5267 1.7048 0.2439 0.7194 0.3356
rs2975498 -232.9313 -232.9638 -0.0650 0.2601 0.7340 1.0000
rs2919382 -233.1528 -232.8808 0.5440 0.3797 1.0000 1.0000
rs2976525 -233.3972 -226.4623 13.8697 (p=0.003) 1.0000 0.1337 0.1113
rs4262285 -232.6278 -231.9624 1.3309 0.7630 0.5465 1.0000
rs3735776 -206.4748 -206.0988 0.7519 1.0000 0.2378 1.0000
rs4512342 -233.2366 -231.8204 2.8324 1.0000 0.1638 0.4377
rs10503929 -232.7226 -232.7172 0.0108 0.5518 0.6485 1.0000
rs6992642 -224.9860 -224.0740 1.8240 1.0000 0.2812 1.0000
rs3735781 -233.7141 -233.0421 1.3439 1.0000 0.2677 1.0000
rs3735782 -230.4901 -228.9297 3.1208 0.2204 0.2851 0.7335
Total NRG1  x Age Interaction Effect Interaction Components
Note. Total NRG1  x age interaction effect includes linear, quadratic, and cubic components for this domain. Model 1 includes the main effects of sex, age, 
age2, and age3, and each individual SNP. Model 2 provides the same elements as Model 1 plus SNP x age, SNP x age2, and SNP x age3. -2LL Difference is 
distributed as a chi-square function (critical values: 7.82, df=3, p<0.05). *Proportion of variance cannot be estimated due to its relatively small effect and 
repeated instability in the model. Nominally signif icant (p<0.05) difference values are bolded.
Table 27. Sensorimotor Dexterity (Non-target): Model comparisons and estimation of specif ic components of the SNP x age interaction in cognitive 
performance prediction
 
 
Among non-target SNPs, there were four significant total age interaction effects for 
markers rs1473438, rs1462893, rs726908, and rs6468121. SNP rs1473438 had significant linear 
and cubic components. Markers rs1462893, rs726908, and rs6468121 had significant total age 
interaction effects with no significant contributions from the linear, quadratic, or cubic elements. 
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Non-target marker rs1354336 had a significant cubic interaction component without linear or 
quadratic components or a significant total age interaction effect.  
The individual patterns of cognitive function by age for each SNP (minor allele dosage) 
for this domain are graphed in Figure 11. Cubic curve-fitting was applied due to the cubic nature 
of this domain with age. Given that SNP8NRG221132, rs2466058, rs2466049, and rs2976526 
each have less than five minor allele homozygotes, the pattern for these genotypes should not be 
interpreted. SNPs rs1354336 and rs1462893 have between 12 and 16 minor allele homozygotes, 
thus these specific genotypes should be interpreted with caution. As can be seen across all 
graphs, the interaction patterns in this domain vary widely by marker. In some cases, the minor 
allele confers an advantage (rs1462893, rs726908, and rs2439272), while it confers a detriment 
in others (SNP8NRG221132, SNP8NRG241930, rs1354336, rs776401, rs1473438, rs6468121, 
rs2466058, rs2466049, and rs2976525), and little impact for rs3924999. The age pattern varied 
widely. Some SNP-performance patterns showed only one point of divergence, while others had 
multiple ages of divergence across the lifespan. Among SNPs where the minor allele conferred 
an advantage, the age of divergence ranged from 25 to 50 years; while among SNPs where the 
minor allele was disadvantageous, the age of divergence ranged from 30 to 70 years.  
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Figure 11. Sensorimotor Dexterity (Non-target): Graphs of the interactions between SNP minor allele dose and age in predicting cognitive 
performance. 
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Figure 11 (continued). Sensorimotor Dexterity (Non-target): Graphs of the interactions between SNP minor allele dose and age in 
predicting cognitive performance. 
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3.4.4.3 Correction for Multiple Comparisons. The use of Bonferroni correction, and other 
similar methods, to control experiment-wise alpha error is overly conservative when tests are 
performed on correlated variables. In the present study, the SNPs are correlated with one another 
(through linkage disequilibrium), as are the cognitive domains. In order to more accurately 
control experiment-wise alpha error, the P-values Adjusted for Correlated Tests (pACT) program 
(Conneely & Boehnke, 2007), which takes into account the intercorrelations among both the 
cognitive domains and the SNP set, was used. This program was not designed to be used with 
interaction data, thus the trait values were residualized on sex, age, and the mean SNP effect for 
each participant and domain. Given the SNP effects are small, this probably introduced little or 
no bias. In addition, only the linear component of the SNP x age interaction could be tested, 
without the quadratic and/or cubic components. To our knowledge, no other program exists that 
can account for the intercorrelations between both independent and dependent variables when 
interactional data is used.  
Figure 11 (continued). Sensorimotor Dexterity (Non-target): Graphs of the interactions between SNP minor allele dose and age in predicting 
cognitive performance. 
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Two pACT analyses were performed: one for the target SNPs and target domains, and the 
other on all SNPs and all domains. Based on the observed correlational structure among both the 
target SNPs and target cognitive domains, pACT estimated that the 95 (19 SNPs * 5 domains) 
correlated tests performed was equivalent to 49 independent tests.  Thus, the significance level 
needed to yield an experiment-wise alpha error of .05 was .001 (.05/49) for the target-target 
analyses. At this level of significance, none of the nominally significant interactions remained 
significant at the level of the linear component.  
For the analysis including all SNPs and all domains, pACT estimated that the 288 (36 
SNPs * 8 domains) correlated tests was equivalent to 156 independent tests. The significance 
level needed to yield an experiment-wise alpha error of .05 was .0004 (.05/156) for the overall 
analyses. At this level of significance, none of the nominally significant interactions remain 
significant for the linear component. However, there are multiple highly significant -2LL model 
differences for the sensorimotor domain that exceed this threshold. Specifically, the interactions 
for SNP8NRG221132, rs776401, and rs1473438 remain significant after correction. In all three 
of these cases, the significance of the model change difference is driven by nominally significant 
linear and cubic components. Although the pACT was not able to be performed on the -2LL 
model data, the pACT results from the linear interaction provide a guideline for estimating the 
significance threshold. 
3.4.5 Sensitivity Analyses: Re-estimation of Models with Diagnosis and IQ as Covariates 
To better understand the previous results and assess the importance of characteristics that might 
be causally related to cognitive function in this sample, the models were re-estimated with 
diagnosis and intelligence as covariates. Because schizophrenia-spectrum diagnoses have been 
related to mild-to-moderate impairments in cognition, and because intelligence level is closely 
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related to cognitive function, spectrum diagnosis (i.e., schizoaffective disorder-bipolar type, 
bipolar disorder I and II, MDD with psychotic features, other organic or nonorganic psychosis, 
and cluster A personality disorder) versus other psychopathology plus no diagnosis group status 
and age-standardized WRAT scores were included as covariates in sensitivity analyses of the 
previously nominally significant interaction findings. This step provided the ability to gauge 
whether the previous significant findings might be the result of diagnostic and intelligence-
related variance that is causally related to cognitive function, allowing a better understanding of 
the relationships between these characteristics and test the robustness of our previous results.  
These analyses were conducted using the stage 3 residuals, thus stages 1-3 of the 
previous models did not change. Spectrum diagnosis and WRAT were entered as covariates for 
only those SNP and domain combinations in which one or more components (linear, quadratic, 
and/or cubic) or the overall -2LL model difference was nominally significant. As can be seen in 
Tables 28 (target domains) and 29 (non-target domains), the spectrum variable was only a 
significant covariate for eight of nine SNPs in the Emotional Processing task and not significant 
for any other domain. This is consistent with the previous analyses (Tables 12 and 13) that 
showed that the performance of the spectrum group was not always significantly different when 
compared to the no diagnosis and/or other psychopathology groups. The effects of WRAT as a 
covariate, however, were highly significant for nearly every SNP-domain analysis, which is 
consistent with the significant Pearson correlations (Table 14) between WRAT and domain 
performance within this sample.  
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Marker Spectrum WRAT
Total Proportion 
of Variance 
Explained Spectrum WRAT
Total Proportion 
of Variance 
Explained Spectrum WRAT
Total Proportion 
of Variance 
Explained Spectrum WRAT
Total Proportion 
of Variance 
Explained
SNP8NRG221132
SNP8NRG221533/rs35753505 0.1842 1.587 x 10-10 0.1370 0.0143 4.235 x 10-12 0.1667
rs4298458 0.0161 3.869 x 10-12 0.1643
SNP8NRG241930
rs1081062
rs4566990 0.4035 1.507 x 10-8 0.0513 0.0087 2.054 x 10-12 0.1776
rs1354335
rs1354336
rs1354334 0.0092 1.825 x 10-12 0.1766
SNP8NRG444511/rs13268724
rs776401 0.0736 1.757 x 10-12 0.1584
rs1473438 0.4540 3.928 x 10-18 0.2541 0.0061 3.316 x 10-12 0.1745
rs1462893
rs10954821 0.0144 3.497 x 10-12 0.1694
rs726908 0.0921 3.818 x 10-10 0.1316
rs10954855
rs2439306
rs2466062
rs3924999 0.2324 1.267 x 10-10 0.1355
rs2466060
rs2439272 0.4313 2.258 x 10-8 0.0470
rs6468121 0.6778 3.573 x 10-7 0.0308
rs2466058 0.1953 1.543 x 10-10 0.1337
rs2466049 0.1951 1.668 x 10-10 0.1335
rs723811 0.0148 4.395 x 10-12 0.1612
rs6988339 0.4765 6.893 x 10-8 0.0399
rs2975498
rs2919382
rs2976525
rs4262285 0.0130 3.612 x 10-12 0.1667
rs3735776
rs4512342
rs10503929
rs6992642
rs3735781
rs3735782 0.3693 2.484 x 10-8 0.0279
Table 28. Target Domains: Signif icance of spectrum diagnoses and IQ as covariates for previously signif icant interaction models
Note. Unadjusted p-values are reported and nominally signif icant (p<0.05) values are bolded. Covariate estimation w as only performed for SNP-domain combinations that had signif icant interactions previously. Shaded 
cells indicate target SNPs-target cognitive domain estimations. Proportion of variance explained incorporates both the spectrum and WRAT contributions. Spectrum: schizoaffective disorder-bipolar type, bipolar disorder I & 
II, MDD w ith psychotic features, other organic or nonorganic psychosis, and cluster A personality disorder; WRAT: Wide Range Achievement Test, reading subtest.
Abstraction & Mental Flexibility Attention Spatial Processing Emotional Processing
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Table 29. Non-Target Domains: Signif icance of spectrum diagnoses and IQ as covariates for previously signif icant interaction models
Marker Spectrum WRAT
Total Proportion 
of Variance 
Explained Spectrum WRAT
Total Proportion 
of Variance 
Explained
SNP8NRG221132 0.7704 3.890 x 10-6 0.0924
SNP8NRG221533/rs35753505
rs4298458
SNP8NRG241930 0.8046 3.550 x 10-6 0.0976
rs1081062
rs4566990 0.6068 0.0350 0.0194
rs1354335
rs1354336 0.5716 7.966 x 10-6 0.0712
rs1354334
SNP8NRG444511/rs13268724
rs776401 0.7600 1.215 x 10-6 0.0897
rs1473438 0.5704 4.039 x 10-6 0.0950
rs1462893 0.7413 0.00002 0.0765
rs10954821
rs726908 0.6148 4.687 x 10-6 0.0932
rs10954855
rs2439306
rs2466062
rs3924999 0.5223 3.485 x 10-6 0.0920
rs2466060
rs2439272 0.7341 1.846 x 10-6 0.0979
rs6468121 0.4828 8.533 x 10-7 0.1131
rs2466058 0.8022 3.941 x 10-6 0.0969
rs2466049 0.7845 3.399 x 10-6 0.0978
rs723811
rs6988339
rs2975498
rs2919382
rs2976525 0.7718 3.902 x 10-6 0.0925
rs4262285
rs3735776
rs4512342
rs10503929
rs6992642
rs3735781
rs3735782
Spatial Memory Sensorimotor Dexterity
Note. Unadjusted p-values are reported and nominally signif icant (p<0.05) values are bolded. Covariate estimation w as only 
performed for SNP-domain combinations that had signif icant interactions previously. Proportion of variance explained 
incorporates both the spectrum and WRAT contributions. Spectrum: schizoaffective disorder-bipolar type, bipolar disorder I & II, 
MDD w ith psychotic features, other organic or nonorganic psychosis, and cluster A personality disorder; WRAT: Wide Range 
Achievement Test, reading subtest.  
 
3.4.5.1 SNP x Age Interactions in Target Domains with Spectrum and WRAT Covaried. 
Overall, there were numerous changes in the significance levels of interactions that had been 
previously nominally significant at the level of the linear, quadratic, or cubic components and/or 
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-2LL model difference in the target cognitive domains. These results can be compared to the 
previous findings in Tables 20-23.  
At the level of the -2LL model difference, as seen in Tables 30-33, there were 11 changes 
in significance in the target domains, eight of which were interactions that were previously 
nominally significant but became non-significant when spectrum and WRAT were added into the 
model. Three previously non-significant interactions became nominally significant with these 
covariates, one in the domain of Abstraction/Mental Flexibility and two in the Attention domain. 
At the level of the linear component, nine changes in significance were found, eight of which 
became non-significant, and one, in the Emotional Processing domain, became nominally 
significant. At the level of the quadratic component, seven changes were detected, all involving 
previously nominally significant interactions that became non-significant. In general, the 
proportion of variance explained by the interaction components when these covariates were 
included in the model was reduced compared to the previous analyses. 
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Marker Model1 Model2 -2LL Difference
Linear Component 
p-values
Quadratic 
Component 
p-values
Total Proportion 
of Variance 
Explained
SNP8NRG221132
SNP8NRG221533/rs35753505 -141.9276 -138.9148 6.0256 (0.049) [0.032] 0.0146 [0.0089] 0.6875 0.018
rs4298458
SNP8NRG241930
rs1081062
rs4566990
rs1354335
rs1354336
rs1354334
SNP8NRG444511/rs13268724
rs776401
rs1473438
rs1462893
rs10954821
rs726908 -141.7220 -138.4714 6.5011 (0.038) [ns] 0.0112 [0.0469] 0.6353 0.020
rs10954855
rs2439306
rs2466062
rs3924999 -142.4214 -141.0236 2.7957 0.1173 0.4905 0.009
rs2466060
rs2439272
rs6468121
rs2466058 -142.5702 -140.7777 3.5850 0.0623 0.8217 0.011
rs2466049 -142.5981 -140.7472 3.7018 0.0587 0.8127 0.011
rs723811
rs6988339
rs2975498
rs2919382
rs2976525
rs4262285
rs3735776
rs4512342
rs10503929
rs6992642
rs3735781
rs3735782
Total NRG1  x Age Interaction Effect Interaction Components
Note. Total NGR1  x age interaction effect includes linear and quadratic effects for this domain. Model 1 includes the main effects of sex, age and 
age2, each individual SNP, and the main effects of spectrum diagnostic status and IQ. Model 2 provides the same elements as Model 1 plus SNP x age 
and SNP x age2. -2LL Difference is distributed as a chi-square function (critical value: 5.99, df=2, p<0.05). Shaded cells indicate target SNPs-target 
cognitive domain estimations. Nominally signif icant (p<0.05) difference values are bolded. P-values for the previous model are provided in square 
brackets ([ ]) for currently signif icant effects. ns: non-signif icant.
Table 30. Abstraction and Mental Flexibility (Target): Model comparisons and estimation of specif ic components of the SNP x age interaction for 
previously signif icant f indings w hen spectrum diagnosis and IQ are included as covariates
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Marker Model1 Model2 -2LL Difference
Linear Component 
p-values
Quadratic 
Component 
p-values
Total Proportion 
of Variance 
Explained
SNP8NRG221132
SNP8NRG221533/rs35753505
rs4298458
SNP8NRG241930
rs1081062
rs4566990 -318.3273 -317.1517 2.3512 0.1323 0.6667 0.031
rs1354335
rs1354336
rs1354334
SNP8NRG444511/rs13268724
rs776401
rs1473438
rs1462893
rs10954821
rs726908
rs10954855
rs2439306
rs2466062
rs3924999
rs2466060
rs2439272 -318.4292 -316.8517 3.1550 0.1344 0.2900 0.011
rs6468121 -311.5479 -309.8980 3.2998 0.0694 0.9428 0.015
rs2466058
rs2466049
rs723811
rs6988339 -319.5867 -315.5571 8.0592 (0.018) [ns] 0.0136 [0.0431] 0.1038 0.031
rs2975498
rs2919382
rs2976525
rs4262285
rs3735776
rs4512342
rs10503929
rs6992642
rs3735781
rs3735782 -315.0592 -310.3720 9.3744 (0.009) [ns] 0.0050 [0.0535] 0.0954 0.043
Total NRG1  x Age Interaction Effect Interaction Components
Note. Total NGR1  x age interaction effect includes linear and quadratic effects for this domain. Model 1 includes the main effects of sex, age and 
age2, each individual SNP, and the main effects of spectrum diagnostic status and IQ. Model 2 provides the same elements as Model 1 plus SNP x age 
and SNP x age2. -2LL Difference is distributed as a chi-square function (critical value: 5.99, df=2, p<0.05). Shaded cells indicate target SNPs-target 
cognitive domain estimations. Nominally signif icant (p<0.05) difference values are bolded. P-values for the previous model are provided in square 
brackets ([ ]) for currently signif icant effects. ns: non-signif icant.
Table 31. Attention (Target): Model comparisons and estimation of specif ic components of the SNP x age interaction for previously signif icant 
f indings w hen spectrum diagnosis and IQ are included as covariates
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Marker Model1 Model2 -2LL Difference
Linear 
Component 
p-values
Quadratic 
Component 
p-values
Total Proportion 
of Variance 
Explained
SNP8NRG221132
SNP8NRG221533/rs35753505
rs4298458
SNP8NRG241930
rs1081062
rs4566990
rs1354335
rs1354336
rs1354334
SNP8NRG444511/rs13268724
rs776401
rs1473438 -112.4051 -111.9380 0.9342 0.3955 0.5989 0.004
rs1462893
rs10954821
rs726908
rs10954855
rs2439306
rs2466062
rs3924999
rs2466060
rs2439272
rs6468121
rs2466058
rs2466049
rs723811
rs6988339
rs2975498
rs2919382
rs2976525
rs4262285
rs3735776
rs4512342
rs10503929
rs6992642
rs3735781
rs3735782
Total NRG1  x Age Interaction Effect Interaction Components
Note. Total NGR1  x age interaction effect includes linear and quadratic effects for this domain. Model 1 includes the main effects of sex, 
age and age2, each individual SNP, and the main effects of spectrum diagnostic status and IQ. Model 2 provides the same elements as 
Model 1 plus SNP x age and SNP x age2. -2LL Difference is distributed as a chi-square function (critical value: 5.99, df=2, p<0.05). Shaded 
cells indicate target SNPs-target cognitive domain estimations. Nominally signif icant (p<0.05) difference values are bolded. P-values for the 
previous model are provided in square brackets ([ ]) for currently signif icant effects.
Table 32. Spatial Processing (Target): Model comparisons and estimation of specif ic components of the SNP x age interaction for 
previously signif icant f indings w hen spectrum diagnosis and IQ are included as covariates
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Marker Model1 Model2 -2LL Difference
Linear 
Component 
p-values
Quadratic 
Component 
p-values
Total Proportion 
of Variance 
Explained
SNP8NRG221132
SNP8NRG221533/rs35753505 -235.0025 -233.0888 3.8274 0.0611 0.8665 0.010
rs4298458 -237.2113 -236.1266 2.1694 0.1394 0.9384 0.007
SNP8NRG241930
rs1081062
rs4566990 -235.2268 -234.7914 0.8708 0.6933 0.3959 *
rs1354335
rs1354336
rs1354334 -235.1049 -234.8154 0.5790 0.8419 0.4645 *
SNP8NRG444511/rs13268724
rs776401 -231.1943 -229.8751 2.6384 0.1021 0.1909 0.012
rs1473438 -235.1721 -233.2794 3.7854 0.0439 [ns] 0.2606 0.015
rs1462893
rs10954821 -236.8999 -236.1654 1.4689 0.4247 0.3864 0.004
rs726908
rs10954855
rs2439306
rs2466062
rs3924999
rs2466060
rs2439272
rs6468121
rs2466058
rs2466049
rs723811 -237.9115 -237.4147 0.9936 0.3479 0.6341 0.001
rs6988339
rs2975498
rs2919382
rs2976525
rs4262285 -237.5613 -235.6574 3.8078 0.0880 0.4212 0.011
rs3735776
rs4512342
rs10503929
rs6992642
rs3735781
rs3735782
Total NRG1  x Age Interaction Effect Interaction Components
Note. Total NGR1  x age interaction effect includes linear and quadratic effects for this domain. Model 1 includes the main effects of sex, 
age and age2, each individual SNP, and the main effects of spectrum diagnostic status and IQ. Model 2 provides the same elements as Model 
1 plus SNP x age and SNP x age2. -2LL Difference is distributed as a chi-square function (critical value: 5.99, df=2, p<0.05). Shaded cells 
indicate target SNPs-target cognitive domain estimations. Nominally signif icant (p<0.05) difference values are bolded. P-values for the 
previous model are provided in square brackets ([ ]) for currently signif icant effects. ns: non-signif icant.
Table 33. Emotional Processing (Target): Model comparisons and estimation of specif ic components of the SNP x age interaction for 
previously signif icant f indings w hen spectrum diagnosis and IQ are included as covariates
 
 
3.4.5.2 SNP x Age Interactions in Non-target Domains with Spectrum and WRAT 
Covaried. There were also numerous changes in the significance levels of interactions that had 
been previously nominally significant in the non-target cognitive domains. These results can be 
directly compared to the previous findings in Tables 26 and 27.  
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At the level of the -2LL model difference, as seen in Tables 34-35, there were eight 
changes in significance, all of which became non-significant with the addition of spectrum and 
WRAT as covariates. At the level of the linear component, five changes in significance were 
found, all of which became non-significant. There were zero changes at the level of the quadratic 
component. At the level of the cubic component (Sensorimotor Dexterity), five changes were 
detected, all involving previously nominally significant interactions that became non-significant. 
Overall, the proportion of variance explained by the interaction components when these 
covariates were included in the model was mixed; sometimes including these covariates 
increased the variance explained and sometimes it decreased it.  
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Marker
Linear 
Component 
p-values
Proportion of 
Variance
SNP8NRG221132
SNP8NRG221533/rs35753505
rs4298458
SNP8NRG241930
rs1081062
rs4566990 0.0861 0.004
rs1354335
rs1354336
rs1354334
SNP8NRG444511/rs13268724
rs776401
rs1473438
rs1462893
rs10954821
rs726908
rs10954855
rs2439306
rs2466062
rs3924999
rs2466060
rs2439272
rs6468121
rs2466058
rs2466049
rs723811
rs6988339
rs2975498
rs2919382
rs2976525
rs4262285
rs3735776
rs4512342
rs10503929
rs6992642
rs3735781
rs3735782
Spatial Memory
Table 34. Spatial Memory (Non-Target): Model comparisons and estimation of specif ic components of the SNP x age 
interaction for previously signif icant f indings w hen spectrum diagnosis and IQ are included as covariates
Note. Nominally signif icant (p<0.05) difference values are bolded. P-values for the previous model are provided in square 
brackets ([ ]) for currently signif icant effects.
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Marker Model1 Model2 -2LL Difference
Linear 
Component 
p-values
Quadratic 
Component 
p-values
Cubic Component p-
values
Total Proportion 
of Variance 
Explained
SNP8NRG221132 -914.9657 -914.2265 1.4784 0.9283 0.2950 0.7905 0.0027
SNP8NRG221533/rs35753505
rs4298458
SNP8NRG241930 -906.8233 -906.5339 0.5788 0.6810 0.5475 0.6455 *
rs1081062
rs4566990
rs1354335
rs1354336 -903.0893 -901.5359 3.1068 0.1864 0.7483 0.0909 0.026
rs1354334
SNP8NRG444511/rs13268724
rs776401 -885.0334 -880.4461 9.1746 (0.027) [0.000000] 0.1008 0.9367 0.01126 [0.00006] 0.049
rs1473438 -912.0624 -906.9998 10.1252 (0.018) [0.00003] 0.0805 0.6730 0.00843 [0.0002] 0.070
rs1462893 -912.5865 -909.6540 5.8650 0.7864 0.3353 0.4761 0.048
rs10954821
rs726908 -911.7173 -905.3300 12.7746 (0.005) [0.001] 0.9185 0.7048 0.1659 0.029
rs10954855
rs2439306
rs2466062
rs3924999 -912.8120 -909.4497 6.7246 0.4313 0.4029 0.8453 0.075
rs2466060
rs2439272 -912.4454 -911.4444 2.0020 0.4633 0.3376 0.3481 *
rs6468121 -907.0537 -906.0711 1.9652 0.8639 0.2348 0.6323 *
rs2466058 -914.5545 -912.2974 4.5142 0.1830 0.2191 0.0759 0.005
rs2466049 -912.1083 -910.0887 4.0392 0.2416 0.2440 0.0972 0.003
rs723811
rs6988339
rs2975498
rs2919382
rs2976525 -914.9656 -913.3722 3.1868 0.6514 0.2820 0.1834 0.010
rs4262285
rs3735776
rs4512342
rs10503929
rs6992642
rs3735781
rs3735782
Total NRG1  x Age Interaction Effect Interaction Components
Note. Total NGR1  x age interaction effect includes linear and quadratic effects for this domain. Model 1 includes the main effects of sex, age, age2, and age3, each 
individual SNP, and the main effects of spectrum diagnostic status and IQ. Model 2 provides the same elements as Model 1 plus SNP x age, SNP x age 2, and SNP x age3.  
-2LL Difference is distributed as a chi-square function (critical values: 7.82, df=3, p<0.05). Nominally signif icant (p<0.05) difference values are bolded. P-values for the 
previous model are provided in square brackets ([ ]) for currently signif icant effects.
Table 35. Sensorimotor Dexterity (Non-Target): Model comparisons and estimation of specif ic components of the SNP x age interaction for previously signif icant 
f indings w hen spectrum diagnosis and IQ are included as covariates
 
3.4.5.3 Summary. Overall, there were a number of previously nominally significant 
interactions that became non-significant when spectrum diagnosis and WRAT were included in 
the models, as well as a few that became nominally significant. This suggests that some of the 
variance in WRAT scores accounts for the previous nominally significant findings across 
multiple domains, while the variance in spectrum diagnosis only accounts for some findings in 
Emotional Processing. When this variation is removed through covarying, the interactions are no 
longer nominally significant.  
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3.4.6 Exploratory Analyses: Estimation of Sex, Age, SNP, and Interaction Effects on the WRAT 
Given the highly significant effect of the WRAT as a covariate in the previous analyses and the 
fact that it generally reduced the significance of previously nominally significant SNP x age 
interactions on cognitive performance, the raw (non-age-standardized) WRAT scores were 
examined as a trait of interest. Before proceeding with the multi-stage model, the genetic 
correlation and heritability of WRAT performance were estimated. As done previously with the 
cognitive domains, Rg was estimated in the combined affected and unaffected sample with age 
and sex screened as covariates. Rg was estimated to be -0.29 with sex as a covariate (age was not 
significant and omitted from the estimation) and was significantly different from both zero 
(p=0.043) and one (p=7.5 x 10
-16
). WRAT scores were also highly heritable in the unaffected 
sample: h
2
 = 0.69 (p=1.6 x 10
-13
).  
In stage 1 of the multi-stage model, the main effect of sex on the WRAT raw score was 
estimated, finding a trend towards significance (p=0.092) where females perform slightly better 
than males. As done with the cognitive domains, linear and curvilinear regression was performed 
in SPSS to investigate the relationship between WRAT performance and age using the residuals 
from the sex effects analysis. This analysis revealed a general lack of age effects on WRAT 
scores, with no significant R-square change values for linear, quadratic, and/or cubic models. 
This WRAT performance across age is presented in Figure 12. Using SOLAR, the main effect of 
the linear age component was also estimated and found to be non-significant (p=0.208). 
Importantly, the lack of age effects on WRAT scores also suggests that there are not potentially 
problematic cohort effects on WRAT performance, and perhaps other cognitive domains, in this 
sample. 
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Figure 12. Graph of the relationship between age and WRAT performance 
 
The main effects of individual SNPs on WRAT score were estimated in SOLAR using 
the residuals from stage 2. Table 36 presents the unadjusted significance levels and proportion of 
variance explained by individual SNPs. There were no significant main effects of SNPs on 
WRAT performance.    
The linear interactions between age and WRAT performance were estimated using the 
residuals from the stage 3 analysis. Table 36 also presents the unadjusted significance levels and 
proportion of variance explained by individual SNPs. Overall, there were very few significant 
interactions. Only rs2992642 and rs3735781 showed nominally significant interactions with age 
in predicting WRAT scores, and neither was significant after correction for multiple comparisons 
using a pACT-modified Bonferroni correction (p<.0024).  
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Marker p-value
Proportion of 
Variance
Linear Component 
p-value
Proportion of 
Variance
SNP8NRG221132 0.5190 0.8407
SNP8NRG221533/rs35753505 0.6009 0.5928
rs4298458 0.6707 0.5217
SNP8NRG241930 0.2153 0.1348
rs1081062 0.9286 0.4392
rs4566990 0.3675 0.8325
rs1354335 0.1208 0.2037
rs1354336 0.6187 0.3872
rs1354334 0.2702 0.8123
SNP8NRG444511/rs13268724 0.1592 0.2219
rs776401 0.6947 0.9090
rs1473438 0.7487 0.7732
rs1462893 0.2063 0.3988
rs10954821 0.8147 0.3545
rs726908 0.3198 0.7520
rs10954855 0.2821 0.4276
rs2439306 0.7855 0.6280
rs2466062 0.2295 0.2335
rs3924999 0.3150 0.8060
rs2466060 0.4366 0.9289
rs2439272 0.4623 0.7004
rs6468121 0.3113 0.6431
rs2466058 0.8159 0.8057
rs2466049 0.7587 0.7531
rs723811 0.5179 0.7631
rs6988339 0.2687 0.7486
rs2975498 0.4466 0.8304
rs2919382 0.3426 0.7511
rs2976525 0.3228 0.8272
rs4262285 0.3104 0.8631
rs3735776 0.7002 0.2196
rs4512342 0.4839 0.4420
rs10503929 0.8146 0.5172
rs6992642 0.7920 0.0140 0.0340
rs3735781 0.7208 0.0374 0.0269
rs3735782 0.9595 0.1000
Note. Unadjusted p-values are reported. Proportion of variance is provided w hen the effect is signif icant (p<0.05). 
Nominally signif icant (p<0.05) values are bolded.
Stage 3: SNP Effects Stage 4: SNP x Age Interactions
Table 36. Stages 3 and 4: Estimation of the main effects of individual SNPs and SNP x age interactions in the prediction 
of WRAT scores
 
 
The models for these two SNPs were re-estimated including spectrum as a covariate. 
There were no significant main effects of spectrum for either of these SNPs on WRAT 
performance, and both SNP x age interactions remained significant: rs6992642 (p=0.013, 
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explaining 3.4% of the variation in WRAT score) and rs3735781 (p=0.037, explaining 2.7% of 
variation).  
3.4.7 Exploratory Analyses: Estimation of Sex, Age, SNP, and Interaction Effects on CNB Factor Scores 
Given that the eight cognitive domains included in the computerized neurocognitive battery 
(CNB) used in this study are theoretically intercorrelated, this common variation was examined. 
Pearson correlations were calculated and exploratory factor analysis was used to determine 
whether the variation in these eight observed variables reflected fewer unobserved variables. 
Both the correlations and the factor analysis were performed on the sex- and age-residualized 
cognitive scores. As can be seen in Table 37, the domains are moderately to highly correlated 
with each other, as hypothesized. Every domain-domain correlation was significant, with 
Pearson coefficients ranging from 0.205 (Attention and Spatial Memory) to 0.513 (Emotional 
Processing and Spatial Processing). 
 
Abstraction & 
Mental Flexibility Attention
Spatial 
Processing
Emotional 
Processing Verbal Memory Facial Memory Spatial Memory
Sensorimotor 
Dexterity
Abstraction & 
Mental Flexibility 0.357 0.452 0.370 0.245 0.313 0.240 0.240
Attention 0.000 0.332 0.453 0.284 0.336 0.205 0.371
Spatial 
Processing 0.000 0.000 0.513 0.365 0.420 0.306 0.279
Emotional 
Processing 0.000 0.000 0.000 0.338 0.483 0.210 0.386
Verbal Memory 0.000 0.000 0.000 0.000 0.402 0.303 0.236
Facial Memory 0.000 0.000 0.000 0.000 0.000 0.358 0.303
Spatial Memory 0.000 0.000 0.000 0.000 0.000 0.000 0.219
Sensorimotor 
Dexterity 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Note.  Pearson correlation values are presented above the diagonal w ith p-values presented below  the shaded diagonal.
Table 37. Pearson correlations and p-values among the cognitive domains
 
 
 
 The significant correlations between all domains suggested reasonable factorability of the 
data. In addition, the Kaiser-Meyer-Olkin Measure of Sampling Adequacy was 0.855 (above the 
suggested threshold of 0.60) and Bartlett’s Test of Sphericity was significant (χ2(28) = 585.746, 
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p = 0.000). The diagonal values of the anti-image correlation matrix, which are the Measures of 
Sampling Adequacy, were all above 0.826, supporting the inclusion of each domain in the 
analysis. Finally, the communalities were all above 0.30, except for Spatial Memory (0.268), as 
shown in Table 38, further confirming that each domain shared common variance with other 
domains. Given these overall indicators, an exploratory factor analysis was conducted with all 
eight cognitive domains. 
Principal components analysis extracted one factor. Initial eigenvalues showed that this 
factor explained 42.06% of the total variance among the eight domains. Given that only one 
factor was extracted, no rotation was possible. The factor loading matrix for this solution is 
presented in Table 38. Overall, this analysis indicated that there was one distinct factor 
underlying the eight cognitive domains. The strength of factor loadings were (in order from 
highest to lowest): Emotional Processing, Facial Memory, Attention, Abstraction/Mental 
Flexibility, Verbal Memory, Sensorimotor Dexterity, Spatial Memory, and Spatial Processing.  
 
Table 38. Factor loadings and commonalities based on a principal components analysis w ith no rotation
CNB Factor Communality
Abstraction & Mental Flexibility 0.622 0.386
Attention 0.648 0.420
Spatial Processing 0.272 0.528
Emotional Processing 0.750 0.562
Verbal Memory 0.606 0.367
Facial Memory 0.711 0.506
Spatial Memory 0.518 0.268
Sensorimotor Dexterity 0.572 0.327
Note.  CNB: computerized neurocognitive battery.  
 
 
Factor scores for analyses were calculated from this exploratory factor analysis using the 
regression method. Although the domain scores used in the factor analysis were based on the 
sex- and age-residualized variables, the factor score was re-residualized for both sex and age to 
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eliminate any potential sex or age effects that might have remained in the composite variable. Rg 
was estimated in the combined affected and unaffected sample; however, age and sex could not 
be used as covariates due to repeated convergence failure. Rg was estimated to be -0.16 and was 
not significantly different from zero (p=0.553), but was significantly different from one 
(p=0.00001). The heritability of the factor score was highly significant: h
2
 = 0.52 (p=4.0 x 10
-7
). 
This factor was also moderately and significantly correlated with the age-standardized WRAT 
score (r=0.49, p=0.000).  
In stage 1 of the multi-stage model, the main effect of sex on the factor score was 
estimated and found to be non-significant (p=0.773). As in previous analyses, linear and 
curvilinear regression was performed in SPSS to investigate the relationship between factor score 
and age using the residuals from the sex effects analysis. This analysis revealed a significant 
quadratic relationship between age and factor score where the age of slope change was 47.42 
years, as seen in Figure 13. Quadratic effects were therefore included in all subsequent analyses. 
The main effects of age were also estimated in SOLAR in stage 2, and as expected, the linear 
component was not significant (p=0.198), while the quadratic component was (p=5.099 x 10
-9
). 
Together, the linear and quadratic components explained 9.39% of the variation in factor score.  
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Figure 13. Graph of the relationship between age and factor score 
 
 
The main effects of individual SNPs on factor score were estimated in SOLAR using the 
residuals from stage 2. Table 39 presents the unadjusted significance levels and proportion of 
variance explained by individual SNPs. There were no significant main effects of SNPs on factor 
score.    
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Marker p-value
Proportion of 
Variance
SNP8NRG221132 0.1011
SNP8NRG221533/rs35753505 0.5838
rs4298458 0.3566
SNP8NRG241930 0.3655
rs1081062 0.7033
rs4566990 0.2163
rs1354335 0.8175
rs1354336 0.2203
rs1354334 0.5139
SNP8NRG444511/rs13268724 0.8714
rs776401 0.6486
rs1473438 0.6341
rs1462893 0.1149
rs10954821 0.5108
rs726908 0.3123
rs10954855 0.1920
rs2439306 0.3552
rs2466062 0.1626
rs3924999 0.3171
rs2466060 0.6407
rs2439272 0.6262
rs6468121 0.4108
rs2466058 0.9162
rs2466049 0.9023
rs723811 0.8796
rs6988339 0.5265
rs2975498 0.5483
rs2919382 0.6015
rs2976525 0.6665
rs4262285 0.4442
rs3735776 0.1759
rs4512342 0.5879
rs10503929 0.2469
rs6992642 0.8196
rs3735781 0.7654
rs3735782 0.8422
Note. Unadjusted p-values are reported. Proportion of variance is 
provided w hen the effect is signif icant (p<0.05). Nominally 
signif icant (p<0.05) values are bolded.
Table 39. Estimation of the main effects of individual SNPs on factor score
 
 
The linear and quadratic interactions between age and factor score, as well as the -2LL 
model differences, were estimated using the residuals from the stage 3 analysis, as seen in Table 
40.  
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Marker Model1 Model2 -2LL Difference
Linear 
Component 
p-values
Quadratic 
Component 
p-values
Total 
Proportion of 
Variance 
Explained
SNP8NRG221132 -229.0379 -228.4698 1.1361 0.8464 0.2865
SNP8NRG221533/rs35753505 -229.3833 -228.4739 1.8188 0.3467 0.5292
rs4298458 -229.9569 -229.5163 0.8812 0.7762 0.4132
SNP8NRG241930 -226.0461 -224.8021 2.4880 0.2390 0.3391
rs1081062 -229.5804 -229.2126 0.7356 0.5094 0.6052
rs4566990 -229.6176 -228.2384 2.7585 0.1555 0.2854
rs1354335 -225.2893 -225.2757 0.0273 0.9318 0.8837
rs1354336 -227.3073 -227.2345 0.1454 0.7041 0.9736
rs1354334 -230.1687 -229.2724 1.7927 0.4764 0.2158
SNP8NRG444511/rs13268724 -230.3687 -230.2422 0.2531 0.7314 0.7023
rs776401 -228.9099 -228.0193 1.7813 0.6239 0.2423
rs1473438 -228.7369 -228.0522 1.3693 0.7588 0.2763
rs1462893 -229.0634 -227.3030 3.5207 0.1153 0.2279
rs10954821 -230.1657 -229.6667 0.9979 0.6205 0.4627
rs726908 -228.1448 -225.8964 4.4967 0.0376 0.6368 0.044
rs10954855 -229.5306 -229.1052 0.8507 0.9899 0.3571
rs2439306 -224.7313 -224.6199 0.2228 0.6636 0.8329
rs2466062 -223.4538 -223.3081 0.2914 0.8830 0.6195
rs3924999 -228.5134 -228.2898 0.4470 0.6990 0.6518
rs2466060 -209.1356 -208.7716 0.7281 0.4194 0.6232
rs2439272 -230.0226 -229.3255 1.3942 0.2826 0.7777
rs6468121 -226.3669 -225.6886 1.3566 0.2499 0.9663
rs2466058 -230.3763 -229.4880 1.7767 0.5597 0.2231
rs2466049 -228.9428 -228.0668 1.7521 0.5747 0.2230
rs723811 -230.3704 -230.2575 0.2258 0.7613 0.7697
rs6988339 -230.1813 -228.4310 3.5006 0.0620 0.8224
rs2975498 -230.2017 -228.9092 2.5849 0.1091 0.7586
rs2919382 -230.2454 -229.9245 0.6418 0.5033 0.6894
rs2976525 -230.2890 -228.4704 3.6370 0.0924 0.3436
rs4262285 -230.0892 -229.4481 1.2822 0.5749 0.9815
rs3735776 -201.0062 -200.8983 0.2159 0.6592 0.7753
rs4512342 -230.1590 -229.1085 2.1010 0.3695 0.3608
rs10503929 -229.7115 -229.5995 0.2239 0.9576 0.6586
rs6992642 -224.6785 -224.3944 0.5681 0.4537 0.9066
rs3735781 -230.1183 -229.8272 0.5821 0.4465 0.9433
rs3735782 -227.5358 -226.2800 2.5116 0.1316 0.5779
Total NRG1  x Age Interaction Effect Interaction Components
Note. Total NGR1  x age interaction effect includes linear and quadratic effects for this domain. Model 1 includes the main effects of 
sex, age and age2. Model 2 provides the same elements as Model 1 plus SNP x age and SNP x age2. -2LL Difference is distributed 
as a chi-square function (critical value: 5.99, df=2, p<0.05). Shaded cells indicate target SNPs-target cognitive domain estimations. 
Nominally signif icant (p<0.05) difference values are bolded.
Table 40. Factor Score: Model comparisons and estimation of specif ic components of the SNP x age interaction in predicting factor 
score
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Overall, there were no significant -2LL model differences, but there was one nominally 
significant interaction component: the linear component of the interaction with rs726908 
explained 4.4% of the variance in factor score. This was no longer significant after correction for 
multiple comparisons using a pACT-modified Bonferroni correction (p<.0032). The model for 
this SNP was re-estimated including spectrum diagnosis and WRAT performance as covariates. 
Significant main effects of both spectrum (p=0.017) and WRAT score (1.63 x 10
-17
) on CNB 
factor score were found, but the SNP x age interaction on CNB factor score was not significant at 
the linear (p=0.194) or quadratic level (p=0.550).  
 104 
4.0 DISCUSSION 
4.1 SUMMARY OF FINDINGS 
The current study utilized a multi-stage analytic strategy to better understand NRG1 SNP x age 
interactions in the prediction of cognitive performance. A summary of each analysis is provided 
below.  
4.1.1 Selection of Target and Non-Target Cognitive Domains 
Given the a priori hypothesis that cognitive domains with significant genetic correlation with 
affected status and heritability would be more likely to show significant SNP x age interaction 
effects than domains without these two characteristics, cognitive domains were designated as 
being either “target” or “non-target.” This designation allowed for a two-step correction for 
multiple comparisons; first, with the target domains alone and then with all domains. This 
procedure allowed for a multiple comparison correction that was more appropriate for the target 
domains, thus allowing a correction that would reduce alpha error risk while maintaining 
appropriate power to detect significant effects. 
 The target/non-target designation was based on the genetic correlation with affected 
status and the heritability of each domain. Genetic correlations provide an estimate of the amount 
of shared genetic variance that underlies the relationship between cognitive performance and 
schizophrenia, enabling the identification of variables that are likely important to schizophrenia’s 
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etiology. Thus, the genetic correlation value was weighted more heavily when assessing each 
domain for the target/non-target designation. Heritability levels estimate the amount of variance 
in cognitive performance that is due to genetic variation, but are not specific to schizophrenia, 
thus this value was ranked second when making designations.  
Based on the procedure described above, the following five domains were designated as 
target domains: Abstraction/Mental Flexibility, Attention, Spatial Processing, Emotional 
Processing, and Verbal Memory. These domains were significantly genetically correlated with 
schizophrenia in this sample, indicating the presence of shared genetic effects between these 
domains and affected status (see Table 15), and were significantly heritable, suggesting that a 
significant amount of variation in performance in these cognitive areas is due to genetic variation 
(see Table 16). In contrast, Facial Memory, Spatial Memory, and Sensorimotor Dexterity were 
designated as non-target domains because they were not significantly genetically correlated with 
schizophrenia, despite having significant heritabilities.  
Taken together, these findings suggest that although a large amount of the variation in 
cognitive function on the present computerized neurocognitive battery is due to genetic variation, 
it is not all related to schizophrenia, and the amount related to affected status varies among 
cognitive domains. The discussion of results is organized based on this target/non-target 
distinction. 
4.1.2 Summary of Major Findings: Target Cognitive Domains 
As hypothesized, the main effects of age were significant for every target domain, with most 
showing a curvilinear pattern whereby cognition improved until early- to mid-adulthood and then 
began to decline, although Verbal Memory showed a linear decline with age (see Figure 4). 
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There were seven nominally significant SNP main effects across the target cognitive 
domains that encompassed six individual SNPs (see Table 19), three of which were target 
markers (SNP8NRG241930 – Verbal Memory; rs10954855 – Attention and Emotional 
Processing; rs3924999 – Emotional Processing) and three that were non-target (rs726908 – 
Emotional Processing; rs3735776 – Abstraction/Mental Flexibility; rs4512342 – 
Abstraction/Mental Flexibility). Spatial processing was the only target domain that had no 
nominally significant SNP main effects. 
Overall, there were numerous nominally significant total SNP x age interaction effects 
and/or significant specific components of interactions across multiple domains and markers (see 
Tables 20-24). The target domain with the most nominally significant interactions was 
Emotional Processing (fifteen), followed by Abstraction/Mental Flexibility and Attention (six 
each). In contrast, Spatial Processing (one) and Verbal Memory (zero) had few significant 
interactions. Interestingly, the interactions tended to be clustered toward the 5’ end of the gene 
for Emotional Processing, while they were spread across the gene for Abstraction/Mental 
Flexibility and Attention. Importantly, however, none of these interactions remained significant 
after correction by a modified Bonferroni procedure for the target SNPs-target domains (p<.001). 
Overall, these findings suggest that there are nominally significant NRG1 x age 
interactions in the prediction of some, but not all, of the target cognitive areas. More specifically, 
Emotional Processing, Abstraction/Mental Flexibility, and Attention each had potentially 
promising findings, although none exceeded the correction for multiple comparisons. Given that 
these domains are significantly genetically correlated with schizophrenia and heritable, this 
suggests that these interactions may be informative when considering the pathogenesis of 
schizophrenia.  
 107 
4.1.3 Summary of Major Findings: Non-target Cognitive Domains 
The main effects of age were also significant for every non-target domain. Facial memory 
showed a quadratic relationship with age whereby cognition improved until mid-life and then 
began to decline, while Spatial Memory showed a linear decline with age, and Sensorimotor 
Dexterity had a cubic relationship with age such that performance declined until early adulthood 
and then remained stable before declining again in mid-late life (see Figure 5). There were only 
two nominally significant SNP main effects across the non-target cognitive domains (see Table 
19), one with target SNP rs2466060 (Spatial Memory) and one with non-target SNP rs1462893 
(Facial Memory). Sensorimotor dexterity did not have any nominally significant SNP main 
effects. 
Investigation of the interactions between age and SNPs in the non-target domains (see 
Tables 25-27) found relatively few effects across individual markers in Facial (zero) and Spatial 
Memory (one). However, 22 total nominally significant interaction effects were detected for 
Sensorimotor Dexterity. Three of these interactions (SNP8NRG221132, rs776401, and 
rs1473438) remained significant after correction by a modified Bonferroni procedure that 
included all SNPs and all domains (p<.0004). 
Overall, these findings suggest that there are significant SNP x age interactions in the 
prediction of Sensorimotor Dexterity, including several that exceeded correction for multiple 
comparisons. However, although moderately heritable (h
2
 = 0.187, p=0.028), Sensorimotor 
Dexterity was not significantly genetically correlated with schizophrenia (Rg = -0.143, p=0.559). 
Thus these results are likely unrelated to the pathogenesis of the disorder and may instead 
indicate that these SNPs play an important age-moderated role in Sensorimotor Dexterity in the 
general population. 
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4.1.4 Summary of Major Findings: Covariate and Exploratory Analyses 
To investigate the robustness of these findings, analyses were conducted to explore the NRG1 x 
age and cognition relationships while covarying schizophrenia-spectrum diagnostic status and 
intelligence. These specific covariates were chosen due to a large literature that links them with 
cognitive function. In the case of spectrum diagnostic status, the literature consistently shows 
that patients with schizophrenia-spectrum disorders have cognitive deficits that are thought to 
share pathophysiological mechanisms with schizophrenia (Buchanan et al., 2005; Goldberg & 
Green, 2002). In the case of crystallized verbal intelligence (as measured by the WRAT), the 
literature suggests that, although commonly used neuropsychological tests measure some 
independent cognitive variation, they also often load onto a latent “g” or intelligence-like factor 
(Dickinson & Harvey, 2009). Given that these two variables may be significantly related to 
performance on the current study’s cognitive tasks and NRG1, they were included as covariates 
to determine whether they might mediate any potential NRG1 x age interactions on cognition. 
In most cases, previously significant interactions that were reassessed with these 
variables as covariates became non-significant, however the effects were not equally strong for 
both covariates. Except in the domain of Emotional Processing, spectrum diagnosis was a largely 
non-significant covariate, suggesting that it did not mediate NRG1 x age interactions outside of 
this domain. Intelligence, however, was a significant covariate for most analyses, suggesting that 
intelligence-related variance may partially mediate some of the SNP x age interactions on 
cognitive performance in this study. 
Because verbal intelligence appeared to be involved in NRG1 x age interactions on 
multiple cognitive domains when included as a covariate, its own relationship with NRG1 and 
age was explored. Intelligence (as measured by the raw, non-age-standardized WRAT scores) 
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was significantly genetically correlated with schizophrenia and highly heritable in the current 
sample. However, there were no significant main effects of age or NRG1 SNPs on intelligence. 
Interestingly, there were only two nominally significant interactions between two non-target 
NRG1 SNPs (rs6992642, rs3735781) and age in the prediction of intelligence, neither of which 
was significant after modified Bonferroni correction (p<.0024). These findings suggest that 
although intelligence is genetically correlated with schizophrenia, and thus potentially provides 
information about the pathogenesis of the disorder, this is likely independent of NRG1, as it is 
not associated with the SNPs in the current sample. 
As expected, the cognitive domains were also significantly intercorrelated with one 
another, thus exploratory factor analysis was used to better understand the relationships among 
the domains. This analysis found that one factor explained approximately 42% of the total 
variance. This factor was significantly heritable, but interestingly, was not genetically correlated 
with schizophrenia. A significant quadratic relationship between age and factor score was 
evident in which performance improved until approximately 47 years of age, at which time it 
began to decline. However, there were no significant main effects of NRG1 SNPs. There was 
only one significant interaction with age (rs726908) that was no longer significant after 
Bonferroni correction (p<.0032). Overall, this suggests that there are few significant SNP x age 
interactions on the common variation shared among domains, and furthermore, that this common 
variation is not genetically related to schizophrenia. Instead, it appears that the unique elements 
of the cognitive tests show more interactions and are more likely to be associated with the 
etiology of schizophrenia.  
 
 
 110 
4.1.5 Summary of Major Findings: SNP-wise Patterns 
Overall, there were few main effects of individual NRG1 SNPs on individual cognitive domains 
(see Table 19). Nominally significant SNP effects were seen across eight SNPs, with rs10954855 
being the SNP with the most effects across domains (two).  
Although there were relatively few SNP main effects, there were many more SNP-by-age 
interactions across the domains. In total, 24 individual SNPs had at least one nominally 
significant total interaction effect and/or specific interaction component. Overall, the SNPs with 
the most significant interaction findings were SNP8NRG221533/rs35753505 (target SNP; 4 
significant effects in Abstraction/Mental Flexibility and Emotional Processing), rs776401 (target; 
5 significant effects in Emotional Processing and Sensorimotor Dexterity), and rs1473438 (non-
target; 6 significant effects in Spatial Processing, Emotional Processing, and Sensorimotor 
Dexterity). All three of these SNPs are upstream of the first exon, between 31,474,141 and 
31,831,015bp on the gene. The functions of these SNPs are unknown at this time, although 
SNP8NRG221533/rs35753505 and rs776401 have been associated with schizophrenia 
previously (Benzel et al., 2007; Stefansson et al., 2002). 
4.2 DOMAIN-WISE FINDINGS AND COMPARISONS TO CURRENT LITERATURE 
Overall, there appear to be potentially promising interactions between NRG1 variants and age in 
the prediction of cognition in several domains. To better understand the findings of the current 
study, we will discuss the domains with the greatest number of nominally significant SNP x age 
interactions in greater detail, beginning with the most significant target domain. For a summary 
of the results in these domains, see Table 41.  
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Rg (p) h
2 (p)
Age of 
Slope 
Change
Significant SNP x Age 
Interactions
Target/
Non-
Target p-value^
Minor 
Allele 
Effect
Approximate Age 
of Divergence 
Among 
Genotypes
SNP x Age: 
Significant after 
IQ Covariation?
SNP8NRG221533/rs35753505 T 0.005 +/- 25, 50 N
rs4298458 T 0.130 +/- 25, 55 N
rs4566990 NT 0.009 + 30, 75 N
rs1354334 NT 0.005 + 30, 60 N
rs776401 T 0.002 +/- 30, 70 N
rs1473438 NT 0.003 +/- 25, 70 Y
rs10954821 NT 0.045 +/- 25, 65 N
rs723811 NT 0.042 + <15, 60 N
rs4262285 T 0.017 +/- <15, 40 N
SNP8NRG221533/rs35753505 T 0.009 + 50 Y
rs726908 NT 0.047 +/- 30 Y
rs3924999 T 0.049 + <15, 70 N
rs2466058 T 0.037 +/- 40 N
rs2466049 T 0.030 + 40 N
rs4566990 NT 0.034 + <15, 30 N
rs2439272 T 0.040 + 30 N
rs6468121 NT 0.011 - 20, 60 N
rs6988339 T 0.043 + 30 Y
rs3735782 NT 0.054 - <15, 30 Y
SNP8NRG221132 T 0.0001 - <15, 40, 60 N
SNP8NRG241930 T 0.001 - 50 N
rs1354336 NT 0.022 - <15, 40, 70 N
rs776401 T 0.000000 - <15, 40, 70 Y
rs1473438 NT 0.0000008 - <15, 40, 65 Y
rs1462893 NT 0.015 + 45 N
rs726908 NT 0.001 + 25 Y
rs3924999 T 0.043 +/- <15, 50, 80 N
rs2439272 T 0.011 + 50 N
rs6468121 NT 0.023 - 55 N
rs2466058 T 0.042 - <15, 30, 70 N
rs2466049 T 0.038 - <15, 30, 70 N
rs2976525 T 0.003 - <15, 40, 75 N
20, 55
0.187 
(0.0278)
-0.143 
(0.5587)
Note.  P-value listed for Rg is the difference from zero signif icance level. Age of slope change is estimated for sensorimotor dexterity. Interactions 
listed include those signif icant at the -2LL and/or the specif ic component levels. ^P-value reported is the most signif icant p-value across all interactions 
betw een the specif ic domain and SNP w hen multiple signif icant interactions or specif ic components are signif icant. Minor allele effect on performance: 
minor allele is advantageous (+), disadvantageous (-), or mixed (+/-) across the lifespan. Signif icant after IQ covariation: interaction remains signif icant 
(yes; Y) or is non-signif icant (no; N) after covariation w ith intelligence. T: target SNP; NT: non-target SNP.
Sensorimotor 
Dexterity 
(Non-target)
Table 41. Summary of important results for the most signif icant domains
Emotional 
Processing 
(Target)
Attention 
(Target)
Abstraction & 
Mental 
Flexibility 
(Target)
25.75
0.172 
(0.059)
-0.604 
(0.0047)
22.61
0.394       
(3.0 x 10-5)
-0.358 
(0.0542)
36.42
0.169 
(0.023)
-0.552 
(0.0147)
 
4.2.1 Target Domain: Emotional Processing 
The target domain of Emotional Processing showed significant genetic correlation with affected 
status, significant heritability, and a quadratic pattern in which performance rose and then began 
to decline at approximately 23 years of age (see Table 41 and Figure 4). There were 15 
significant interaction effects: seven total interaction effects and eight interaction components 
across nine SNPs (see Table 41), although none were significant after correction for multiple 
comparisons. The effect of the minor allele in this domain was inconsistent across SNPs, often 
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changing from being advantageous during one part of the lifespan to being detrimental in 
another, or vice versa (see Figure 9). The age at which performance-allele patterns began to 
diverge was typically split due to the shifting effect of the minor allele, with a divergence early 
in life (before age 30) and then later in life (at/after age 50). To our knowledge, no other studies 
have assessed NRG1 in relation to emotional processing performance.  
4.2.2 Target Domain: Abstraction/Mental Flexibility 
The target domain of Abstraction/Mental Flexibility also showed significant genetic correlation 
with affected status, significant heritability, and a quadratic pattern where the age at which 
performance began to decline was approximately 26 years (see Table 41 and Figure 4). There 
were six nominally significant SNP x age interaction effects: one of which was a total interaction 
effect and five that were interaction components across five SNPs. The effect of the minor alleles 
in this domain was generally advantageous to performance, especially at mid-life or later; 
however, two SNPs showed a pattern in which they were advantageous and disadvantageous at 
different parts of the lifespan (see Figure 6). Performance-allele patterns generally begin to 
diverge between the ages of 30 and 50 years.   
To our knowledge, only one other study has addressed the relationship between 
abstraction and mental flexibility tasks and NRG1. Kircher et al. (2009) found that the minor 
allele of SNP8NRG221533/rs35753505 was related to poorer semantic verbal fluency (often 
considered to be related to abstraction/mental flexibility skills) compared to the major allele in a 
sample of healthy individuals. In the current study, Abstraction/Mental Flexibility performance 
showed a significant age interaction with rs35753505 at both the total interaction effect and 
specific component levels. In contrast to Kircher et al. (2009), there was no significant main 
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effect of this SNP on Abstraction/Mental Flexibility performance and the minor allele was 
advantageous to performance in the SNP x age interaction.  
4.2.3 Target Domain: Attention 
The target domain of Attention showed significant genetic correlation with affected status, 
significant heritability, and a quadratic pattern in which performance began to decline at 
approximately 36 years of age (see Table 41 and Figure 4). There were six significant interaction 
effects: one which was a total interaction effect and five that were interaction components across 
five SNPs. The effects of the minor alleles in this domain were inconsistent; they conveyed an 
advantage to performance in three interactions but were detrimental in two others (see Figure 7). 
The age at which performance-allele patterns began to diverge was also inconsistent, with some 
SNPs showing divergence at 20 years and others at 60 years.  
To our knowledge, one other study has investigated the relationship between NRG1 and 
attention. Stefanis et al. (2007) found that sustained attention was associated with 
SNP8NRG221533/rs35753505 and microsatellite 433E1006, whereby the minor allele of 
SNP8NRG221533/rs35753505 and the G allele of the microsatellite were associated with poorer 
performance in a sample of Greek military conscripts. This SNP lacked both main effects and 
SNP x age interactions in the domain of attention in the current sample, and microsatellites were 
not genotyped in this study. 
4.2.4 Non-Target Domain: Sensorimotor Dexterity 
Surprisingly, the non-target domain of Sensorimotor Dexterity showed the highest number of 
significant interactions and was the only domain that had interactions that survived correction for 
multiple comparisons. Performance in this domain was significantly heritable, but was not 
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significantly genetically correlated with schizophrenia (see Table 41), thus these findings are 
unlikely to be related to the pathogenesis of this disorder and are more likely to apply to 
sensorimotor function in the general population.  
This domain showed a cubic pattern where the performance declined until the age of 
approximately 20 years, stabilized, and then began declining again at the age of 55 (see Figure 
5). There were 22 significant interaction effects: 11 total interaction effects and 11 interaction 
components across 13 SNPs. The effect of the minor allele in this domain was often detrimental 
to performance, with only four SNPs showing an advantage during some part of the lifespan (see 
Figure 11). Divergence of performance-allele patterns occurred typically during early life, mid-
life, and late life due to the cubic relationship that this domain had with age. To our knowledge, 
no other study has assessed the relationship between NRG1 and sensorimotor dexterity 
performance. 
4.3 AGE PATTERNS IN RELATION TO SCHIZOPHRENIA AGE OF ONSET 
In terms of the main effects of age, for most quadratic and cubic domains, the age at which 
cognitive performance began to worsen was near the end of the peak age of onset for 
schizophrenia. More specifically, Abstraction/Mental Flexibility, Emotional Processing, Facial 
Memory, and Sensorimotor Dexterity had performance patterns that showed declines between 
20-28 years of age, while Attention and Spatial Processing showed a worsening of cognition 
during the late 30s and early 40s (see Figures 4 and 5). Studies have commonly shown that fluid 
intelligence, and frontal cortical function more generally, plateaus or begins to decline in early 
adulthood (Craik & Bialystok, 2006), which is generally consistent with the findings of the 
current study.  
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However, in the analyses of SNP x age interactions, changes in genotype-performance 
patterns did not typically occur near the peak age of onset in most cases, although very different 
patterns were evident in the effects of the minor allele across the lifespan and across different 
cognitive domains. Across the total 34 nominally significant interactions, the majority of the 
interactions showed very complex patterns in which SNP-performance patterns diverged 
multiple times across the lifespan (n=22), while a few prototypical examples of early (n=1), 
middle (n=2), and late (n=9) divergence were apparent and are discussed in more detail below. 
The timing of divergence indicates the time at which genotype effects became differentiated, and 
thus may be of importance in terms of understanding the contribution that NRG1 SNPs may 
make to the onset of schizophrenia. As such, interactions that display early (earlier than age 20; 
before the period of greatest risk on onset), middle (between 20-30; during the period of greatest 
risk), and late (after age 30; in the post-risk period) divergence will be the focus of the following 
qualitative descriptions. In these discussions, we will focus solely on the pattern of divergence 
and ignore (1) the pattern of the minor allele homozygote because there are typically far fewer 
participants in this genotype group, and (2) the direction of the minor allele effect. 
 
4.3.1 Prototypical Performance by Genotype Patterns: Early Divergence 
There was only one interaction that showed an early divergence. In the domain of 
Abstraction/Mental Flexibility (see Figure 6), rs726908 showed a pattern in which the major 
allele homozygote and heterozygote are divergent before the age of 15. These genotype groups 
converge near the age of 45, at which time Abstraction/Mental Flexibility performance between 
them remains largely similar throughout the remainder of life. One hypothesis is that divergence 
of genotype effects may occur early, in this pre-onset period and may serve to time the onset of 
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schizophrenia; however, this sample provides only a snapshot of these effects due to the fact that 
all participants were 15 years or older at the time of study participation, thus limiting our ability 
to assess this hypothesis.  
4.3.2 Prototypical Performance by Genotype Patterns: Middle Divergence 
There were two interactions that showed prominent genotype effects in the risk period. As seen 
in Figure 7, rs2439272 and rs6988339 both show a pattern in which Attention performance is 
largely similar between the major allele homozygote and the heterozygote until the age of 
approximately 25-30, at which time the groups diverge for the rest of the lifespan. This 
divergence occurs at the end of the traditional risk period for schizophrenia, and thus may have 
some importance for age of onset, as hypothesized.  
Multiple patterns of change in this age period could support the hypothesis that these 
SNP effects may be related to onset of the disorder, including (1) a parallel pattern in which 
genotype differences emerge at the time of greatest risk and remain stable across the lifespan; (2) 
an amplification pattern in which the differences emerge and then increase throughout life; or (3) 
an effect that is only temporary near the onset period where genotype patterns converge again 
after the risk period. The findings in the Attention domain are consistent with the first, parallel-
type pattern.  
4.3.3 Prototypical Performance by Genotype Patterns: Late Divergence 
Somewhat surprisingly, the most common prototypical pattern (n=9) was one where divergence 
between genotype groups occurred past the typical risk period for schizophrenia. This pattern 
was seen across multiple domains and is most clearly illustrated in the domains of 
Abstraction/Mental Flexibility, Emotional Processing, and Sensorimotor Dexterity. 
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 In the domain of Abstraction/Mental Flexibility (see Figure 6), markers rs35753505, 
rs2466058, and rs2466049 all show a pattern in which the genotype groups perform relatively 
similarly until the age of 40-55, at which time the groups diverge for the rest of the lifespan. In 
Emotional Processing (see Figure 9), rs4262285 and rs4298458 diverge at approximately 40 and 
60 years of age, respectively, and remain separate throughout the rest of the lifespan. In the 
domain of Sensorimotor Dexterity (see Figure 11), SNP8NRG241930, rs1462893, rs2439272, 
and rs6468121 show a pattern in which the genotype groups are very similar until approximately 
the ages of 35-55 at which time the groups diverge throughout the rest of the lifespan.  
Interestingly, in each of these examples, the genotype effects begin after the risk period 
and increase in magnitude as age increases. This suggests that it is not a static change that is 
maintained between genotypes across the lifespan, but rather that the genotype effects become 
exaggerated with continued aging. This pattern is consistent with the hypothesis that NRG1 
SNPs play an important role in the continued function of the nervous system and cognitive 
performance throughout life. But this pattern is inconsistent with the idea that changes in 
genotype-performance patterns near the peak age of onset could serve to time the onset of the 
disorder.  
This pattern of persisting, cumulative SNP effects over the lifespan may be consistent 
with the hypothesized lack of age-related down-regulation of neurodevelopmental genes 
generally in schizophrenia (Torkamani et al., 2010), in which the effects accumulate over the 
lifespan due to continued expression of these genes over the lifespan, as well as the findings of 
overexpression of NRG1 specifically (Chong et al., 2008; Hashimoto et al., 2004; Law et al., 
2006). Although it would be expected that this over-expression would be related to the age of 
onset, and thus occur during the period of greatest risk for the disorder, a growing literature 
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suggests that there are molecular as well as progressive neurodevelopmental changes in this 
disorder (Archer, 2010; Torkamani et al., 2010). While the results of the current study do not 
suggest that NRG1 effects are particularly strong at the typical age of onset of schizophrenia, it 
may be that the accumulated effects of NRG1 over the lifespan are related to some of the 
progressive changes in brain structure that occur after schizophrenia onset (for a review, see 
Archer, 2010).  
It is also interesting when considering the findings of a recent study that employed both 
linkage and association methods to better understand the genetic causes of Alzheimer’s disease 
with psychosis (ADP) in families multiplex for ADP (Go et al., 2005). This study found a 
significant linkage peak on chromosome 8p that encompassed the NRG1 gene, a significant 
association between NRG1 SNP rs3924999 and affected status, and an association that trended 
toward significance for the NRG1 haplotype of rs3924999, SNP8NRG221533/rs35753505, and 
SNP8NRG243177. However, a study utilizing a mixed sample of Alzheimer’s disease patients 
with and without psychosis failed to replicate these findings (Middle et al., 2010). Taken 
together, the findings by Go et al. (2005) and the current study may suggest that NRG1 has 
continuing effects on cognition over the lifespan in individuals at risk for psychosis due to a 
family history of schizophrenia-spectrum disorders or Alzheimer’s disease with psychosis. 
Another consideration of these patterns is the increased interindividual variation in 
cognition that is believed to occur later in life. A number of studies have found increased 
interindividual variation in cognitive functioning in older participants when compared to younger 
ones (Christensen et al., 1994); however, other studies have failed to replicate these findings (for 
a review, see Christensen et al., 1994). Such increased individual differences are believed to 
result from changes in genetic and/or environmental contributions to cognitive performance 
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associated with aging (Finkel, Pedersen, Plomin, & McClearn, 1998). For example, age-related 
increases or decreases in genetic expression, as well as the accumulation of both genetic effects 
and environmental experiences and insults throughout the lifespan, may all contribute to greater 
interindividual variation in older age. This is consistent with the findings of the current study that 
suggest that the accumulation of NRG1 SNP effects, as well as other factors, may impact 
cognition late in life. However, given that the most common genotype pattern was complex, 
rather than one of the prototypical patterns, it may be that NRG1’s genotype patterns are 
generally complex across the lifespan and that no simple, clear pattern actually exists. 
4.4 SPECULATIONS AND FUTURE HYPOTHESES 
Although the findings of the current study are largely not significant after correction for multiple 
comparisons and thus may not replicate, these preliminary findings warrant further speculation 
and investigation as they may hint at previously unknown relationships between NRG1 and the 
progressive changes associated with schizophrenia.  
The idea of a progressive neurodevelopmental disorder is not inconsistent with the 
aforementioned early and late neurodevelopmental hypotheses of schizophrenia. Rather, it 
suggests that molecular changes continue over the lifespan in individuals with schizophrenia due 
to genetic, environmental, and gene x environment influences. The most well-replicated finding 
of this progression is a reduction in brain volume that is present at the time of disorder onset, but 
continues over the lifespan in at least some patients. Overall cerebral volume is typically seen 
with a corresponding increase in cerebrospinal fluid, with specific areas of tissue reduction 
evident in frontal and temporal white and grey matter regions (for a review, see Dutt et al., 2009, 
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and Andreasen et al., 2011). At present, there are relatively few studies of the genetic effects that 
are related to these structural changes, however.  
One hypothesis emergent from the current study is that there may be a genetic association 
between NRG1 variants and these structural changes due to the numerous roles that NRG1 plays 
in neurodevelopment and the continued function of the brain throughout the lifespan. Indeed, 
there is some evidence for this idea. Two recent studies showed that the NRG1 markers were 
genetically associated with reduced hippocampal volume (Gruber et al., 2008) and enlarged 
lateral ventricles (Mata et al., 2009) in patients with schizophrenia; however, these findings were 
not supported by a more recent study (Dutt et al., 2009). In the only known study (Andreasen et 
al., 2011) of epistatic, or interactional, genetic effects of NRG1 and progressive brain changes, 
Andreasen et al. (2011) found an interaction between variants in NRG1 and Reelin that was 
associated with small increases, rather than decreases, in the volume of the caudate and putamen 
in a longitudinally followed schizophrenia sample.  
Overall, these findings suggest that NRG1 may have a role in the progressive brain 
changes seen in patients with schizophrenia, which is consistent with the findings in the current 
study that showed increasing genotypic effects of the gene late in life in multiple cognitive 
domains. However, the mechanisms behind these changes have yet to be identified. It may be 
that the roles that NRG1 originally plays in the early development of the CNS are ongoing in the 
brains of patients with schizophrenia, impacting processes such as synaptic maintenance later in 
life in patients compared to healthy individuals and resulting in progressive changes. Such 
questions may be answered once the ways in which NRG1 SNPs regulate NRG1 expression or 
are related to other downstream biological changes have been identified. 
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4.5 STRENGTHS AND LIMITATIONS 
To our knowledge, this is the first study of its kind, as previous studies on this topic have relied 
on gene expression analyses in post-mortem samples without antemortem cognitive assessment 
or have neglected to take into account age effects across adolescence – late adulthood when 
assessing genotype-phenotype relationships. This study is unique because of the lifespan 
developmental approach that was employed in the investigation of genetic effects on cognition in 
schizophrenia. In addition, the use of the large, multigenerational, multiplex family sample is a 
powerful study design and the sample had a very wide age range that captured much of the risk 
period for psychosis conversion and into late life. Moreover, existing studies typically assesses 
only a few cognitive domains and a few SNPs, while the current study used a comprehensive 
cognitive battery and large number of NRG1 SNPs. 
Despite these strengths, the current study has some limitations. First, very few findings 
survived correction by a modified Bonferroni correction, suggesting that although these findings 
may be promising, they must be replicated in a larger, better powered sample to be considered 
convincing. At the nominal significance level of .05, statistical power was good (power = .80) 
for analyses that included both affected and unaffected individuals, being able to detect effects 
that accounted for approximately 1% of trait variance. However, power was reduced for analyses 
that included only the unaffected sample and was further reduced when correcting for multiple 
comparisons.  
In addition, although much of the risk period for conversion to psychosis was captured by 
the age ranges present in this sample, the number of teenagers in the sample was relatively small, 
and there were no participants in the sample under the age of 15 years. It is important to increase 
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the number of participants aged 10-20 years old to better detect any amplification of genetic 
effects related to age of onset.  
Moreover, all of the interpretations of the current study’s findings with reference to 
schizophrenia depend on the presence of an etiological relationship between NRG1 and 
schizophrenia. Although NRG1 is a strong functional candidate for schizophrenia and many 
genetic studies of schizophrenia have found linkage and association to the 8p chromosomal 
region and to NRG1 specifically, a number have found no relationship, including multiple large 
genome-wide studies. In the current study, the relationship between NRG1 and schizophrenia 
was not specifically assessed due to the small number of schizophrenia patients in the sample. 
This prevented the investigation of these interactions in a patient-only sample which may have 
helped elucidate the relationship between NRG1 and schizophrenia further. This study also 
lacked a genotyped control group, preventing the assessment of these findings in a non-
schizophrenia-related sample, and thus we are unable to determine whether the patterns found in 
the current sample also exist in the general population. 
The current study also utilized a cross-sectional design that confounds age with birth 
cohort effects. A prospective longitudinal study design would have allowed investigation of age 
effects without possible birth cohort-related concerns that might be particularly strong on 
cognitive function and intelligence level. Although it is difficult to separate cohort effects from 
the effects of age-related changes in a cross-sectional design, the lack of age effects on WRAT 
scores suggests an absence of cohort effects on verbal intelligence, and perhaps other cognitive 
domains as well. 
Although some of the individuals in this study who were unaffected at the time of 
participation may go on to develop schizophrenia, at the time of their clinical evaluation and 
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study participation, they had no history of this disorder and were found to be free of the disorder 
and the increased variance that accompanies it (e.g., due to symptoms, medication effects and 
side effects, and a history of prolonged hospitalization). Thus their performance reflects that of 
an individual at higher risk for the disorder, which was the goal of the multiplex family design.  
Finally, although a literature based SNP set was utilized in this study, a more 
comprehensive tag SNP (tSNP) design might have further elucidated the individual NRG1 SNPs 
that are important in cognitive performance. However, an estimated 348 NRG1 SNPs are needed 
for tSNP designs due to the size and complexity of this gene. 
4.6 FUTURE DIRECTIONS 
Future directions aimed at resolving the limitations in the current study include replicating this 
study with a well-powered relative sample that includes a large teenage cohort. In addition, it 
may be informative to replicate these findings in a schizophrenia sample and healthy control 
sample. Of particular interest would be replications within the domains of Emotional Processing, 
Abstraction/Mental Flexibility, Attention, and Sensorimotor Dexterity and the markers 
SNP8NRG221132, SNP8NRG221533/rs35753505, rs776401, and rs1473438, as these domains 
and SNPs showed the most number of nominally and/or Bonferroni-corrected significant 
interactions. These replications would help evaluate, and possibly support, the findings presented 
in the current study, and would allow a better understanding of the role that these interactions 
play in the teenage years, as well as in patients and the general population. Importantly, if these 
results were replicated in a healthy sample, that would suggest that NRG1 x age interactions on 
cognitive performance are present in the general population. 
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 Other directions in answering the question of NRG1 x age interactions with 
reference to cognition include studying additional markers within NRG1, such as a tSNP set or 
the microsatellites previously associated with schizophrenia (T. Li et al., 2004; Stefansson et al., 
2003; Stefansson et al., 2002). Additionally, the use of methods and models that incorporate 
epistatic and environmental influences that might play a moderating role in these interactions 
may be helpful in better understanding these relationships. There is evidence that variations in 
both NRG1 and the ErbB receptor tyrosine kinase family may be associated with an elevated risk 
for schizophrenia (Benzel et al., 2007; Norton et al., 2006), thus studies of the NRG1-ErbB 
signaling pathway may further elucidate the pathophysiology of schizophrenia-related cognitive 
dysfunction as it pertains to NRG1 and age. Finally, incorporation of NRG1 genetic studies into 
longitudinal studies of the progressive brain changes related to psychosis may also further 
elucidate the late emerging genotype effects seen in the current study.  
4.7 CONCLUSIONS 
Overall, the current study found a number of nominally significant NRG1 SNP x age interactions 
across several cognitive domains and individual genetic markers, although very few withstood 
correction for multiple comparisons, and thus it may be the case that these nominally significant 
findings represent alpha error.  
However, there were a number of nominally significant findings present in several the 
domains of Emotional Processing, Abstraction/Mental Flexibility, Attention, and Sensorimotor 
Dexterity, perhaps suggesting that these domains do show truly significant relationships with 
NRG1 SNPs and age that would be replicated with a larger sample. The patterns seen here 
suggest that NRG1’s effects are generally consistent across early and mid-life, and as such, may 
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have no special role in explaining schizophrenia’s peak age of onset. There were, however, some 
interesting patterns found later in life. Although these are likely not informative for 
schizophrenia onset, they may suggest that NRG1 SNP effects are important for the hypothesis 
that schizophrenia is a neurodevelopmental disorder characterized by progressive brain and 
molecular changes throughout the lifespan. The findings of the current study may suggest a role 
for NRG1 and its related signaling networks in these ongoing processes.  
In addition, these SNP effects may be important for understanding cognition throughout 
the lifespan outside of the context of schizophrenia. This seems particularly true for 
Sensorimotor Dexterity performance, which although having the most interactions and the only 
interactions that withstood correction for multiple comparisons, was not significantly genetically 
correlated with schizophrenia. This may suggest that NRG1 x age interactions are relevant to 
cognitive function in the general population, especially in this domain.  
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